sampleID	AJCC_Stage_nature2012	Age_at_Initial_Pathologic_Diagnosis_nature2012	CN_Clusters_nature2012	Converted_Stage_nature2012	Days_to_Date_of_Last_Contact_nature2012	Days_to_date_of_Death_nature2012	ER_Status_nature2012	Gender_nature2012	HER2_Final_Status_nature2012	Integrated_Clusters_no_exp__nature2012	Integrated_Clusters_unsup_exp__nature2012	Integrated_Clusters_with_PAM50__nature2012	Metastasis_Coded_nature2012	Metastasis_nature2012	Node_Coded_nature2012	Node_nature2012	OS_Time_nature2012	OS_event_nature2012	PAM50Call_RNAseq	PAM50_mRNA_nature2012	PR_Status_nature2012	RPPA_Clusters_nature2012	SigClust_Intrinsic_mRNA_nature2012	SigClust_Unsupervised_mRNA_nature2012	Survival_Data_Form_nature2012	Tumor_T1_Coded_nature2012	Tumor_nature2012	Vital_Status_nature2012	_INTEGRATION	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_BRCA	_PANCAN_DNAMethyl_PANCAN	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_BRCA	_PANCAN_mutation_PANCAN	_PATIENT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_surgery_metastatic_procedure	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	breast_cancer_surgery_margin_status	breast_carcinoma_estrogen_receptor_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_pos_cell_score	breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_progesterone_receptor_status	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr	days_to_additional_surgery_locoregional_procedure	days_to_additional_surgery_metastatic_procedure	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	disease_code	distant_metastasis_present_ind2	er_detection_method_text	er_level_cell_percentage_category	fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng	followup_case_report_form_submission_reason	form_completion_date	gender	her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt	her2_erbb_method_calculation_method_text	her2_erbb_pos_finding_cell_percent_category	her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt	her2_immunohistochemistry_level_result	her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt	her2_neu_breast_carcinoma_copy_analysis_input_total_number	her2_neu_chromosone_17_signal_ratio_value	her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr	histological_type	histological_type_other	history_of_neoadjuvant_treatment	hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr	icd_10	icd_o_3_histology	icd_o_3_site	immunohistochemistry_positive_cell_score	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	lab_proc_her2_neu_immunohistochemistry_receptor_status	lab_procedure_her2_neu_in_situ_hybrid_outcome_type	lost_follow_up	lymph_node_examined_count	margin_status	menopause_status	metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt	metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts	metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt	metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt	metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl	metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr	metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ	metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt	metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt	metastatic_breast_carcinoma_progesterone_receptor_status	metastatic_site_at_diagnosis	metastatic_site_at_diagnosis_other	methylation_Clusters_nature2012	miRNA_Clusters_nature2012	mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn	mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn	mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	oct_embedded	other_dx	pathologic_M	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	patient_id	person_neoplasm_cancer_status	pgr_detection_method_text	pos_finding_her2_erbb2_other_measurement_scale_text	pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt	pos_finding_progesterone_receptor_other_measurement_scale_text	positive_finding_estrogen_receptor_other_measurement_scale_text	postoperative_rx_tx	primary_lymph_node_presentation_assessment	progesterone_receptor_level_cell_percent_category	project_code	radiation_therapy	sample_type	sample_type_id	surgical_procedure_purpose_other_text	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	vial_number	vital_status	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_BRCA_RPPA_RBN	_GENOMIC_ID_TCGA_BRCA_mutation	_GENOMIC_ID_TCGA_BRCA_PDMRNAseq	_GENOMIC_ID_TCGA_BRCA_hMethyl450	_GENOMIC_ID_TCGA_BRCA_RPPA	_GENOMIC_ID_TCGA_BRCA_PDMRNAseqCNV	_GENOMIC_ID_TCGA_BRCA_mutation_curated_wustl_gene	_GENOMIC_ID_TCGA_BRCA_hMethyl27	_GENOMIC_ID_TCGA_BRCA_PDMarrayCNV	_GENOMIC_ID_TCGA_BRCA_miRNA_HiSeq	_GENOMIC_ID_TCGA_BRCA_mutation_wustl_gene	_GENOMIC_ID_TCGA_BRCA_miRNA_GA	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_percentile	_GENOMIC_ID_data/public/TCGA/BRCA/miRNA_GA_gene	_GENOMIC_ID_TCGA_BRCA_gistic2thd	_GENOMIC_ID_data/public/TCGA/BRCA/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_BRCA_G4502A_07_3	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2	_GENOMIC_ID_TCGA_BRCA_gistic2	_GENOMIC_ID_TCGA_BRCA_PDMarray
TCGA-5T-A9QA-01																													TCGA-5T-A9QA-01										TCGA-5T-A9QA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52.0	Left	No axillary staging		TCGA-5T-A9QA-F66889	TCGA-5T-A9QA	TCGA-5T-A9QA-01A		Positive	3 Point Scale				Negative			NO			-19031.0	31.0		0.0	303.0							70-79%			2014-10-25	FEMALE			10-19%		2+					Other, specify		No		C50.9	8523/3	C50.9	2+	YES		Excisional Biopsy	650.0	NO	Equivocal	Negative	NO																																NO			True	No	MX	NX	T2	Stage IIA	TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22.pdf	A9QA							YES	NO			YES	Primary Tumor	1		7th		YES	NO	5T	Breast	A	LIVING	2013.0	41ab76d7-fae0-490c-9545-be576b64b827	41ab76d7-fae0-490c-9545-be576b64b827			TCGA-5T-A9QA-01	TCGA-5T-A9QA-01A-11D-A41Q-05	9E71A150-8FD7-466C-96AF-AAB29520BCDC	TCGA-5T-A9QA-01				TCGA-5T-A9QA-01			41ab76d7-fae0-490c-9545-be576b64b827		TCGA-5T-A9QA-01A-11D-A41E-01	TCGA-5T-A9QA-01		41ab76d7-fae0-490c-9545-be576b64b827	TCGA-5T-A9QA-01A-11D-A41E-01	
TCGA-A2-A04T-01	Stage IIA	62.0	1.0	Stage IIA	2246.0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	2246.0	0.0	Basal	Basal-like	Negative	Basal	-13.0	-12.0	followup	T_Other	T2	LIVING	TCGA-A2-A04T-01	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 5		TCGA-A2-A04T	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62.0	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A04T-F9343	TCGA-A2-A04T	TCGA-A2-A04T-01A		Negative					Negative	Lumpectomy		YES			-22707.0	1979.0		0.0	2246.0							<10%			2011-3-17	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200.0	NO	Equivocal	Negative		3.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5.0	5.0									0.0	0.0	True	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01.pdf	A04T	TUMOR FREE								<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2004.0	79d7a589-60bd-4b4a-89c1-d557fe24c733	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA-A2-A04T-01A-31-A13A-20		TCGA-A2-A04T-01		2724de89-78e5-4da5-b2d9-350a986a8abb	TCGA-A2-A04T-01	TCGA-A2-A04T-01A-21W-A050-09	TCGA-A2-A04T-01A-21D-A032-05	TCGA-A2-A04T-01			TCGA-A2-A04T-01	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA-A2-A04T-01	TCGA-A2-A04T-01A-21D-A036-01		TCGA-A2-A04T-01A-21R-A034-07	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA-A2-A04T-01A-21D-A036-01	TCGA-A2-A04T-01
TCGA-A2-A0CV-01	Stage IIB	41.0	2.0	No_Conversion	1929.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Positive	N1	1929.0	0.0	LumA	Luminal A	Positive	LumA/B	-5.0	-7.0	followup	T_Other	T2	LIVING	TCGA-A2-A0CV-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation c1uster 9	TCGA-A2-A0CV	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41.0	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0CV-F59321	TCGA-A2-A0CV			Positive					Positive	Modified Radical Mastectomy		NO			-15289.0			0.0	3011.0							90-99%		Scheduled Follow-up Submission	2014-5-8	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative	Negative	NO	18.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	6.0								NO	4.0	0.0		No	M0	N1a	T2	Stage IIB		A0CV	TUMOR FREE						YES		90-99%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast		LIVING	2005.0	a8154f60-e391-44b5-b378-c944c5e8621d	a8154f60-e391-44b5-b378-c944c5e8621d	TCGA-A2-A0CV-01A-21-A13B-20	TCGA-A2-A0CV-01A-31D-A10Y-09	TCGA-A2-A0CV-01		b595e1e2-77fa-4ebd-b2d4-054e8b9ca3ae	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31D-A10Y-09	TCGA-A2-A0CV-01A-31D-A112-05	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31D-A10Y-09		a8154f60-e391-44b5-b378-c944c5e8621d		TCGA-A2-A0CV-01A-31D-A111-01	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31R-A115-07	a8154f60-e391-44b5-b378-c944c5e8621d	TCGA-A2-A0CV-01A-31D-A111-01	TCGA-A2-A0CV-01
TCGA-A2-A0EQ-01	Stage IIA	64.0	4.0	Stage IIA	2426.0		Negative	FEMALE	Positive	1.0	1.0	4.0	Negative	M0	Negative	N0	2426.0	0.0	Her2	HER2-enriched	Negative	Basal	-2.0	-5.0	followup	T_Other	T2	LIVING	TCGA-A2-A0EQ-01	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-A2-A0EQ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64.0	Left	Other (specify)	Sentinel lymph node and non-sentinel lymph node biopsy	TCGA-A2-A0EQ-F13720	TCGA-A2-A0EQ		Negative	Negative		0		Lumpectomy	Negative	Lumpectomy		YES			-23543.0			0.0	2426.0							<10%		Scheduled Follow-up Submission	2011-6-13	FEMALE					3+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy			Positive	Negative		2.0	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	5.0								NO	0.0	0.0		No	M0	N0 (i-)	T2	Stage IIA		A0EQ	TUMOR FREE								<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast		LIVING	2004.0	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA-A2-A0EQ-01A-21-A13C-20	TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01		cd49aac8-9c6e-41d7-816c-1bdcb4aaca4a	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01A-11D-A032-05	TCGA-A2-A0EQ-01		TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01A-11D-A036-01		TCGA-A2-A0EQ-01A-11R-A034-07	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA-A2-A0EQ-01A-11D-A036-01	TCGA-A2-A0EQ-01
TCGA-A2-A0ET-01	Stage IIIA	58.0	3.0	No_Conversion	1066.0		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1066.0	0.0	LumA	Luminal A	Positive		-10.0	-3.0	followup	T_Other	T2	LIVING	TCGA-A2-A0ET-01	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A2-A0ET	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0ET-F13713	TCGA-A2-A0ET	TCGA-A2-A0ET-01A		Positive					Positive	Lumpectomy		NO			-21464.0	674.0		0.0	1066.0							90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.09		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	890.0	NO	Equivocal	Negative		15.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	1.0								NO	5.0	0.0	True	No	M0	N2a	T2	Stage IIIA	TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC.pdf	A0ET	TUMOR FREE				Intensity=Strong	Intensity=Strong			70-79%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2008.0	4eb0c00d-595c-47ee-bcad-818c7723656d	4eb0c00d-595c-47ee-bcad-818c7723656d		TCGA-A2-A0ET-01A-31D-A045-09	TCGA-A2-A0ET-01			TCGA-A2-A0ET-01	TCGA-A2-A0ET-01A-31D-A045-09	TCGA-A2-A0ET-01A-31D-A032-05	TCGA-A2-A0ET-01		TCGA-A2-A0ET-01A-31D-A045-09	TCGA-A2-A0ET-01	4eb0c00d-595c-47ee-bcad-818c7723656d	TCGA-A2-A0ET-01	TCGA-A2-A0ET-01A-31D-A036-01		TCGA-A2-A0ET-01A-31R-A034-07	4eb0c00d-595c-47ee-bcad-818c7723656d	TCGA-A2-A0ET-01A-31D-A036-01	TCGA-A2-A0ET-01
TCGA-A2-A0T0-01	Stage IIB	59.0	1.0	No_Conversion	533.0		Negative	FEMALE	Negative	2.0	2.0	2.0	Negative	M0	Positive	N1	533.0	0.0	Basal	Basal-like	Negative	Basal	-13.0	0.0	followup	T_Other	T2	LIVING	TCGA-A2-A0T0-01	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 12	TCGA-A2-A0T0	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59.0	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0T0-F13944	TCGA-A2-A0T0	TCGA-A2-A0T0-01A		Negative					Negative	Lumpectomy		NO			-21575.0	268.0		0.0	533.0							<10%		Scheduled Follow-up Submission	2011-7-18	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190.0	NO	Negative			14.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5.0	5.0								NO	2.0		True	No	M0	N1	T2	Stage IIB	TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096.pdf	A0T0	TUMOR FREE								<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2009.0	7e073ecd-452a-4cba-9dfd-8601f3245721	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01A-11-A13D-20	TCGA-A2-A0T0-01A-22D-A099-09	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01A-22D-A10P-05	87565b35-30bd-4e31-bb26-404baf053cdc	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01A-22D-A099-09		TCGA-A2-A0T0-01		TCGA-A2-A0T0-01A-22D-A099-09	TCGA-A2-A0T0-01	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01A-22D-A087-01		TCGA-A2-A0T0-01A-22R-A084-07	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01A-22D-A087-01	TCGA-A2-A0T0-01
TCGA-A2-A0YG-01	Stage IIIC	63.0	5.0	No_Conversion	665.0		Positive	FEMALE	Positive	1.0	1.0	4.0	Negative	M0	Positive	N3	665.0	0.0	LumB	Luminal B	Positive	Her2	-2.0	-5.0	followup	T_Other	T2	LIVING	TCGA-A2-A0YG-01	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-A2-A0YG	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0YG-F16753	TCGA-A2-A0YG	TCGA-A2-A0YG-01A		Positive		2+			Positive	Lumpectomy		NO			-23058.0	329.0		0.0	666.0							90-99%		Scheduled Follow-up Submission	2011-9-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	1530.0	NO	Positive			18.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0								NO	14.0		True	No	M0	N3a	T2	Stage IIIC	TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5.pdf	A0YG	TUMOR FREE								<10%		YES	Primary Tumor	1			YES	NO	YES	A2	Breast	A	LIVING	2009.0	c539f561-93db-41f3-8d9f-71cd77a096a7	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01A-31-A13D-20	TCGA-A2-A0YG-01A-21D-A10G-09	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01A-21D-A10A-05	2d2789e0-0933-496a-a29b-63c0b05cfa19	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01A-21D-A10G-09		TCGA-A2-A0YG-01		TCGA-A2-A0YG-01A-21D-A10G-09	TCGA-A2-A0YG-01	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01A-21D-A107-01		TCGA-A2-A0YG-01A-21R-A109-07	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01A-21D-A107-01	TCGA-A2-A0YG-01
TCGA-A2-A0YK-01	Stage IIA	61.0	5.0	Stage IIA	587.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Negative	N0	587.0	0.0	Normal	Normal-like	Negative	ReacII	-5.0	-7.0	followup	T_Other	T2	LIVING	TCGA-A2-A0YK-01	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A0YK	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61.0	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0YK-F16750	TCGA-A2-A0YK	TCGA-A2-A0YK-01A		Positive					Negative	Simple Mastectomy		YES			-22625.0	280.0		0.0	588.0							90-99%		Scheduled Follow-up Submission	2011-9-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	620.0	NO	Negative			3.0	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1.0	6.0								NO	0.0	0.0	True	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0YK.C3B5F075-864A-4D8B-B0CB-1B1FA28ACF4F.pdf	A0YK	TUMOR FREE								<10%		NO	Primary Tumor	1			YES	NO	YES	A2	Breast	A	LIVING	2009.0	ae614f7b-b310-4c60-bd50-9e02be984943	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01A-31-A13D-20	TCGA-A2-A0YK-01A-22D-A117-09	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01A-22D-A10A-05	07e19b85-cee6-4ea4-8588-5df93bf33053	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01A-22D-A117-09		TCGA-A2-A0YK-01		TCGA-A2-A0YK-01A-22D-A117-09	TCGA-A2-A0YK-01	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01A-22D-A107-01		TCGA-A2-A0YK-01A-22R-A109-07	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01A-22D-A107-01	TCGA-A2-A0YK-01
TCGA-A2-A25A-01	Stage IIA	44.0	2.0	Stage IIA	2968.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2968.0	0.0	Normal		Positive				enrollment	T_Other	T2	LIVING	TCGA-A2-A25A-01	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation cluster 4	TCGA-A2-A25A	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44.0	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-A2-A25A-F30927	TCGA-A2-A25A	TCGA-A2-A25A-01A		Positive					Positive	Simple Mastectomy		YES			-16084.0	2927.0		0.0	3276.0					NO		<10%		Scheduled Follow-up Submission	2012-4-19	FEMALE					2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160.0	NO	Equivocal	Negative		14.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4.0									NO	0.0	0.0	True	Yes	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf	A25A	TUMOR FREE							YES	<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2003.0	50c720f4-dbcb-4b8b-9808-d130f5197d27	50c720f4-dbcb-4b8b-9808-d130f5197d27	TCGA-A2-A25A-01A-21-A17I-20	TCGA-A2-A25A-01A-12D-A16D-09	TCGA-A2-A25A-01	TCGA-A2-A25A-01A-12D-A16G-05	bf3c63c7-643e-43b2-b5ea-3c2185ba9238	TCGA-A2-A25A-01	TCGA-A2-A25A-01A-12D-A16D-09			TCGA-A2-A25A-01	TCGA-A2-A25A-01A-12D-A16D-09		50c720f4-dbcb-4b8b-9808-d130f5197d27		TCGA-A2-A25A-01A-12D-A16C-01	TCGA-A2-A25A-01		50c720f4-dbcb-4b8b-9808-d130f5197d27	TCGA-A2-A25A-01A-12D-A16C-01	
TCGA-A2-A3Y0-01																													TCGA-A2-A3Y0-01										TCGA-A2-A3Y0	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A3Y0-F59118	TCGA-A2-A3Y0	TCGA-A2-A3Y0-01A		Positive	3 Point Scale				Negative	Modified Radical Mastectomy		NO			-21024.0	845.0		0.0	1546.0							90-99%			2014-5-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	850.0	NO	Negative		NO	39.0	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1.0	0.0	True	No	M0	N1a	T2	Stage IIB	TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC.pdf	A3Y0	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		NO	YES	A2	Breast	A	LIVING	2010.0	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5			TCGA-A2-A3Y0-01	TCGA-A2-A3Y0-01A-11D-A23D-05		TCGA-A2-A3Y0-01	TCGA-A2-A3Y0-01A-11D-A23C-09			TCGA-A2-A3Y0-01			9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5		TCGA-A2-A3Y0-01A-11D-A238-01	TCGA-A2-A3Y0-01		9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	TCGA-A2-A3Y0-01A-11D-A238-01	
TCGA-A7-A0CE-11		57.0			309.0			FEMALE									309.0	0.0							followup			LIVING	TCGA-A7-A0CE-11		C4-BRCA/Basal							mutation cluster 5	TCGA-A7-A0CE	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57.0	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CE-F39153	TCGA-A7-A0CE	TCGA-A7-A0CE-11A		Negative					Negative	Lumpectomy		YES			-20863.0	129.0		0.0	1074.0							<10%	2.9		2013-1-14	FEMALE	Vysis AutoVysion System			PathVysion	2+	389.0	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290.0	NO	Equivocal	Negative	NO	1.0	Negative	Indeterminate (neither Pre or Postmenopausal)																													NO	0.0	0.0	False	No	M0	N0 (i-)	T2	Stage IIA		A0CE	TUMOR FREE						YES		<10%		YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009.0	2d5351f1-e9d7-44a3-ae43-f595a0151516	2d5351f1-e9d7-44a3-ae43-f595a0151516				TCGA-A7-A0CE-11A-21D-A10Q-05								TCGA-A7-A0CE-11	2d5351f1-e9d7-44a3-ae43-f595a0151516	TCGA-A7-A0CE-11			TCGA-A7-A0CE-11A-21R-A089-07	2d5351f1-e9d7-44a3-ae43-f595a0151516		
TCGA-A7-A0CH-11		79.0			232.0			FEMALE									232.0	0.0							followup			LIVING	TCGA-A7-A0CH-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0CH	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79.0	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-A7-A0CH-F39148	TCGA-A7-A0CH	TCGA-A7-A0CH-11A								Simple Mastectomy		YES			-29104.0	121.0		0.0	1079.0										2013-1-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	390.0	NO			NO	2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	False	No	M0	N0 (i-)	T2	Stage IIA		A0CH	TUMOR FREE						YES				NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009.0	a4b19504-8f04-48db-b88b-d76b8b3c3881	a4b19504-8f04-48db-b88b-d76b8b3c3881				TCGA-A7-A0CH-11A-32D-A10Q-05									a4b19504-8f04-48db-b88b-d76b8b3c3881				TCGA-A7-A0CH-11A-32R-A089-07	a4b19504-8f04-48db-b88b-d76b8b3c3881		
TCGA-A7-A0D9-11		37.0			272.0			FEMALE									272.0	0.0	Normal						followup			LIVING	TCGA-A7-A0D9-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0D9	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37.0	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-A7-A0D9-F39771	TCGA-A7-A0D9	TCGA-A7-A0D9-11A		Positive					Negative	Simple Mastectomy		YES			-13836.0	173.0		0.0	1139.0							90-99%			2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1830.0	NO	Negative		NO	1.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0.0	0.0	False	No	M0	N0 (i-)	T2	Stage IIA		A0D9	TUMOR FREE						YES		<10%		NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009.0	fc5bb351-c5f7-4d8c-850c-13e69e13e04d	fc5bb351-c5f7-4d8c-850c-13e69e13e04d				TCGA-A7-A0D9-11A-53D-A10Q-05									fc5bb351-c5f7-4d8c-850c-13e69e13e04d				TCGA-A7-A0D9-11A-53R-A089-07	fc5bb351-c5f7-4d8c-850c-13e69e13e04d		
TCGA-A7-A0DA-01	Stage IIA	62.0	1.0	Stage IIA	373.0		Negative	FEMALE	Negative	2.0	2.0	2.0	Negative	M0	Negative	N0	373.0	0.0	Basal	Basal-like	Negative	X	-13.0	0.0	followup	T_Other	T2	LIVING	TCGA-A7-A0DA-01	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 4	mutation cluster 13	TCGA-A7-A0DA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62.0	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DA-F38487	TCGA-A7-A0DA	TCGA-A7-A0DA-01A		Negative					Negative	Lumpectomy					-22708.0	177.0		0.0	1085.0										2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	350.0	NO	Negative		NO	1.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5.0	4.0								NO	0.0		False	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510.pdf	A0DA	TUMOR FREE						YES				YES	Primary Tumor	1			YES	YES	NO	A7	Breast	A	LIVING	2009.0	9d04c180-7c23-490e-92cf-c018629b8b7f	9d04c180-7c23-490e-92cf-c018629b8b7f	TCGA-A7-A0DA-01A-11-A13C-20	TCGA-A7-A0DA-01A-31D-A10Y-09	TCGA-A7-A0DA-01		190fcd17-0d7a-4d28-9958-492d56360678	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31D-A10Y-09	TCGA-A7-A0DA-01A-31D-A112-05	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31D-A10Y-09		9d04c180-7c23-490e-92cf-c018629b8b7f		TCGA-A7-A0DA-01A-31D-A111-01	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31R-A115-07	9d04c180-7c23-490e-92cf-c018629b8b7f	TCGA-A7-A0DA-01A-31D-A111-01	TCGA-A7-A0DA-01
TCGA-A7-A0DB-11		56.0			266.0			FEMALE									266.0	0.0	Normal						followup			LIVING	TCGA-A7-A0DB-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0DB	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56.0	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DB-F38479	TCGA-A7-A0DB	TCGA-A7-A0DB-11A		Positive					Positive	Simple Mastectomy		YES			-20570.0	167.0		0.0	1007.0				FPPP			90-99%			2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400.0	NO	Negative		NO	4.0	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	False	No	M0	N0 (i-)	T2	Stage IIA		A0DB	TUMOR FREE						YES		60-69%	TCGA	YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009.0	3f3bdfbb-3490-42e4-9511-9df4b8a126a3	3f3bdfbb-3490-42e4-9511-9df4b8a126a3				TCGA-A7-A0DB-11A-33D-A093-05									3f3bdfbb-3490-42e4-9511-9df4b8a126a3				TCGA-A7-A0DB-11A-33R-A089-07	3f3bdfbb-3490-42e4-9511-9df4b8a126a3		
TCGA-A7-A0DC-11		63.0			386.0			FEMALE									386.0	0.0	Normal						followup			LIVING	TCGA-A7-A0DC-11										TCGA-A7-A0DC	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63.0	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DC-F40607	TCGA-A7-A0DC	TCGA-A7-A0DC-11A		Positive					Negative	Simple Mastectomy		YES			-23294.0	238.0		0.0	906.0							90-99%			2013-2-25	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	470.0	NO	Negative		NO	3.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	False	No	M0	N0 (i-)	T1c	Stage IA		A0DC	TUMOR FREE						YES		<10%		YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009.0	cb3f974e-6bce-4757-a350-aef8e7925086	cb3f974e-6bce-4757-a350-aef8e7925086				TCGA-A7-A0DC-11A-41D-A10Q-05									cb3f974e-6bce-4757-a350-aef8e7925086				TCGA-A7-A0DC-11A-41R-A089-07	cb3f974e-6bce-4757-a350-aef8e7925086		
TCGA-A7-A13E-11		62.0			326.0			FEMALE									326.0	0.0	Normal						followup			LIVING	TCGA-A7-A13E-11		C4-BRCA/Basal								TCGA-A7-A13E	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		62.0	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13E-F30405	TCGA-A7-A13E	TCGA-A7-A13E-11A		Positive					Negative	Lumpectomy		NO			-22690.0	220.0	614.0	0.0	326.0			556	FPPP			20-29%	3.0	Additional New Tumor Event	2012-4-9	FEMALE				PathVysion HER-2 D Probe Kit	2+	561.0	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	770.0	NO	Equivocal	Negative		12.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Negative												Negative								Other, specify	Distant Metastasis	Lung, Bone, Liver, Brain and Skin Nodules		YES	2.0		False	No	MX	N1	T2	Stage IIB		A13E	WITH TUMOR								<10%	TCGA	NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	DECEASED	2010.0	80efdbaa-067b-4018-89b2-b8869bfb9163	80efdbaa-067b-4018-89b2-b8869bfb9163				TCGA-A7-A13E-11A-61D-A12R-05	E408026E-6C07-4F2E-A609-29F21E997938					TCGA-A7-A13E-11			80efdbaa-067b-4018-89b2-b8869bfb9163			TCGA-A7-A13E-11	TCGA-A7-A13E-11A-61R-A12P-07	80efdbaa-067b-4018-89b2-b8869bfb9163		
TCGA-A7-A13F-11		44.0			387.0			FEMALE									387.0	0.0	Normal						followup			LIVING	TCGA-A7-A13F-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-A7-A13F	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44.0	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13F-F39779	TCGA-A7-A13F	TCGA-A7-A13F-11A		Positive					Positive	Modified Radical Mastectomy		NO			-16363.0	121.0		0.0	765.0								2.8	Scheduled Follow-up Submission	2013-2-1	FEMALE				PathVysion HER-2 D Probe Kit	2+	403.0	3.0	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	960.0	NO	Equivocal	Negative	NO	11.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	3.0		False	No	M0	N1a	T3	Stage IIIA		A13F	TUMOR FREE						YES				YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2010.0	82f3157c-09cc-40d7-872e-59f82f5f31f4	82f3157c-09cc-40d7-872e-59f82f5f31f4				TCGA-A7-A13F-11A-42D-A12R-05	2F10F1D9-54A0-42EB-B9B7-C9733D431824					TCGA-A7-A13F-11			82f3157c-09cc-40d7-872e-59f82f5f31f4			TCGA-A7-A13F-11	TCGA-A7-A13F-11A-42R-A12P-07	82f3157c-09cc-40d7-872e-59f82f5f31f4		
TCGA-A7-A13G-11		79.0			348.0			FEMALE									348.0	0.0	LumA						followup			LIVING	TCGA-A7-A13G-11									mutation cluster 4	TCGA-A7-A13G	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			79.0	Left	Sentinel node biopsy alone		TCGA-A7-A13G-F35039	TCGA-A7-A13G	TCGA-A7-A13G-11A		Positive					Positive	Simple Mastectomy		NO			-28969.0	69.0		0.0	718.0		586.0	586		NO		90-99%		Scheduled Follow-up Submission	2012-9-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	880.0	NO	Negative		NO	1.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	New Primary Tumor	Skin, right leg	YES	YES	0.0		False	Yes	MX	N0	T2	Stage IIA		A13G	TUMOR FREE						YES	YES	50-59%		NO	Solid Tissue Normal	11		7th	YES	YES	NO	A7	Breast	A	LIVING	2010.0	76f30f56-7b80-4938-b514-1e1c2d24ff66	76f30f56-7b80-4938-b514-1e1c2d24ff66				TCGA-A7-A13G-11A-51D-A13T-05									76f30f56-7b80-4938-b514-1e1c2d24ff66					76f30f56-7b80-4938-b514-1e1c2d24ff66		
TCGA-A7-A13H-01																													TCGA-A7-A13H-01	Iq			BRCA non-CIMP c9			miRNA cluster 4			TCGA-A7-A13H	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			61.0	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13H-F41651	TCGA-A7-A13H	TCGA-A7-A13H-01A		Positive					Positive	Simple Mastectomy		YES			-22643.0	62.0		0.0	899.0		840.0	795		NO		80-89%	2.7		2013-3-25	FEMALE				Pathvysion HER2 D Probe Kit	2+	371.0	3.2	2.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140.0	NO	Equivocal	Negative	NO	12.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	New Primary Tumor	Skin lesion-Basal Cell Left Lower Lateral Back	YES	YES	2.0	2.0	False	No	MX	N1a	T2	Stage IIB	TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf	A13H	TUMOR FREE						NO	YES	30-39%		NO	Primary Tumor	1		7th		YES	NO	A7	Breast	A	LIVING	2010.0	4f0fdfc6-6578-4d9a-92ae-6d82291a3785	4f0fdfc6-6578-4d9a-92ae-6d82291a3785			TCGA-A7-A13H-01	TCGA-A7-A13H-01A-11D-A22B-05		TCGA-A7-A13H-01	TCGA-A7-A13H-01A-11D-A228-09			TCGA-A7-A13H-01			4f0fdfc6-6578-4d9a-92ae-6d82291a3785		TCGA-A7-A13H-01A-11D-A227-01	TCGA-A7-A13H-01		4f0fdfc6-6578-4d9a-92ae-6d82291a3785	TCGA-A7-A13H-01A-11D-A227-01	
TCGA-A7-A26I-01	Stage IIA	65.0	1.0	Stage IIA	122.0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	122.0	0.0	Basal		Negative				enrollment	T_Other	T2	LIVING	TCGA-A7-A26I-01	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4		mutation cluster 5	TCGA-A7-A26I	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65.0	Left	Axillary lymph node dissection alone		TCGA-A7-A26I-F39791	TCGA-A7-A26I	TCGA-A7-A26I-01A	Negative	Negative				Other	Negative	Lumpectomy	Re-Excision of Superior Margin	NO			-23948.0	40.0		0.0	661.0					NO			2.0	Scheduled Follow-up Submission	2013-2-1	FEMALE				Path Vysion HER-2 D probe kit	2+	229.0	2.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	120.0	NO	Equivocal	Negative	NO	2.0	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5.0									NO	0.0		False	Yes	M0	N0	T2	Stage IIA	TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf	A26I	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th	YES	YES	NO	A7	Breast	A	LIVING	2011.0	5610fa97-eac4-4306-aead-983ee6570baf	5610fa97-eac4-4306-aead-983ee6570baf	TCGA-A7-A26I-01A-21-A17I-20	TCGA-A7-A26I-01A-11D-A167-09	TCGA-A7-A26I-01	TCGA-A7-A26I-01A-11D-A16A-05	c74b933c-9dd5-42a6-a906-4951a21e8bc2	TCGA-A7-A26I-01	TCGA-A7-A26I-01A-11D-A167-09,TCGA-A7-A26I-01B-06D-A22N-09			TCGA-A7-A26I-01	TCGA-A7-A26I-01A-11D-A167-09		5610fa97-eac4-4306-aead-983ee6570baf		TCGA-A7-A26I-01A-11D-A166-01	TCGA-A7-A26I-01		5610fa97-eac4-4306-aead-983ee6570baf	TCGA-A7-A26I-01A-11D-A166-01	
TCGA-A7-A26J-01	Stage IIA	49.0	3.0	Stage IIA	67.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	67.0	0.0	LumA		Positive				enrollment	T_Other	T2	LIVING	TCGA-A7-A26J-01	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A7-A26J	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49.0	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26J-F39793	TCGA-A7-A26J			Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-17930.0			0.0	627.0				FPPP	NO		90-99%		Scheduled Follow-up Submission	2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	4.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4.0	6.0								NO	0.0			No	M0	N0	T2	Stage IIA		A26J	TUMOR FREE						YES	YES	70-79%	TCGA	NO	Primary Tumor	1		7th	YES	YES	NO	A7	Breast		LIVING	2011.0	ed40061b-ad15-4f91-94ae-ae276394f42d	ed40061b-ad15-4f91-94ae-ae276394f42d		TCGA-A7-A26J-01A-11D-A167-09	TCGA-A7-A26J-01	TCGA-A7-A26J-01B-02D-A27B-05,TCGA-A7-A26J-01A-11D-A27B-05,TCGA-A7-A26J-01A-11D-A16A-05		TCGA-A7-A26J-01	TCGA-A7-A26J-01B-02D-A272-09,TCGA-A7-A26J-01A-11D-A272-09,TCGA-A7-A26J-01A-11D-A167-09			TCGA-A7-A26J-01	TCGA-A7-A26J-01A-11D-A167-09		ed40061b-ad15-4f91-94ae-ae276394f42d		TCGA-A7-A26J-01A-11D-A275-01	TCGA-A7-A26J-01		ed40061b-ad15-4f91-94ae-ae276394f42d	TCGA-A7-A26J-01A-11D-A275-01	
TCGA-A7-A4SA-01																													TCGA-A7-A4SA-01										TCGA-A7-A4SA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40.0	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A4SA-F49560	TCGA-A7-A4SA	TCGA-A7-A4SA-01A		Positive	3 Point Scale				Negative	Simple Mastectomy		YES			-14906.0	127.0		0.0	454.0							80-89%			2013-10-3	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	220.0	NO	Negative		NO	10.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1.0	0.0	False	No	M0	N1a	T2	Stage IIB	TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf	A4SA	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		YES	NO	A7	Breast	A	LIVING	2012.0	781945fb-6d9e-4b45-8082-57675f21dc4a	781945fb-6d9e-4b45-8082-57675f21dc4a			TCGA-A7-A4SA-01	TCGA-A7-A4SA-01A-11D-A268-05	95bdb84b-c36a-4c64-8059-445ebf7adbb4	TCGA-A7-A4SA-01	TCGA-A7-A4SA-01A-11D-A25Q-09			TCGA-A7-A4SA-01			781945fb-6d9e-4b45-8082-57675f21dc4a		TCGA-A7-A4SA-01A-11D-A25N-01	TCGA-A7-A4SA-01		781945fb-6d9e-4b45-8082-57675f21dc4a	TCGA-A7-A4SA-01A-11D-A25N-01	
TCGA-A8-A06U-01	Stage IIB	80.0		Stage IIB	882.0	882.0	Positive	FEMALE	Equivocal				Negative	M0	Positive	N1	882.0	1.0	LumA	Luminal A	Positive	LumA/B	-2.0	-5.0	enrollment	T_Other	T2	DECEASED	TCGA-A8-A06U-01	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06U	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80.0	Right Upper Outer Quadrant			TCGA-A8-A06U-F40817	TCGA-A8-A06U	TCGA-A8-A06U-01A		Positive					Positive	Other					-29525.0	759.0	883.0	0.0											2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			250.0	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0											False	Yes	M0	N1a	T2	Stage IIB	TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16.pdf	A06U	TUMOR FREE										NO	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2008.0	89f9e509-5f4c-439b-b610-860f209332d2	89f9e509-5f4c-439b-b610-860f209332d2	TCGA-A8-A06U-01A-21-A13A-20	TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01		f47ef5b8-45ae-4cd2-915a-ba5f790465bd	TCGA-A8-A06U-01	TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01A-11D-A00Y-05	TCGA-A8-A06U-01		TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01	89f9e509-5f4c-439b-b610-860f209332d2	TCGA-A8-A06U-01	TCGA-A8-A06U-01A-11D-A011-01		TCGA-A8-A06U-01A-11R-A00Z-07	89f9e509-5f4c-439b-b610-860f209332d2	TCGA-A8-A06U-01A-11D-A011-01	TCGA-A8-A06U-01
TCGA-A8-A06X-01	Stage IIB	77.0	1.0	Stage IIB	943.0	943.0	Positive	FEMALE	Positive				Negative	M0	Negative	N0	943.0	1.0	LumB	Luminal B	Negative	LumA/B	-2.0	-5.0	enrollment	T_Other	T3	DECEASED	TCGA-A8-A06X-01	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 10	TCGA-A8-A06X	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77.0	Right Upper Outer Quadrant			TCGA-A8-A06X-F40818	TCGA-A8-A06X	TCGA-A8-A06X-01A		Positive					Negative	Other					-28338.0	1276.0	943.0	0.0											2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			760.0	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3.0												False	No	M0	N0	T3	Stage IIB	TCGA-A8-A06X.738B601A-24D8-4261-B000-198648213070.pdf	A06X	TUMOR FREE										YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2006.0	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	TCGA-A8-A06X-01A-11-A13A-20	TCGA-A8-A06X-01A-21W-A019-09	TCGA-A8-A06X-01		1896a8eb-415e-4b05-aad1-dec8b4a5c473	TCGA-A8-A06X-01	TCGA-A8-A06X-01A-21W-A019-09	TCGA-A8-A06X-01A-21D-A00Y-05	TCGA-A8-A06X-01		TCGA-A8-A06X-01A-21W-A019-09		3ea9e7f1-39af-4089-b1c0-3c62db4e3102		TCGA-A8-A06X-01A-21D-A011-01		TCGA-A8-A06X-01A-21R-A00Z-07	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	TCGA-A8-A06X-01A-21D-A011-01	TCGA-A8-A06X-01
TCGA-A8-A08L-01	Stage IIIA	89.0	1.0	Stage IIIA	304.0	304.0	Positive	FEMALE	Negative	5.0	2.0	1.0	Negative	M0	Positive	N2	304.0	1.0	Her2	HER2-enriched	Negative	X	-2.0	-6.0	enrollment	T_Other	T3	DECEASED	TCGA-A8-A08L-01	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 1	TCGA-A8-A08L	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					89.0	Left			TCGA-A8-A08L-F40847	TCGA-A8-A08L	TCGA-A8-A08L-01A		Positive					Negative	Other					-32842.0	698.0	304.0	0.0											2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			200.0	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	1.0											False	No	M0	N2a	T3	Stage IIIA	TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4.pdf	A08L	TUMOR FREE										YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2008.0	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	TCGA-A8-A08L-01A-21-A13A-20	TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01		7a837782-6edf-48bb-83db-40548ddd2b69	TCGA-A8-A08L-01	TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01A-11D-A00Y-05	TCGA-A8-A08L-01		TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	TCGA-A8-A08L-01	TCGA-A8-A08L-01A-11D-A011-01		TCGA-A8-A08L-01A-11R-A00Z-07	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	TCGA-A8-A08L-01A-11D-A011-01	TCGA-A8-A08L-01
TCGA-A8-A08X-01	Stage IIIC	43.0	3.0	Stage IIIC	1034.0		Negative	FEMALE	Positive	2.0	2.0	1.0	Negative	M0	Positive	N3	1034.0	0.0	Her2	HER2-enriched	Negative	Her2	-13.0	-10.0	enrollment	T_Other	T4	LIVING	TCGA-A8-A08X-01	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A08X	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43.0	Left			TCGA-A8-A08X-F40558	TCGA-A8-A08X	TCGA-A8-A08X-01A		Negative					Negative	Other					-15705.0	941.0		0.0	1308.0			366							2013-2-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			170.0	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1.0	3.0								YES			False	No	M0	N3a	T4d	Stage IIIC	TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558.pdf	A08X	TUMOR FREE						YES				YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007.0	354adce5-6ca4-4d6d-a519-4eabc01c6b36	354adce5-6ca4-4d6d-a519-4eabc01c6b36	TCGA-A8-A08X-01A-11-A13B-20	TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01		3fd8c428-08bb-4598-b3cb-0c4a33fc4eab	TCGA-A8-A08X-01	TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01A-21D-A00Y-05	TCGA-A8-A08X-01		TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01	354adce5-6ca4-4d6d-a519-4eabc01c6b36	TCGA-A8-A08X-01	TCGA-A8-A08X-01A-21D-A011-01		TCGA-A8-A08X-01A-21R-A00Z-07	354adce5-6ca4-4d6d-a519-4eabc01c6b36	TCGA-A8-A08X-01A-21D-A011-01	TCGA-A8-A08X-01
TCGA-A8-A091-01	Stage IIA	61.0	4.0	Stage IIA	580.0		Positive	FEMALE	Negative	1.0	3.0	3.0	Negative	M0	Negative	N0	580.0	0.0	LumA	Luminal A	Negative	LumA/B	-10.0	-3.0	enrollment	T_Other	T2	LIVING	TCGA-A8-A091-01	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A091	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61.0	Right			TCGA-A8-A091-F40557	TCGA-A8-A091	TCGA-A8-A091-01A		Positive					Negative	Other					-22554.0	637.0		0.0	1004.0			243							2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180.0	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	2.0								YES			False	Yes	M0	N0	T2	Stage IIA	TCGA-A8-A091.FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7.pdf	A091	TUMOR FREE						YES				YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008.0	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	TCGA-A8-A091-01A-21-A13B-20	TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01		30426ea5-f884-4216-9435-4ba810f8687e	TCGA-A8-A091-01	TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01A-11D-A00Y-05	TCGA-A8-A091-01		TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	TCGA-A8-A091-01	TCGA-A8-A091-01A-11D-A011-01		TCGA-A8-A091-01A-11R-A00Z-07	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	TCGA-A8-A091-01A-11D-A011-01	TCGA-A8-A091-01
TCGA-A8-A096-01	Stage IIA	73.0	2.0	Stage IIA	0.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0.0	0.0	LumB	Luminal B	Positive		-12.0	-4.0	enrollment	T_Other	T2	LIVING	TCGA-A8-A096-01	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A096	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73.0	Right				TCGA-A8-A096	TCGA-A8-A096-01A		Positive					Positive	Other					-26723.0	394.0		0.0	0.0										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110.0	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0											False	No	M0	N0	T2	Stage IIA	TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6.pdf	A096	TUMOR FREE											Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009.0	7bf79330-52fa-4111-88fe-b3ea62bcc63a	7bf79330-52fa-4111-88fe-b3ea62bcc63a		TCGA-A8-A096-01A-11W-A019-09	TCGA-A8-A096-01			TCGA-A8-A096-01	TCGA-A8-A096-01A-11W-A019-09	TCGA-A8-A096-01A-11D-A00Y-05	TCGA-A8-A096-01		TCGA-A8-A096-01A-11W-A019-09	TCGA-A8-A096-01	7bf79330-52fa-4111-88fe-b3ea62bcc63a	TCGA-A8-A096-01	TCGA-A8-A096-01A-11D-A011-01		TCGA-A8-A096-01A-11R-A00Z-07	7bf79330-52fa-4111-88fe-b3ea62bcc63a	TCGA-A8-A096-01A-11D-A011-01	TCGA-A8-A096-01
TCGA-A8-A09B-01	Stage IIIB	58.0	4.0	Stage IIIB	365.0		Positive	FEMALE	Negative	1.0	3.0	3.0	Negative	M0	Positive	N1	365.0	0.0	LumA	Luminal A	Positive	LumA	0.0	-3.0	enrollment	T_Other	T4	LIVING	TCGA-A8-A09B-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A09B	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58.0	Left			TCGA-A8-A09B-F40550	TCGA-A8-A09B			Positive					Positive	Other					-21520.0			0.0	365.0										2013-2-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0												No	M0	N1a	T4b	Stage IIIB		A09B	TUMOR FREE						YES				YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009.0	df95b9f5-437f-438d-89b4-7c556e79b616	df95b9f5-437f-438d-89b4-7c556e79b616	TCGA-A8-A09B-01A-21-A13B-20	TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01		cc046686-7a84-4a71-8b94-70b2ec82c616	TCGA-A8-A09B-01	TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01A-11D-A00Y-05	TCGA-A8-A09B-01		TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01	df95b9f5-437f-438d-89b4-7c556e79b616	TCGA-A8-A09B-01	TCGA-A8-A09B-01A-11D-A011-01		TCGA-A8-A09B-01A-11R-A00Z-07	df95b9f5-437f-438d-89b4-7c556e79b616	TCGA-A8-A09B-01A-11D-A011-01	TCGA-A8-A09B-01
TCGA-A8-A09I-01	Stage IIA	84.0	5.0	Stage IIA	1006.0		Positive	FEMALE	Positive	1.0	1.0	4.0	Negative	M0	Negative	N0	1006.0	0.0	LumB	Luminal B	Positive	Her2	-2.0	-5.0	enrollment	T_Other	T2	LIVING	TCGA-A8-A09I-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A09I	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84.0	Right Lower Outer Quadrant			TCGA-A8-A09I-F40333	TCGA-A8-A09I	TCGA-A8-A09I-01A		Positive					Positive	Other					-30711.0	698.0		0.0	1371.0										2013-2-17	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			430.0	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3.0	4.0								NO			False	Yes	M0	N0	T2	Stage IIA	TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA.pdf	A09I	TUMOR FREE						YES				NO	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008.0	433b49ba-949b-4914-985a-be19b3b32502	433b49ba-949b-4914-985a-be19b3b32502	TCGA-A8-A09I-01A-11-A13A-20	TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01		93a8128c-9314-44b7-8737-0c5b08c057f4	TCGA-A8-A09I-01	TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01A-22D-A032-05	TCGA-A8-A09I-01		TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01	433b49ba-949b-4914-985a-be19b3b32502	TCGA-A8-A09I-01	TCGA-A8-A09I-01A-22D-A036-01		TCGA-A8-A09I-01A-22R-A034-07	433b49ba-949b-4914-985a-be19b3b32502	TCGA-A8-A09I-01A-22D-A036-01	TCGA-A8-A09I-01
TCGA-A8-A09R-01	Stage IIB	82.0	5.0	Stage IIB	273.0		Positive	FEMALE	Negative	1.0	1.0	4.0	Negative	M0	Positive	N1	273.0	0.0	LumB	Luminal B	Positive	Her2	0.0	-3.0	enrollment	T_Other	T2	LIVING	TCGA-A8-A09R-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A09R	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					82.0	Left Lower Inner Quadrant			TCGA-A8-A09R-F40330	TCGA-A8-A09R	TCGA-A8-A09R-01A		Positive					Positive	Other					-30196.0	149.0		0.0	273.0										2013-2-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180.0	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0								NO			False	No	M0	N1	T2	Stage IIB	TCGA-A8-A09R.5E615F92-6FD0-48C7-AC37-78526974BCFC.pdf	A09R	TUMOR FREE						YES				YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009.0	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	TCGA-A8-A09R-01A-21-A13B-20	TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01		7c1073e9-1995-4dfa-a9aa-e260e8999d54	TCGA-A8-A09R-01	TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01A-11D-A00Y-05	TCGA-A8-A09R-01		TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	TCGA-A8-A09R-01	TCGA-A8-A09R-01A-11D-A011-01		TCGA-A8-A09R-01A-11R-A00Z-07	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	TCGA-A8-A09R-01A-11D-A011-01	TCGA-A8-A09R-01
TCGA-A8-A09V-01	Stage IIA	51.0	2.0	Stage IIA	457.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	457.0	0.0	LumA	Luminal A	Positive		-12.0	-3.0	enrollment	T_Other	T2	LIVING	TCGA-A8-A09V-01	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7			mutation c1uster 9	TCGA-A8-A09V	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51.0	Right Upper Inner Quadrant			TCGA-A8-A09V-F40328	TCGA-A8-A09V	TCGA-A8-A09V-01A		Positive					Positive	Other					-18628.0	333.0		0.0	457.0										2013-2-17	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			60.0	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2.0									NO			False	No	M0	N0	T2	Stage IIA	TCGA-A8-A09V.E0B04FB6-9500-4786-B6D9-303165EF9090.pdf	A09V	TUMOR FREE						YES				YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009.0	416041ff-f179-4c72-a281-f39d32c595c1	416041ff-f179-4c72-a281-f39d32c595c1		TCGA-A8-A09V-01A-11D-A045-09	TCGA-A8-A09V-01			TCGA-A8-A09V-01	TCGA-A8-A09V-01A-11D-A045-09	TCGA-A8-A09V-01A-11D-A032-05	TCGA-A8-A09V-01		TCGA-A8-A09V-01A-11D-A045-09		416041ff-f179-4c72-a281-f39d32c595c1		TCGA-A8-A09V-01A-11D-A036-01		TCGA-A8-A09V-01A-11R-A034-07	416041ff-f179-4c72-a281-f39d32c595c1	TCGA-A8-A09V-01A-11D-A036-01	TCGA-A8-A09V-01
TCGA-A8-A0A1-01	Stage IIA	84.0	2.0	Stage IIA	365.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	365.0	0.0	LumA	Luminal A	Positive		-5.0	-7.0	enrollment	T_Other	T2	LIVING	TCGA-A8-A0A1-01	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-A8-A0A1	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84.0	Right				TCGA-A8-A0A1	TCGA-A8-A0A1-01A		Positive					Positive	Other					-30742.0	241.0		0.0	365.0										2011-5-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			90.0	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0											False	No	M0	N0	T2	Stage IIA	TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0.pdf	A0A1	TUMOR FREE											Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009.0	8522865b-457c-4199-a870-bf8353f2b0a5	8522865b-457c-4199-a870-bf8353f2b0a5		TCGA-A8-A0A1-01A-11W-A019-09	TCGA-A8-A0A1-01			TCGA-A8-A0A1-01	TCGA-A8-A0A1-01A-11W-A019-09	TCGA-A8-A0A1-01A-11D-A00Y-05	TCGA-A8-A0A1-01		TCGA-A8-A0A1-01A-11W-A019-09	TCGA-A8-A0A1-01	8522865b-457c-4199-a870-bf8353f2b0a5	TCGA-A8-A0A1-01	TCGA-A8-A0A1-01A-11D-A011-01		TCGA-A8-A0A1-01A-11R-A00Z-07	8522865b-457c-4199-a870-bf8353f2b0a5	TCGA-A8-A0A1-01A-11D-A011-01	TCGA-A8-A0A1-01
TCGA-A8-A0A9-01	Stage IIA	80.0	3.0	Stage IIA	396.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	396.0	0.0	LumA	Luminal B	Positive		0.0	-3.0	enrollment	T_Other	T2	LIVING	TCGA-A8-A0A9-01	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A0A9	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80.0	Left Upper Outer Quadrant			TCGA-A8-A0A9-F40323	TCGA-A8-A0A9	TCGA-A8-A0A9-01A		Positive					Positive	Other					-29370.0	272.0		0.0	822.0										2013-2-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100.0	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3.0	2.0								NO			False	No	M0	N0	T2	Stage IIA	TCGA-A8-A0A9.8612388B-3680-4BD8-986C-E7ABE9F92F91.pdf	A0A9	TUMOR FREE						YES				YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009.0	1766e42e-f8cf-447d-a694-3999a1fec43a	1766e42e-f8cf-447d-a694-3999a1fec43a		TCGA-A8-A0A9-01A-11W-A019-09	TCGA-A8-A0A9-01			TCGA-A8-A0A9-01	TCGA-A8-A0A9-01A-11W-A019-09	TCGA-A8-A0A9-01A-11D-A00Y-05	TCGA-A8-A0A9-01		TCGA-A8-A0A9-01A-11W-A019-09	TCGA-A8-A0A9-01	1766e42e-f8cf-447d-a694-3999a1fec43a	TCGA-A8-A0A9-01	TCGA-A8-A0A9-01A-11D-A011-01		TCGA-A8-A0A9-01A-11R-A00Z-07	1766e42e-f8cf-447d-a694-3999a1fec43a	TCGA-A8-A0A9-01A-11D-A011-01	TCGA-A8-A0A9-01
TCGA-AC-A23H-11		90.0			81.0			FEMALE									81.0	0.0	Normal						enrollment			LIVING	TCGA-AC-A23H-11										TCGA-AC-A23H	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90.0	Right Upper Inner Quadrant|Right Lower Inner Quadrant			TCGA-AC-A23H-F45572	TCGA-AC-A23H	TCGA-AC-A23H-11A		Positive					Negative	Simple Mastectomy					-32873.0	478.0	174.0	0.0	81.0					NO		10-19%			2013-7-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70.0	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			False	No	M0	NX	T2	Stage IIA		A23H	WITH TUMOR						NO	NO			NO	Solid Tissue Normal	11		7th		NO	YES	AC	Breast	A	DECEASED	2009.0	93108690-ccc2-4ae4-89e0-042a654a0228	93108690-ccc2-4ae4-89e0-042a654a0228				TCGA-AC-A23H-11A-12D-A161-05						TCGA-AC-A23H-11			93108690-ccc2-4ae4-89e0-042a654a0228			TCGA-AC-A23H-11		93108690-ccc2-4ae4-89e0-042a654a0228		
TCGA-AC-A2BM-01																			LumB										TCGA-AC-A2BM-01	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2BM	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41.0	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2BM-F66202	TCGA-AC-A2BM	TCGA-AC-A2BM-01A		Positive					Positive	Modified Radical Mastectomy		YES			-15212.0	2164.0		0.0	3022.0					NO		60-69%			2014-10-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120.0	NO		Negative	NO	13.0	Negative																														NO	1.0	1.0	False	No	MX	N1a	T2	Stage IIB	TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf	A2BM	TUMOR FREE						NO	YES	10-19%		NO	Primary Tumor	1		6th		NO	YES	AC	Breast	A	LIVING	2005.0	54f1981b-9d8f-48cc-9586-d2e9a8d468f5	54f1981b-9d8f-48cc-9586-d2e9a8d468f5	TCGA-AC-A2BM-01A-21-A24A-20		TCGA-AC-A2BM-01	TCGA-AC-A2BM-01A-11D-A21R-05	2222f10b-39fd-4aa4-8021-7f320c835f88	TCGA-AC-A2BM-01	TCGA-AC-A2BM-01A-11D-A21Q-09			TCGA-AC-A2BM-01			54f1981b-9d8f-48cc-9586-d2e9a8d468f5		TCGA-AC-A2BM-01A-11D-A21P-01	TCGA-AC-A2BM-01		54f1981b-9d8f-48cc-9586-d2e9a8d468f5	TCGA-AC-A2BM-01A-11D-A21P-01	
TCGA-AC-A2FB-11																			Normal										TCGA-AC-A2FB-11		C3-BRCA/Luminal								TCGA-AC-A2FB	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65.0	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A2FB-F45574	TCGA-AC-A2FB			Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-23851.0			0.0	1234.0					NO		90-99%			2013-7-17	FEMALE			10-19%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy			Positive		NO	1.0	Negative																														NO	0.0			No	MX	N0	T2	Stage IIA		A2FB	TUMOR FREE						YES	YES	<10%		NO	Solid Tissue Normal	11		6th		NO	YES	AC	Breast		LIVING	2009.0	f18b2ff7-eddb-40b5-9bbe-7ef09787ddef	f18b2ff7-eddb-40b5-9bbe-7ef09787ddef				TCGA-AC-A2FB-11A-13D-A17F-05						TCGA-AC-A2FB-11			f18b2ff7-eddb-40b5-9bbe-7ef09787ddef			TCGA-AC-A2FB-11		f18b2ff7-eddb-40b5-9bbe-7ef09787ddef		
TCGA-AC-A2FF-11																			Normal										TCGA-AC-A2FF-11		C3-BRCA/Luminal								TCGA-AC-A2FF	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40.0	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2FF-F58655	TCGA-AC-A2FF	TCGA-AC-A2FF-11A		Positive					Positive	Lumpectomy		YES				1904.0		0.0	2759.0					NO		30-39%			2014-4-17	FEMALE								1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80.0	NO		Negative	NO	7.0	Negative																														NO	3.0	0.0	False	No	MX	N1	T2	Stage IIB		A2FF	TUMOR FREE						YES	YES	70-79%		YES	Solid Tissue Normal	11		6th		NO	YES	AC	Breast	A	LIVING	2006.0	3610639e-d947-446f-8483-86be65c80ed3	3610639e-d947-446f-8483-86be65c80ed3				TCGA-AC-A2FF-11A-13D-A17F-05									3610639e-d947-446f-8483-86be65c80ed3					3610639e-d947-446f-8483-86be65c80ed3		
TCGA-AC-A2FM-11																													TCGA-AC-A2FM-11										TCGA-AC-A2FM	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			87.0	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A2FM-F43237	TCGA-AC-A2FM	TCGA-AC-A2FM-11B								Modified Radical Mastectomy		YES			-31805.0	2733.0	792.0	0.0				780		YES					2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	220.0	NO			NO	2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	Distant Metastasis	Bone Marrow	NO	YES	0.0	0.0	False	No	M0	N1mi	T2	Stage IIB		A2FM	WITH TUMOR						NO	YES			NO	Solid Tissue Normal	11		6th		NO	YES	AC	Breast	B	DECEASED	2004.0	68ec8441-f60a-4c80-8a9f-7609a0f81430	68ec8441-f60a-4c80-8a9f-7609a0f81430				TCGA-AC-A2FM-11B-32D-A19Z-05						TCGA-AC-A2FM-11			68ec8441-f60a-4c80-8a9f-7609a0f81430			TCGA-AC-A2FM-11		68ec8441-f60a-4c80-8a9f-7609a0f81430		
TCGA-AC-A2FO-01																			LumA										TCGA-AC-A2FO-01	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14			TCGA-AC-A2FO	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65.0	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node plus Level I and Level II lymph nodes	TCGA-AC-A2FO-F43223	TCGA-AC-A2FO			Positive					Negative	Simple Mastectomy		NO			-23928.0			0.0	2255.0					NO		90-99%			2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative	Indeterminate	NO	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2.0			No	MX	N1	T2	Stage IIB		A2FO	TUMOR FREE						YES	YES			NO	Primary Tumor	1		6th		NO	YES	AC	Breast		LIVING	2005.0	bd07aa68-708b-4bd3-88b9-78a8b9e298f5	bd07aa68-708b-4bd3-88b9-78a8b9e298f5			TCGA-AC-A2FO-01	TCGA-AC-A2FO-01A-11D-A17Z-05		TCGA-AC-A2FO-01	TCGA-AC-A2FO-01A-11D-A17W-09			TCGA-AC-A2FO-01			bd07aa68-708b-4bd3-88b9-78a8b9e298f5		TCGA-AC-A2FO-01A-11D-A17U-01	TCGA-AC-A2FO-01		bd07aa68-708b-4bd3-88b9-78a8b9e298f5	TCGA-AC-A2FO-01A-11D-A17U-01	
TCGA-AC-A2QJ-01																													TCGA-AC-A2QJ-01	BRCA-LUAD+			BRCA non-CIMP c9	KIRC-like c1		miRNA cluster 5			TCGA-AC-A2QJ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			48.0	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Other (specify)	Sentinel lymph node and axillary lymph node biopsy	TCGA-AC-A2QJ-F44021	TCGA-AC-A2QJ	TCGA-AC-A2QJ-01A		Negative					Negative	Other		NO			-17569.0	160.0	446.0	0.0	69.0			237		NO					2013-6-28	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	150.0	NO	Negative		NO	2.0	Negative	Peri (6-12 months since last menstrual period)																									Bone	Distant Metastasis		NO	YES	0.0		False	No	M0	N0	T4b	Stage IIIB	TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf	A2QJ	WITH TUMOR						YES	YES			YES	Primary Tumor	1	Mastectomy	7th		YES	NO	AC	Breast	A	DECEASED	2011.0	49a0f1eb-6ece-48fc-970f-3922263fd20b	49a0f1eb-6ece-48fc-970f-3922263fd20b	TCGA-AC-A2QJ-01A-21-A24A-20		TCGA-AC-A2QJ-01	TCGA-AC-A2QJ-01A-12D-A19Z-05	5755434d-e797-4963-b728-caefc7bd49d5	TCGA-AC-A2QJ-01	TCGA-AC-A2QJ-01A-12D-A19Y-09			TCGA-AC-A2QJ-01			49a0f1eb-6ece-48fc-970f-3922263fd20b		TCGA-AC-A2QJ-01A-12D-A19X-01	TCGA-AC-A2QJ-01		49a0f1eb-6ece-48fc-970f-3922263fd20b	TCGA-AC-A2QJ-01A-12D-A19X-01	
TCGA-AC-A3QP-01																													TCGA-AC-A3QP-01					BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3QP	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79.0	Right	Sentinel node biopsy alone		TCGA-AC-A3QP-F56161	TCGA-AC-A3QP	TCGA-AC-A3QP-01A		Positive					Positive	Lumpectomy					-29113.0	184.0		0.0	675.0					NO		70-79%	2.2		2014-1-29	FEMALE					2+	30.0	2.6	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150.0	NO	Equivocal	Negative	NO	2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1.0	1.0	True	No	MX	N1mi	T2	Stage IIB	TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf	A3QP	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	1		7th		YES	NO	AC	Breast	A	LIVING	2011.0	4545ed8f-a83b-4049-9504-ba673ecd6d1d	4545ed8f-a83b-4049-9504-ba673ecd6d1d	TCGA-AC-A3QP-01A-21-A24A-20		TCGA-AC-A3QP-01	TCGA-AC-A3QP-01A-11D-A230-05	334363b1-b6e4-4135-a42d-4d49e62ce2c5	TCGA-AC-A3QP-01	TCGA-AC-A3QP-01A-11D-A22X-09			TCGA-AC-A3QP-01			4545ed8f-a83b-4049-9504-ba673ecd6d1d		TCGA-AC-A3QP-01A-11D-A22W-01	TCGA-AC-A3QP-01		4545ed8f-a83b-4049-9504-ba673ecd6d1d	TCGA-AC-A3QP-01A-11D-A22W-01	
TCGA-AC-A7VB-01																													TCGA-AC-A7VB-01										TCGA-AC-A7VB	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51.0	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A7VB-F66026	TCGA-AC-A7VB			Positive					Negative	Modified Radical Mastectomy		NO			-18806.0			0.0	250.0							80-89%			2014-10-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy					NO	15.0	Negative																														NO	3.0			No	MX	N1a	T1c	Stage IIA		A7VB	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	1		7th		YES	NO	AC	Breast		LIVING	2013.0	a0059fcb-6adc-47f4-8601-b7eed9e12576	a0059fcb-6adc-47f4-8601-b7eed9e12576			TCGA-AC-A7VB-01	TCGA-AC-A7VB-01A-11D-A357-05		TCGA-AC-A7VB-01				TCGA-AC-A7VB-01			a0059fcb-6adc-47f4-8601-b7eed9e12576		TCGA-AC-A7VB-01A-11D-A350-01	TCGA-AC-A7VB-01		a0059fcb-6adc-47f4-8601-b7eed9e12576	TCGA-AC-A7VB-01A-11D-A350-01	
TCGA-AC-A8OS-01																													TCGA-AC-A8OS-01										TCGA-AC-A8OS	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71.0	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-AC-A8OS			Positive					Positive	Simple Mastectomy		YES			-26248.0			0.0	70.0							90-99%			2014-2-26	FEMALE			10-19%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Positive			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0		No	MX	N0 (i-)	T2	Stage IIA		A8OS	TUMOR FREE							YES	<10%			Primary Tumor	1		7th		YES	NO	AC	Breast		LIVING	2013.0	c119a170-e1ba-4965-a9c6-5c0b41ceefba	c119a170-e1ba-4965-a9c6-5c0b41ceefba			TCGA-AC-A8OS-01	TCGA-AC-A8OS-01A-12D-A41Q-05		TCGA-AC-A8OS-01				TCGA-AC-A8OS-01			c119a170-e1ba-4965-a9c6-5c0b41ceefba		TCGA-AC-A8OS-01A-12D-A41E-01	TCGA-AC-A8OS-01		c119a170-e1ba-4965-a9c6-5c0b41ceefba	TCGA-AC-A8OS-01A-12D-A41E-01	
TCGA-AN-A0AL-01	Stage IIIB	41.0	1.0	No_Conversion	197.0		Negative	FEMALE	Negative	2.0	2.0	2.0	Negative	M0	Negative	N0	197.0	0.0	Basal	Basal-like	Negative	Basal	-13.0	0.0	enrollment	T_Other	T4	LIVING	TCGA-AN-A0AL-01	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0AL	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41.0	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0AL-F68944	TCGA-AN-A0AL	TCGA-AN-A0AL-01A		Negative		0			Negative	Modified Radical Mastectomy		NO			-15286.0	49.0		0.0	227.0						dextran coated charcoal	<10%			2014-12-23	FEMALE		dextran coated charcoal	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	300.0	NO	Negative		NO	5.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5.0	3.0								NO	0.0	0.0	False	No	M0	N0	T4	Stage IIIB	TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263.pdf	A0AL	TUMOR FREE	dextran coated charcoal					NO		<10%		NO	Primary Tumor	1		7th		NO	YES	AN	Breast	A	LIVING	2010.0	467314d6-f946-447f-920a-d33b60f66eb2	467314d6-f946-447f-920a-d33b60f66eb2	TCGA-AN-A0AL-01A-21-A13B-20	TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01		b689bc66-7909-4edc-a0e1-701ffcd1a602	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01A-11D-A00Y-05	TCGA-AN-A0AL-01		TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01	467314d6-f946-447f-920a-d33b60f66eb2	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01A-11D-A011-01		TCGA-AN-A0AL-01A-11R-A00Z-07	467314d6-f946-447f-920a-d33b60f66eb2	TCGA-AN-A0AL-01A-11D-A011-01	TCGA-AN-A0AL-01
TCGA-AN-A0AT-01	Stage IIA	62.0	1.0	No_Conversion	10.0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	10.0	0.0	Basal	Basal-like	Negative	Basal	-13.0	-12.0	enrollment	T_Other	T2	LIVING	TCGA-AN-A0AT-01	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-AN-A0AT	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62.0	Right Upper Inner Quadrant	No axillary staging		TCGA-AN-A0AT-F68948	TCGA-AN-A0AT			Negative					Negative	Modified Radical Mastectomy		NO			-22798.0			0.0	10.0										2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative		YES	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5.0										0.0	0.0		No	M0	N0	T2	Stage IIA		A0AT	TUMOR FREE		0		0	0	NO				NO	Primary Tumor	1				NO	YES	AN	Breast		LIVING	2010.0	edda9023-a8d9-45dc-af21-5bba663967e4	edda9023-a8d9-45dc-af21-5bba663967e4	TCGA-AN-A0AT-01A-21-A13C-20	TCGA-AN-A0AT-01A-11D-A045-09	TCGA-AN-A0AT-01		d29e84ac-dc3b-4139-950c-fd197d9ca11f	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11D-A045-09	TCGA-AN-A0AT-01A-11D-A032-05	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11D-A045-09		edda9023-a8d9-45dc-af21-5bba663967e4		TCGA-AN-A0AT-01A-11D-A036-01	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11R-A034-07	edda9023-a8d9-45dc-af21-5bba663967e4	TCGA-AN-A0AT-01A-11D-A036-01	TCGA-AN-A0AT-01
TCGA-AN-A0FF-01	Stage IA	32.0	3.0	No_Conversion	140.0		Positive	FEMALE	Negative	1.0	3.0	4.0	Negative	M0	Negative	N0	140.0	0.0	LumB	Luminal B	Positive	LumA	0.0	-3.0	enrollment	T1	T1	LIVING	TCGA-AN-A0FF-01	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AN-A0FF	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					32.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FF-F68943	TCGA-AN-A0FF	TCGA-AN-A0FF-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-11929.0	75.0		0.0	172.0						dextran coated charcoal	90-99%			2014-12-23	FEMALE		dextran coated charcoal	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	300.0	NO	Negative		NO	14.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4.0	1.0								NO	0.0	0.0	False	No	M0	N0	T1b	Stage IA	TCGA-AN-A0FF.9B4BA15D-A071-4213-AD2C-075A04ED48CD.pdf	A0FF	TUMOR FREE	dextran coated charcoal					NO		90-99%		NO	Primary Tumor	1				NO	YES	AN	Breast	A	LIVING	2010.0	7a5bc56e-e787-4798-8c4d-ee792f9e3149	7a5bc56e-e787-4798-8c4d-ee792f9e3149	TCGA-AN-A0FF-01A-21-A13C-20	TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01		87bf53e1-aab3-44d0-a641-3464095b9a51	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01A-11D-A032-05	TCGA-AN-A0FF-01		TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01	7a5bc56e-e787-4798-8c4d-ee792f9e3149	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01A-11D-A036-01		TCGA-AN-A0FF-01A-11R-A034-07	7a5bc56e-e787-4798-8c4d-ee792f9e3149	TCGA-AN-A0FF-01A-11D-A036-01	TCGA-AN-A0FF-01
TCGA-AN-A0FS-01	Stage IB	55.0	2.0	No_Conversion	191.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Negative	N0	191.0	0.0	LumA	Luminal A	Negative	ReacII	-5.0	-7.0	enrollment	T1	T1	LIVING	TCGA-AN-A0FS-01	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AN-A0FS	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55.0	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FS-F68954	TCGA-AN-A0FS	TCGA-AN-A0FS-01A		Positive		0			Negative	Modified Radical Mastectomy		NO			-20352.0	44.0		0.0	210.0						dextran coated charcoal	90-99%			2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	170.0	NO	Positive		YES	14.0	Negative	Peri (6-12 months since last menstrual period)																				2.0	2.0									0.0	0.0	False	No	M0	N0	T1c	Stage IA	TCGA-AN-A0FS.3CD1D537-29E4-479B-99FA-26D27E192948.pdf	A0FS	TUMOR FREE	dextran coated charcoal				230	NO		<10%		NO	Primary Tumor	1		7th		NO	YES	AN	Breast	A	LIVING	2010.0	29ac13ea-a350-42e9-a3eb-024c537ead94	29ac13ea-a350-42e9-a3eb-024c537ead94	TCGA-AN-A0FS-01A-21-A13C-20	TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01		9cc29dc5-b324-4ee3-b94b-42a1f5927ae9	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01A-11D-A032-05	TCGA-AN-A0FS-01		TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01	29ac13ea-a350-42e9-a3eb-024c537ead94	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01A-11D-A036-01		TCGA-AN-A0FS-01A-11R-A034-07	29ac13ea-a350-42e9-a3eb-024c537ead94	TCGA-AN-A0FS-01A-11D-A036-01	TCGA-AN-A0FS-01
TCGA-AO-A0J8-01	Stage IIA	61.0	2.0	Stage IIA	277.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Negative	N0	277.0	0.0	LumA	Luminal A	Positive	ReacI	-12.0	-3.0	followup	T_Other	T2	LIVING	TCGA-AO-A0J8-01	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0J8	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61.0	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A0J8-F15482	TCGA-AO-A0J8	TCGA-AO-A0J8-01A		Positive		3+			Positive	Lumpectomy		YES			-22284.0	241.0		0.0	680.0							90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	670.0	NO	Negative			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1.0	2.0								NO	0.0	1.0	True	No	M0	N0 (i+)	T2	Stage IIA	TCGA-AO-A0J8.03C7A677-C223-47D6-869E-E6C3250B0C08.pdf	A0J8	TUMOR FREE								70-79%		YES	Primary Tumor	1			YES	NO	YES	AO	Breast	A	LIVING	2009.0	70109263-1d2b-4abe-a582-2b28e87cde67	70109263-1d2b-4abe-a582-2b28e87cde67	TCGA-AO-A0J8-01A-11-A13A-20	TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01		287094b7-2cf5-415d-81f7-5ef0196d181c	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01A-21D-A032-05	TCGA-AO-A0J8-01		TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01	70109263-1d2b-4abe-a582-2b28e87cde67	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01A-21D-A036-01		TCGA-AO-A0J8-01A-21R-A034-07	70109263-1d2b-4abe-a582-2b28e87cde67	TCGA-AO-A0J8-01A-21D-A036-01	TCGA-AO-A0J8-01
TCGA-AO-A0JJ-01	Stage IIB	54.0	2.0	No_Conversion	1512.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Positive	N1	1512.0	0.0	LumA	Luminal A	Positive	LumA/B	-5.0	-7.0	enrollment	T_Other	T2	LIVING	TCGA-AO-A0JJ-01	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 7	mutation c1uster 9	TCGA-AO-A0JJ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54.0	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JJ-F15493	TCGA-AO-A0JJ			Positive		3+			Positive	Modified Radical Mastectomy		NO			-19758.0			0.0	1887.0							90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy			Negative			44.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1.0	7.0								NO	2.0			No	M0	N1a	T2	Stage IIB		A0JJ	TUMOR FREE								70-79%		YES	Primary Tumor	1			YES	NO	YES	AO	Breast		LIVING	2006.0	b5eeba4f-8e46-4084-9054-961ea524cf72	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01A-21-A13A-20	TCGA-AO-A0JJ-01A-11W-A071-09	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01A-11D-A10P-05	c4fcf63c-a35e-451c-bf06-64b36bc30ba0	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01A-11W-A071-09		TCGA-AO-A0JJ-01		TCGA-AO-A0JJ-01A-11W-A071-09	TCGA-AO-A0JJ-01	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01A-11D-A059-01		TCGA-AO-A0JJ-01A-11R-A056-07	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01A-11D-A059-01	TCGA-AO-A0JJ-01
TCGA-AO-A125-01	Stage IIA	72.0	2.0	Stage IIA	3018.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3018.0	0.0	LumA	Luminal A	Positive		-12.0	-3.0	followup	T_Other	T2	LIVING	TCGA-AO-A125-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AO-A125	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72.0	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A125-F19398	TCGA-AO-A125	TCGA-AO-A125-01A		Positive		4+			Positive	Simple Mastectomy		YES			-26466.0	3193.0		0.0	3456.0							50-59%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0			1.0		Other, specify		No		C50.9	8050/3	C50.9	3+	YES		Core needle biopsy	90.0	NO	Negative	Negative		5.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	3.0								NO	0.0	0.0	True	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A125.AE348902-0573-4A57-BBD6-037FA2AF1872.pdf	A125	TUMOR FREE								90-99%		NO	Primary Tumor	1		5th	YES	NO	YES	AO	Breast	A	LIVING	2002.0	6c8cb6ae-99bb-4878-b6f5-9da28be98588	6c8cb6ae-99bb-4878-b6f5-9da28be98588		TCGA-AO-A125-01A-11D-A10M-09	TCGA-AO-A125-01	TCGA-AO-A125-01A-11D-A10N-05		TCGA-AO-A125-01	TCGA-AO-A125-01A-11D-A10M-09		TCGA-AO-A125-01		TCGA-AO-A125-01A-11D-A10M-09	TCGA-AO-A125-01	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01	TCGA-AO-A125-01A-11D-A10L-01		TCGA-AO-A125-01A-11R-A10J-07	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01A-11D-A10L-01	TCGA-AO-A125-01
TCGA-AO-A12G-01	Stage IIA	75.0	2.0	Stage IIA	1265.0		Positive	FEMALE	Negative	1.0	3.0	3.0	Negative	M0	Negative	N0	1265.0	0.0	LumA	Luminal A	Positive	LumA/B	-1.0	0.0	followup	T_Other	T2	LIVING	TCGA-AO-A12G-01	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-AO-A12G	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75.0	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12G-F19448	TCGA-AO-A12G	TCGA-AO-A12G-01A		Positive		2+			Positive	Simple Mastectomy		YES			-27705.0	1415.0		0.0	1639.0							90-99%	67	Scheduled Follow-up Submission	2011-6-16	FEMALE				>=2.0 Positive	2+	23.0	66	1.0		Other, specify		No		C50.9	8022/3	C50.9	4+	YES		Core needle biopsy	280.0	NO	Positive	Negative		4.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	2.0								NO	0.0	1.0	True	No	M0	N0 (i+)	T2	Stage IIA	TCGA-AO-A12G.6CE21603-4200-40BA-94AA-15F24EE4AC7F.pdf	A12G	TUMOR FREE								30-39%		NO	Primary Tumor	1		6th	YES	NO	YES	AO	Breast	A	LIVING	2006.0	348a0fd6-eb6b-4550-a26a-3896c4963b3a	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01A-21-A13D-20	TCGA-AO-A12G-01A-11D-A10M-09	TCGA-AO-A12G-01	TCGA-AO-A12G-01A-11D-A10N-05	e5214399-e1f0-42f1-be38-366c47e438fa	TCGA-AO-A12G-01	TCGA-AO-A12G-01A-11D-A10M-09		TCGA-AO-A12G-01		TCGA-AO-A12G-01A-11D-A10M-09	TCGA-AO-A12G-01	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01	TCGA-AO-A12G-01A-11D-A10L-01		TCGA-AO-A12G-01A-11R-A10J-07	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01A-11D-A10L-01	TCGA-AO-A12G-01
TCGA-AR-A1AM-01																													TCGA-AR-A1AM-01	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AR-A1AM	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52.0	Right Upper Outer Quadrant			TCGA-AR-A1AM-F71733	TCGA-AR-A1AM			Positive					Positive	Simple Mastectomy					-19123.0			0.0	2991.0										2015-3-30	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	12.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1.0			No	M0	N1	T3	Stage IIIA		A1AM	TUMOR FREE						YES	YES			NO	Primary Tumor	1		6th		NO	YES	AR	Breast		LIVING	2006.0	a58de230-f177-4c58-95ec-55b6edb08452	a58de230-f177-4c58-95ec-55b6edb08452	TCGA-AR-A1AM-01A-31-A24A-20		TCGA-AR-A1AM-01	TCGA-AR-A1AM-01A-41D-A22B-05	d30acc0b-b6b7-4134-96f5-4b76004ca893	TCGA-AR-A1AM-01	TCGA-AR-A1AM-01A-41D-A228-09			TCGA-AR-A1AM-01			a58de230-f177-4c58-95ec-55b6edb08452		TCGA-AR-A1AM-01A-41D-A227-01	TCGA-AR-A1AM-01		a58de230-f177-4c58-95ec-55b6edb08452	TCGA-AR-A1AM-01A-41D-A227-01	
TCGA-AR-A1AS-01	Stage II	54.0	3.0	Stage IIB	1242.0		Positive	FEMALE	Negative	3.0	3.0	3.0	Negative	M0	Positive	N1	1242.0	0.0	LumA	Luminal A	Positive	LumA	-7.0	-3.0	enrollment	T_Other	T2	LIVING	TCGA-AR-A1AS-01	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AR-A1AS	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54.0	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AR-A1AS-F49470	TCGA-AR-A1AS	TCGA-AR-A1AS-01A		Positive					Positive	Other					-20028.0	1331.0		0.0	1150.0							70-79%		Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300.0	NO	Negative		NO	17.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	4.0								NO	1.0		True	No	M0	N1	T2	Stage IIB	TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9.pdf	A1AS	TUMOR FREE						NO	YES	70-79%		YES	Primary Tumor	1	Wide local excision	6th	NO	NO	YES	AR	Breast	A	LIVING	2007.0	e7b64cc3-9b2b-4938-9896-84b640d1586f	e7b64cc3-9b2b-4938-9896-84b640d1586f	TCGA-AR-A1AS-01A-21-A13E-20	TCGA-AR-A1AS-01A-11D-A12Q-09	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11D-A12R-05	0db7dee4-ca2e-4f47-a9bc-5e55ca0df269	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11D-A12Q-09		TCGA-AR-A1AS-01	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11D-A12Q-09		e7b64cc3-9b2b-4938-9896-84b640d1586f		TCGA-AR-A1AS-01A-11D-A12N-01	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11R-A12P-07	e7b64cc3-9b2b-4938-9896-84b640d1586f	TCGA-AR-A1AS-01A-11D-A12N-01	TCGA-AR-A1AS-01
TCGA-AR-A24L-01	Stage II	26.0	5.0	Stage IIB	2221.0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2221.0	0.0	LumA		Positive				enrollment	T_Other	T2	LIVING	TCGA-AR-A24L-01	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A24L	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					26.0	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24L-F49488	TCGA-AR-A24L			Positive					Positive	Other					-9706.0		2866.0	0.0	2221.0			1414				10-19%		Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	12.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2.0	4.0					Locoregional Disease			YES	2.0			No	M0	N1	T2	Stage IIB		A24L	WITH TUMOR						YES	YES	10-19%		YES	Primary Tumor	1	Wide local excision	6th	YES	NO	YES	AR	Breast		DECEASED	2005.0	bfa78a45-16bf-410a-816d-bd369ded91e5	bfa78a45-16bf-410a-816d-bd369ded91e5	TCGA-AR-A24L-01A-21-A17I-20	TCGA-AR-A24L-01A-11D-A167-09	TCGA-AR-A24L-01	TCGA-AR-A24L-01A-11D-A16A-05	e1bd54aa-7e28-47ce-98fb-95593ee07f96	TCGA-AR-A24L-01	TCGA-AR-A24L-01A-11D-A167-09			TCGA-AR-A24L-01	TCGA-AR-A24L-01A-11D-A167-09		bfa78a45-16bf-410a-816d-bd369ded91e5		TCGA-AR-A24L-01A-11D-A166-01	TCGA-AR-A24L-01		bfa78a45-16bf-410a-816d-bd369ded91e5	TCGA-AR-A24L-01A-11D-A166-01	
TCGA-AR-A24T-01	Stage III	46.0	2.0	Stage IIIC	1620.0		Positive	FEMALE	Negative				Negative	M0	Positive	N3	1620.0	0.0	LumA		Positive				enrollment	T_Other	T3	LIVING	TCGA-AR-A24T-01	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A24T	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46.0	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24T-F71728	TCGA-AR-A24T	TCGA-AR-A24T-01A		Positive					Positive	Simple Mastectomy					-17135.0	1786.0		0.0	3202.0							10-19%		Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	490.0	NO	Equivocal	Negative	NO	17.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4.0	2.0								NO	15.0		True	No	M0	N3	T3	Stage IIIC	TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf	A24T	TUMOR FREE						YES	YES	10-19%		YES	Primary Tumor	1		6th	YES	NO	YES	AR	Breast	A	LIVING	2006.0	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	TCGA-AR-A24T-01A-21-A17I-20	TCGA-AR-A24T-01A-11D-A167-09	TCGA-AR-A24T-01	TCGA-AR-A24T-01A-11D-A16A-05	7c08cdc2-f620-4ba3-9a66-37bd23d75d3e	TCGA-AR-A24T-01	TCGA-AR-A24T-01A-11D-A167-09			TCGA-AR-A24T-01	TCGA-AR-A24T-01A-11D-A167-09		d2e1fdf7-1ac9-49e9-a611-b15c90772bf6		TCGA-AR-A24T-01A-11D-A166-01	TCGA-AR-A24T-01		d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	TCGA-AR-A24T-01A-11D-A166-01	
TCGA-AR-A24V-01	Stage II	52.0	5.0	Stage IIB	1648.0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1648.0	0.0	LumA		Positive				enrollment	T_Other	T2	LIVING	TCGA-AR-A24V-01	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A24V	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52.0	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24V-F71740	TCGA-AR-A24V	TCGA-AR-A24V-01A		Positive					Positive	Other		YES			-19027.0	1720.0		0.0	3203.0							80-89%		Scheduled Follow-up Submission	2015-3-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400.0	NO	Negative		NO	2.0	Negative	Peri (6-12 months since last menstrual period)																				4.0	4.0								NO	1.0		True	No	M0	N1	T2	Stage IIB	TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA.pdf	A24V	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	1	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006.0	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	TCGA-AR-A24V-01A-11-A17I-20	TCGA-AR-A24V-01A-21D-A167-09	TCGA-AR-A24V-01	TCGA-AR-A24V-01A-21D-A16A-05	38c6af12-c50f-4dbe-8130-0b737b29390a	TCGA-AR-A24V-01	TCGA-AR-A24V-01A-21D-A167-09			TCGA-AR-A24V-01	TCGA-AR-A24V-01A-21D-A167-09		29b04717-c5f2-4d4c-b006-e5c5f0aade7a		TCGA-AR-A24V-01A-21D-A166-01	TCGA-AR-A24V-01		29b04717-c5f2-4d4c-b006-e5c5f0aade7a	TCGA-AR-A24V-01A-21D-A166-01	
TCGA-AR-A2LL-01																			LumB										TCGA-AR-A2LL-01	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14			TCGA-AR-A2LL	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70.0	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LL-F49493	TCGA-AR-A2LL	TCGA-AR-A2LL-01A		Positive					Positive	Simple Mastectomy		YES			-25747.0	1315.0		0.0	2012.0					NO		70-79%			2013-10-2	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1300.0	NO	Equivocal	Negative		4.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0		True	Yes	M0	N0	T3	Stage IIB	TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2.pdf	A2LL	TUMOR FREE						YES	YES	70-79%		NO	Primary Tumor	1		6th		NO	YES	AR	Breast	A	LIVING	2007.0	2c08d3bc-c5f6-4077-86b5-633ed85818ec	2c08d3bc-c5f6-4077-86b5-633ed85818ec	TCGA-AR-A2LL-01A-21-A24A-20		TCGA-AR-A2LL-01	TCGA-AR-A2LL-01A-11D-A17Z-05	6aee5a1d-a53e-4c02-90f5-fdb8e7765573	TCGA-AR-A2LL-01	TCGA-AR-A2LL-01A-11D-A17W-09						2c08d3bc-c5f6-4077-86b5-633ed85818ec		TCGA-AR-A2LL-01A-11D-A17U-01			2c08d3bc-c5f6-4077-86b5-633ed85818ec	TCGA-AR-A2LL-01A-11D-A17U-01	
TCGA-AR-A5QN-01																													TCGA-AR-A5QN-01										TCGA-AR-A5QN	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68.0	Left	Axillary lymph node dissection alone		TCGA-AR-A5QN-F69265	TCGA-AR-A5QN	TCGA-AR-A5QN-01A		Positive					Positive	Modified Radical Mastectomy					-25089.0	328.0		0.0	1013.0										2014-12-31	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	510.0	NO	Positive		NO	19.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	10.0		True	No	M0	N3	T2	Stage IIIC	TCGA-AR-A5QN.A9015F6A-F6BB-4AC8-B681-099232A6DFAC.pdf	A5QN	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		NO	YES	AR	Breast	A	LIVING	2012.0	76353751-a05c-432e-a35b-12f2bf62a494	76353751-a05c-432e-a35b-12f2bf62a494			TCGA-AR-A5QN-01	TCGA-AR-A5QN-01A-12D-A28C-05	29dda56e-2d14-4864-97a2-03bc1a97e7fd	TCGA-AR-A5QN-01	TCGA-AR-A5QN-01A-12D-A28B-09			TCGA-AR-A5QN-01			76353751-a05c-432e-a35b-12f2bf62a494		TCGA-AR-A5QN-01A-12D-A28A-01	TCGA-AR-A5QN-01		76353751-a05c-432e-a35b-12f2bf62a494	TCGA-AR-A5QN-01A-12D-A28A-01	
TCGA-AR-A5QP-01																													TCGA-AR-A5QP-01										TCGA-AR-A5QP	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54.0	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A5QP-F69266	TCGA-AR-A5QP	TCGA-AR-A5QP-01A		Positive					Positive	Lumpectomy					-19805.0	498.0		0.0	1185.0										2014-12-31	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			230.0	NO	Equivocal		NO	40.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1.0		True	No	M0	N1	T2	Stage IIB	TCGA-AR-A5QP.F2409024-D848-4B02-A371-92BEA1105EC4.pdf	A5QP	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		NO	YES	AR	Breast	A	LIVING	2011.0	b2d0c724-40ae-44ca-90eb-ce86a9546c05	b2d0c724-40ae-44ca-90eb-ce86a9546c05			TCGA-AR-A5QP-01	TCGA-AR-A5QP-01A-11D-A28C-05	160070ff-2113-459e-b1ab-ffe2167da75d	TCGA-AR-A5QP-01	TCGA-AR-A5QP-01A-11D-A28B-09			TCGA-AR-A5QP-01			b2d0c724-40ae-44ca-90eb-ce86a9546c05		TCGA-AR-A5QP-01A-11D-A28A-01	TCGA-AR-A5QP-01		b2d0c724-40ae-44ca-90eb-ce86a9546c05	TCGA-AR-A5QP-01A-11D-A28A-01	
TCGA-B6-A0IA-01	Stage IIA	51.0	4.0	Stage IIA	6718.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	6718.0	0.0	LumA	Luminal A	Positive		-12.0	-3.0	followup	T_Other	T2	LIVING	TCGA-B6-A0IA-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-B6-A0IA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51.0	Right	Axillary lymph node dissection alone		TCGA-B6-A0IA-F71513	TCGA-B6-A0IA	TCGA-B6-A0IA-01A		Positive					Positive	Other		NO			-18748.0	6664.0		0.0	8391.0						IHC			Scheduled Follow-up Submission	2015-3-26	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES	Biopsy, NOS	Other method, specify:	70.0	NO			NO	15.0	Negative	Indeterminate (neither Pre or Postmenopausal)																				2.0	4.0								NO	0.0		True	No	M0	N0 (i-)	T2	Stage IIA	TCGA-B6-A0IA.55F3F917-E441-4C10-A3E3-0645A4E8374E.pdf	A0IA	TUMOR FREE	IHC					YES				NO	Primary Tumor	1	Excisional biopsy		YES	NO	YES	B6	Breast	A	LIVING	1992.0	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a		TCGA-B6-A0IA-01A-11W-A050-09	TCGA-B6-A0IA-01			TCGA-B6-A0IA-01	TCGA-B6-A0IA-01A-11W-A050-09	TCGA-B6-A0IA-01A-11D-A032-05	TCGA-B6-A0IA-01		TCGA-B6-A0IA-01A-11W-A050-09	TCGA-B6-A0IA-01	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	TCGA-B6-A0IA-01	TCGA-B6-A0IA-01A-11D-A036-01		TCGA-B6-A0IA-01A-11R-A034-07	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	TCGA-B6-A0IA-01A-11D-A036-01	TCGA-B6-A0IA-01
TCGA-B6-A0IN-01		45.0	3.0	No_Conversion	2573.0	2573.0	Positive	FEMALE							Negative	N0	2573.0	1.0	LumB	Luminal A	Negative		-2.0	-3.0	followup	T1	T1	DECEASED	TCGA-B6-A0IN-01	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IN	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES		NO		45.0	Right Upper Outer Quadrant|Right	No axillary staging		TCGA-B6-A0IN-F12625	TCGA-B6-A0IN	TCGA-B6-A0IN-01A	Negative	Positive				Modified radical mastectomy	Negative	Other		NO			-16705.0	5073.0	2573.0	0.0				1412			Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	20.0	NO					Positive	Indeterminate (neither Pre or Postmenopausal)																				4.0	1.0				Other, specify	Distant Metastasis	bone, brain		YES			True	No	MX	NX	T1c	Stage X	TCGA-B6-A0IN.267F1EFD-AB89-4124-B803-00CC0E8E9CD2.pdf	A0IN	WITH TUMOR	Image Analysis									NO	Primary Tumor	1	Excisional biopsy	4th	YES	NO	YES	B6	Breast	A	DECEASED	1996.0	4eaae575-d631-4e2e-8e70-4b4e0a429d74	4eaae575-d631-4e2e-8e70-4b4e0a429d74		TCGA-B6-A0IN-01A-11W-A050-09	TCGA-B6-A0IN-01			TCGA-B6-A0IN-01	TCGA-B6-A0IN-01A-11W-A050-09	TCGA-B6-A0IN-01A-11D-A032-05	TCGA-B6-A0IN-01		TCGA-B6-A0IN-01A-11W-A050-09	TCGA-B6-A0IN-01	4eaae575-d631-4e2e-8e70-4b4e0a429d74	TCGA-B6-A0IN-01	TCGA-B6-A0IN-01A-11D-A036-01		TCGA-B6-A0IN-01A-11R-A034-07	4eaae575-d631-4e2e-8e70-4b4e0a429d74	TCGA-B6-A0IN-01A-11D-A036-01	TCGA-B6-A0IN-01
TCGA-B6-A0IQ-01	Stage IIIA	40.0	1.0	No_Conversion	4284.0		Negative	FEMALE	Negative	2.0	2.0	2.0	Negative	M0	Positive	N1	4284.0	0.0	Basal	Basal-like	Negative	Basal	-13.0	-12.0	followup	T_Other	T3	LIVING	TCGA-B6-A0IQ-01	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 5	mutation cluster 5	TCGA-B6-A0IQ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40.0	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0IQ-F12629	TCGA-B6-A0IQ	TCGA-B6-A0IQ-01A		Negative					Negative	Modified Radical Mastectomy		NO			-14669.0	5238.0		0.0	4285.0						Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	210.0	NO				26.0	Negative	Indeterminate (neither Pre or Postmenopausal)																				5.0	5.0								NO	1.0		True	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F.pdf	A0IQ	TUMOR FREE	Image Analysis									YES	Primary Tumor	1		4th	YES	NO	YES	B6	Breast	A	LIVING	1996.0	2e9c893c-1d72-49a7-8755-1ede20b26fcf	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA-B6-A0IQ-01A-21-A13B-20	TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01		940d8074-3223-49f6-8d86-d50e9ae69c9b	TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01A-11D-A032-05	TCGA-B6-A0IQ-01		TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01A-11D-A036-01		TCGA-B6-A0IQ-01A-11R-A034-07	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA-B6-A0IQ-01A-11D-A036-01	TCGA-B6-A0IQ-01
TCGA-B6-A0RH-01	Stage IIA	51.0	2.0	Stage IIA	5748.0		Positive	FEMALE	Positive	3.0	3.0	3.0	Negative	M0	Negative	N0	5748.0	0.0	Her2	HER2-enriched	Positive	ReacII	-1.0	-5.0	followup	T_Other	T2	LIVING	TCGA-B6-A0RH-01	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-B6-A0RH	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	YES		51.0	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-B6-A0RH-F71512	TCGA-B6-A0RH	TCGA-B6-A0RH-01A	Negative	Positive					Positive	Modified Radical Mastectomy		NO		2268.0	-18759.0	6821.0	6456.0	0.0	5749.0			2165			Immunohistochemistry			Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	130.0	NO			NO	23.0	Positive	Indeterminate (neither Pre or Postmenopausal)																				2.0	6.0				Other, specify	Locoregional Disease	Chest Wall		NO	0.0		True	No	M0	N0 (i-)	T2	Stage IIA	TCGA-B6-A0RH.3801F39A-6F4B-40C0-9625-9E0818266819.pdf	A0RH	TUMOR FREE	Immunohistochemistry					YES	YES			NO	Primary Tumor	1		6th	YES	NO	YES	B6	Breast	A	DECEASED	1991.0	d40f62c9-c134-4477-98d7-11d343b5e867	d40f62c9-c134-4477-98d7-11d343b5e867	TCGA-B6-A0RH-01A-11-A13C-20	TCGA-B6-A0RH-01A-21D-A10Y-09	TCGA-B6-A0RH-01		90975b3f-f130-4032-804a-88f06b0d3147	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21D-A10Y-09	TCGA-B6-A0RH-01A-21D-A112-05	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21D-A10Y-09		d40f62c9-c134-4477-98d7-11d343b5e867		TCGA-B6-A0RH-01A-21D-A111-01	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21R-A115-07	d40f62c9-c134-4477-98d7-11d343b5e867	TCGA-B6-A0RH-01A-21D-A111-01	TCGA-B6-A0RH-01
TCGA-B6-A0WS-01		58.0	4.0	Stage I		2965.0	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2965.0	1.0	LumA	Luminal A	Positive		0.0	-4.0	followup	T1	T1	DECEASED	TCGA-B6-A0WS-01	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-B6-A0WS	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58.0	Left Upper Outer Quadrant|Left	No axillary staging		TCGA-B6-A0WS-F15707	TCGA-B6-A0WS	TCGA-B6-A0WS-01A		Positive					Positive	Lumpectomy		NO			-21230.0	5113.0	2965.0	0.0							Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	110.0	NO					Positive	Indeterminate (neither Pre or Postmenopausal)																				1.0	7.0								NO			True	No	MX	NX	T1c	Stage X	TCGA-B6-A0WS.36AE47A6-B881-4C1D-8436-EB65783243CF.pdf	A0WS	TUMOR FREE	Image Analysis						NO			NO	Primary Tumor	1		4th	NO	NO	YES	B6	Breast	A	DECEASED	1996.0	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b		TCGA-B6-A0WS-01A-11D-A10Y-09	TCGA-B6-A0WS-01			TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11D-A10Y-09	TCGA-B6-A0WS-01A-11D-A112-05	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11D-A10Y-09		44bd10a8-c4c0-466c-8cd8-31a5da70ba0b		TCGA-B6-A0WS-01A-11D-A111-01	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11R-A115-07	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	TCGA-B6-A0WS-01A-11D-A111-01	TCGA-B6-A0WS-01
TCGA-B6-A0X1-01	Stage IV	48.0	3.0	No_Conversion	5671.0		Negative	FEMALE					Positive	M1	Positive	N2	5671.0	0.0	Basal	Basal-like	Negative	Basal	-13.0	-12.0	followup	T_Other	T2	LIVING	TCGA-B6-A0X1-01	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation cluster 5	TCGA-B6-A0X1	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		48.0	Left	Axillary lymph node dissection alone		TCGA-B6-A0X1-F71498	TCGA-B6-A0X1	TCGA-B6-A0X1-01A		Negative					Negative	Other		NO			-17624.0	6035.0	7455.0	0.0	5677.0			490			Image Analysis			Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240.0	NO			NO	21.0	Negative	Indeterminate (neither Pre or Postmenopausal)																				5.0					Brain	Distant Metastasis			NO	16.0		True	No	M1	N1	T2	Stage IIB	TCGA-B6-A0X1.D792031E-2CCE-4341-B3B3-C7D1D84F8F6B.pdf	A0X1	TUMOR FREE	Image Analysis					NO				NO	Primary Tumor	1	Fine needle aspiration biopsy	4th	YES	NO	YES	B6	Breast	A	DECEASED	1994.0	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	TCGA-B6-A0X1-01A-21-A13D-20	TCGA-B6-A0X1-01A-11D-A10G-09	TCGA-B6-A0X1-01	TCGA-B6-A0X1-01A-11D-A10A-05	03c36239-f261-44e4-829b-01e679a414ad	TCGA-B6-A0X1-01	TCGA-B6-A0X1-01A-11D-A10G-09		TCGA-B6-A0X1-01		TCGA-B6-A0X1-01A-11D-A10G-09		897b769d-f66a-4baf-b5fa-fe92ed49a8b4		TCGA-B6-A0X1-01A-11D-A107-01		TCGA-B6-A0X1-01A-11R-A109-07	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	TCGA-B6-A0X1-01A-11D-A107-01	TCGA-B6-A0X1-01
TCGA-BH-A0AU-11		45.0			746.0			FEMALE									746.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0AU-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AU	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45.0	Left Upper Inner Quadrant			TCGA-BH-A0AU-F60769	TCGA-BH-A0AU			Positive					Positive	Other					-16688.0			0.0	1914.0					NO					2014-6-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Positive	Negative	NO	2.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0.0			No	M0	N0	T2	Stage IIA		A0AU	TUMOR FREE						NO	YES			YES	Solid Tissue Normal	11	left segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	Breast		LIVING	2008.0	eb7e6bfc-79ad-4674-9d58-2cbad8c65658	eb7e6bfc-79ad-4674-9d58-2cbad8c65658				TCGA-BH-A0AU-11A-11D-A12R-05						TCGA-BH-A0AU-11			eb7e6bfc-79ad-4674-9d58-2cbad8c65658			TCGA-BH-A0AU-11	TCGA-BH-A0AU-11A-11R-A12P-07	eb7e6bfc-79ad-4674-9d58-2cbad8c65658		
TCGA-BH-A0AY-11		62.0			777.0			FEMALE									777.0	0.0	Normal						followup			LIVING	TCGA-BH-A0AY-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AY	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62.0	Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0AY-F15456	TCGA-BH-A0AY	TCGA-BH-A0AY-11A		Positive					Positive	Simple Mastectomy		NO			-22703.0	587.0		0.0	777.0									Scheduled Follow-up Submission	2010-11-3	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360.0	NO	Negative			1.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0		True	No	M0	N0 (i-)	T2	Stage IIA		A0AY	TUMOR FREE										NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2008.0	d9c8ecc3-0e92-49e9-99e4-9976785c73a6	d9c8ecc3-0e92-49e9-99e4-9976785c73a6				TCGA-BH-A0AY-11A-23D-A10Q-05	80042D05-76C1-40BE-90E4-5391A86314E9							TCGA-BH-A0AY-11	d9c8ecc3-0e92-49e9-99e4-9976785c73a6	TCGA-BH-A0AY-11			TCGA-BH-A0AY-11A-23R-A089-07	d9c8ecc3-0e92-49e9-99e4-9976785c73a6		
TCGA-BH-A0AZ-11		47.0			867.0			FEMALE									867.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0AZ-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AZ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47.0	Right			TCGA-BH-A0AZ-F58602	TCGA-BH-A0AZ			Positive					Positive	Other					-17465.0			0.0	1919.0					NO					2014-4-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	13.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1.0			No	cM0 (i+)	N1a	T3	Stage IIIA		A0AZ	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11	total mastectomy with sentinel lymph node biopsy with tissue reconstruction	6th		NO	YES	BH	Breast		LIVING	2008.0	ec31d946-74b0-4984-b3d8-cb1bf58e4d20	ec31d946-74b0-4984-b3d8-cb1bf58e4d20				TCGA-BH-A0AZ-11A-22D-A12R-05						TCGA-BH-A0AZ-11			ec31d946-74b0-4984-b3d8-cb1bf58e4d20			TCGA-BH-A0AZ-11		ec31d946-74b0-4984-b3d8-cb1bf58e4d20		
TCGA-BH-A0B2-11		43.0			1242.0			FEMALE									1242.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0B2-11										TCGA-BH-A0B2	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast											TCGA-BH-A0B2-11A														1031.0																																			130.0	NO																																						True																			Solid Tissue Normal	11								A			83b0bb89-66a7-4c70-87e1-78a0cc7de9e6	83b0bb89-66a7-4c70-87e1-78a0cc7de9e6				TCGA-BH-A0B2-11A-11D-A10N-05									83b0bb89-66a7-4c70-87e1-78a0cc7de9e6				TCGA-BH-A0B2-11A-11R-A10J-07	83b0bb89-66a7-4c70-87e1-78a0cc7de9e6		
TCGA-BH-A0B3-11		53.0			1203.0			FEMALE									1203.0	0.0	Normal						followup			LIVING	TCGA-BH-A0B3-11		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A0B3	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53.0	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0B3-F15418	TCGA-BH-A0B3			Negative		0			Negative	Other		NO			-19479.0			0.0	1203.0									Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy			Negative			29.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2.0			No	M0	N1a	T2	Stage IIB		A0B3	TUMOR FREE										YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast		LIVING	2007.0	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437				TCGA-BH-A0B3-11B-21D-A10Q-05								TCGA-BH-A0B3-11	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437	TCGA-BH-A0B3-11			TCGA-BH-A0B3-11B-21R-A089-07	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437		
TCGA-BH-A0B5-11		40.0			1471.0			FEMALE									1471.0	0.0	LumA						enrollment			LIVING	TCGA-BH-A0B5-11		C3-BRCA/Luminal							mutation cluster 1	TCGA-BH-A0B5	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40.0	Left			TCGA-BH-A0B5-F59182	TCGA-BH-A0B5	TCGA-BH-A0B5-11A		Positive					Positive	Modified Radical Mastectomy					-14920.0	1008.0		0.0	2136.0					NO					2014-5-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	600.0	NO	Negative		NO	24.0	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	5.0		True	No	M0	N2a	T2	Stage IIIA		A0B5	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007.0	35429f42-252a-4a9d-8e99-125f26019418	35429f42-252a-4a9d-8e99-125f26019418													35429f42-252a-4a9d-8e99-125f26019418				TCGA-BH-A0B5-11A-23R-A12P-07	35429f42-252a-4a9d-8e99-125f26019418		
TCGA-BH-A0B6-01																													TCGA-BH-A0B6-01	Squamous			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 3			TCGA-BH-A0B6	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47.0	Left Upper Outer Quadrant			TCGA-BH-A0B6-F61943	TCGA-BH-A0B6			Positive					Positive	Other					-17346.0			0.0	2483.0					NO					2014-7-10	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Positive		NO	4.0	Negative																														NO	0.0			Yes	M0	N0	T1c	Stage I		A0B6	TUMOR FREE						NO	YES			YES	Primary Tumor	1	segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast		LIVING	2006.0	b455387f-a8b4-43b8-b898-89628723d7da	b455387f-a8b4-43b8-b898-89628723d7da	TCGA-BH-A0B6-01A-21-A24A-20		TCGA-BH-A0B6-01	TCGA-BH-A0B6-01A-11D-A19Z-05	e7cb5207-9749-4bfb-9982-58a8efca7a8f	TCGA-BH-A0B6-01	TCGA-BH-A0B6-01A-11D-A19Y-09						b455387f-a8b4-43b8-b898-89628723d7da		TCGA-BH-A0B6-01A-11D-A19X-01			b455387f-a8b4-43b8-b898-89628723d7da	TCGA-BH-A0B6-01A-11D-A19X-01	
TCGA-BH-A0B7-11		42.0			1733.0			FEMALE									1733.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0B7-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0B7	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42.0	Right			TCGA-BH-A0B7-F58717	TCGA-BH-A0B7	TCGA-BH-A0B7-11A		Positive					Positive	Other					-15593.0	1391.0		0.0	2559.0					NO					2014-4-22	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	930.0	NO	Positive		NO	17.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1.0		True	No	M0	N1a	T2	Stage IIB		A0B7	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP	6th		NO	YES	BH	Breast	A	LIVING	2006.0	30cee921-7fb5-4543-aeb6-ab3eaf669f84	30cee921-7fb5-4543-aeb6-ab3eaf669f84					A353AE14-6488-43F1-A9D1-BBD0C66D0814			TCGA-BH-A0B7-11A-34D-A112-05		TCGA-BH-A0B7-11			30cee921-7fb5-4543-aeb6-ab3eaf669f84			TCGA-BH-A0B7-11	TCGA-BH-A0B7-11A-34R-A115-07	30cee921-7fb5-4543-aeb6-ab3eaf669f84		
TCGA-BH-A0B8-11		64.0			1569.0			FEMALE									1569.0	0.0	Normal						followup			LIVING	TCGA-BH-A0B8-11									mutation c1uster 9	TCGA-BH-A0B8	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64.0	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0B8-F15442	TCGA-BH-A0B8	TCGA-BH-A0B8-11A		Positive		3+			Positive	Lumpectomy		NO			-23380.0	1401.0		0.0	1569.0							90-99%		Scheduled Follow-up Submission	2010-11-3	FEMALE					2+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	400.0	NO	Equivocal	Negative		2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0		True	No	M0	N0 (i-)	T1b	Stage I		A0B8	TUMOR FREE								30-39%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006.0	61e357f3-e4e1-49b8-9e37-7e0ef5a29e23	61e357f3-e4e1-49b8-9e37-7e0ef5a29e23				TCGA-BH-A0B8-11A-41D-A093-05									61e357f3-e4e1-49b8-9e37-7e0ef5a29e23				TCGA-BH-A0B8-11A-41R-A089-07	61e357f3-e4e1-49b8-9e37-7e0ef5a29e23		
TCGA-BH-A0BA-11		51.0			1132.0			FEMALE									1132.0	0.0	Normal						followup			LIVING	TCGA-BH-A0BA-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51.0	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BA-F15461	TCGA-BH-A0BA	TCGA-BH-A0BA-11A		Positive		1+			Positive	Modified Radical Mastectomy		NO			-18839.0	1266.0		0.0	1132.0							80-89%		Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Mixed Histology (please specify)	Infiltrating ductal & lobular	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	220.0	NO	Negative			27.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	27.0		True	No	M0	N3a	T3	Stage IIIC		A0BA	TUMOR FREE								40-49%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006.0	3bfd1811-bd2a-439d-8dde-237abcf855af	3bfd1811-bd2a-439d-8dde-237abcf855af				TCGA-BH-A0BA-11A-22D-A10Q-05									3bfd1811-bd2a-439d-8dde-237abcf855af				TCGA-BH-A0BA-11A-22R-A089-07	3bfd1811-bd2a-439d-8dde-237abcf855af		
TCGA-BH-A0BC-01	Stage IIIC	60.0	2.0	No_Conversion	974.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Positive	N3	974.0	0.0	LumA	Luminal A	Positive	ReacI	-4.0	-4.0	followup	T_Other	T2	LIVING	TCGA-BH-A0BC-01	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0BC	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60.0	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BC-F4487	TCGA-BH-A0BC	TCGA-BH-A0BC-01A		Positive		1+			Positive	Other		NO			-21949.0	1098.0		0.0	974.0							90-99%			2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	160.0	NO	Negative			18.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	4.0									12.0		True	No	M0	N3	T2	Stage IIIC	TCGA-BH-A0BC.9714A9F8-B507-43E6-9D56-1852F5D1F675.pdf	A0BC	TUMOR FREE								30-39%		YES	Primary Tumor	1	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007.0	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01A-11-A13B-20	TCGA-BH-A0BC-01A-22D-A099-09	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01A-22D-A10P-05	6b66ea4c-8556-4fc6-8014-f99e59727021	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01A-22D-A099-09		TCGA-BH-A0BC-01		TCGA-BH-A0BC-01A-22D-A099-09	TCGA-BH-A0BC-01	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01A-22D-A087-01		TCGA-BH-A0BC-01A-22R-A084-07	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01A-22D-A087-01	TCGA-BH-A0BC-01
TCGA-BH-A0BC-11		60.0			974.0			FEMALE									974.0	0.0	Normal						followup			LIVING	TCGA-BH-A0BC-11		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0BC	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60.0	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BC-F4487	TCGA-BH-A0BC	TCGA-BH-A0BC-11A		Positive		1+			Positive	Other		NO			-21949.0	1098.0		0.0	974.0							90-99%			2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200.0	NO	Negative			18.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														12.0		True	No	M0	N3	T2	Stage IIIC		A0BC	TUMOR FREE								30-39%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007.0	32336250-dc07-4e96-9a6c-3c7094fd5342	32336250-dc07-4e96-9a6c-3c7094fd5342				TCGA-BH-A0BC-11A-22D-A093-05								TCGA-BH-A0BC-11	32336250-dc07-4e96-9a6c-3c7094fd5342	TCGA-BH-A0BC-11			TCGA-BH-A0BC-11A-22R-A089-07	32336250-dc07-4e96-9a6c-3c7094fd5342		
TCGA-BH-A0BJ-11		41.0			660.0			FEMALE									660.0	0.0	Normal						followup			LIVING	TCGA-BH-A0BJ-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0BJ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41.0	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BJ-F4480	TCGA-BH-A0BJ	TCGA-BH-A0BJ-11A		Positive		3+			Positive	Other		NO			-15027.0	595.0		0.0	660.0						H-Score 300	90-99%			2010-11-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200.0	NO	Negative			18.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														2.0		True	No	M0	N1a	T2	Stage IIB		A0BJ	TUMOR FREE	H-Score 260			H-Score	H Score			70-79%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008.0	4317b197-dc43-44f2-8854-557832570098	4317b197-dc43-44f2-8854-557832570098				TCGA-BH-A0BJ-11A-23D-A10Q-05								TCGA-BH-A0BJ-11	4317b197-dc43-44f2-8854-557832570098	TCGA-BH-A0BJ-11			TCGA-BH-A0BJ-11A-23R-A089-07	4317b197-dc43-44f2-8854-557832570098		
TCGA-BH-A0BM-11		54.0			1117.0			FEMALE									1117.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0BM-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BM	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54.0	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BM-F34064	TCGA-BH-A0BM	TCGA-BH-A0BM-11A		Positive		0			Negative	Lumpectomy		NO			-20049.0	1080.0		0.0	1876.0									Scheduled Follow-up Submission	2012-7-29	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100.0	NO	Negative			24.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	3.0		True	No	M0	N1a	T2	Stage IIB		A0BM	TUMOR FREE										NO	Solid Tissue Normal	11		6th	YES	NO	YES	BH	Breast	A	LIVING	2007.0	fe538d53-c7ce-455f-afe6-cb4fc3a63dbd	fe538d53-c7ce-455f-afe6-cb4fc3a63dbd				TCGA-BH-A0BM-11A-12D-A093-05									fe538d53-c7ce-455f-afe6-cb4fc3a63dbd				TCGA-BH-A0BM-11A-12R-A089-07	fe538d53-c7ce-455f-afe6-cb4fc3a63dbd		
TCGA-BH-A0BQ-11		39.0			826.0			FEMALE									826.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0BQ-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0BQ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39.0	Left			TCGA-BH-A0BQ-F58695	TCGA-BH-A0BQ	TCGA-BH-A0BQ-11A		Positive					Positive	Other					-14494.0	1197.0		0.0	2255.0		1750.0	1709		NO					2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340.0	NO	Positive		NO	2.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																									Other, specify	Locoregional Recurrence	Dermis and epidermis	YES	YES	0.0		True	No	M0	N0	T1c	Stage I		A0BQ	TUMOR FREE						NO	YES			NO	Solid Tissue Normal	11	Total mastectomy with retromammary lymph node excision	6th		NO	YES	BH	Breast	A	LIVING	2007.0	4096c8a6-5ead-4410-8da1-a20b0f37cce8	4096c8a6-5ead-4410-8da1-a20b0f37cce8								TCGA-BH-A0BQ-11A-33D-A112-05		TCGA-BH-A0BQ-11			4096c8a6-5ead-4410-8da1-a20b0f37cce8			TCGA-BH-A0BQ-11	TCGA-BH-A0BQ-11A-33R-A115-07	4096c8a6-5ead-4410-8da1-a20b0f37cce8		
TCGA-BH-A0BS-11		55.0			1640.0			FEMALE									1640.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0BS-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BS	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55.0	Left			TCGA-BH-A0BS-F61955	TCGA-BH-A0BS	TCGA-BH-A0BS-11A		Positive					Positive	Simple Mastectomy					-20374.0	1164.0		0.0	2612.0					NO					2014-8-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200.0	NO		Negative	NO	11.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0		True	No	M0	N1c	T3	Stage IIIA		A0BS	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007.0	10d54893-647f-40a9-8aa7-602e04d55faf	10d54893-647f-40a9-8aa7-602e04d55faf				TCGA-BH-A0BS-11A-11D-A12R-05						TCGA-BH-A0BS-11			10d54893-647f-40a9-8aa7-602e04d55faf			TCGA-BH-A0BS-11	TCGA-BH-A0BS-11A-11R-A12P-07	10d54893-647f-40a9-8aa7-602e04d55faf		
TCGA-BH-A0BT-11		56.0			1386.0			FEMALE									1386.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0BT-11		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0BT	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56.0	Right Upper Inner Quadrant			TCGA-BH-A0BT-F59143	TCGA-BH-A0BT	TCGA-BH-A0BT-11A		Positive					Positive	Other					-20625.0	1167.0		0.0	2365.0					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130.0	NO	Negative		NO		Negative																														NO			True	No	M0	N1mi	T1c	Stage IIA		A0BT	TUMOR FREE						YES				YES	Solid Tissue Normal	11	segmental mastectomy with sentinel lymph node excision and biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007.0	8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef	8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef				TCGA-BH-A0BT-11A-21D-A12R-05						TCGA-BH-A0BT-11			8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef			TCGA-BH-A0BT-11		8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef		
TCGA-BH-A0BV-01	Stage IIB	78.0	5.0	No_Conversion	1519.0		Positive	FEMALE	Negative	1.0	3.0	3.0	Negative	M0	Positive	N1	1519.0	0.0	LumA	Luminal A	Positive	LumA/B	0.0	-4.0	followup	T_Other	T2	LIVING	TCGA-BH-A0BV-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 4	TCGA-BH-A0BV	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78.0	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BV-F4513	TCGA-BH-A0BV	TCGA-BH-A0BV-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-28699.0	1328.0		0.0	1519.0							90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	450.0	NO	Negative			25.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	7.0									2.0		True	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0BV.7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3.pdf	A0BV	TUMOR FREE								50-59%		NO	Primary Tumor	1			YES	NO	YES	BH	Breast	A	LIVING	2006.0	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	TCGA-BH-A0BV-01A-21-A13B-20	TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01		7815a57a-e2d9-42ae-93f3-6ddcf1f33ab2	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01A-11D-A00Y-05	TCGA-BH-A0BV-01		TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01A-11D-A011-01		TCGA-BH-A0BV-01A-11R-A00Z-07	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	TCGA-BH-A0BV-01A-11D-A011-01	TCGA-BH-A0BV-01
TCGA-BH-A0BV-11		78.0			1519.0			FEMALE									1519.0	0.0	Normal						followup			LIVING	TCGA-BH-A0BV-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BV	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78.0	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BV-F4513	TCGA-BH-A0BV	TCGA-BH-A0BV-11A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-28699.0	1328.0		0.0	1519.0							90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200.0	NO	Negative			25.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														2.0		True	No	M0	N1a	T2	Stage IIB		A0BV	TUMOR FREE								50-59%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006.0	452bf9da-c065-4d95-8272-adce3684a9e9	452bf9da-c065-4d95-8272-adce3684a9e9				TCGA-BH-A0BV-11A-31D-A10Q-05								TCGA-BH-A0BV-11	452bf9da-c065-4d95-8272-adce3684a9e9	TCGA-BH-A0BV-11			TCGA-BH-A0BV-11A-31R-A089-07	452bf9da-c065-4d95-8272-adce3684a9e9		
TCGA-BH-A0BW-11		71.0			355.0			FEMALE									355.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0BW-11		C4-BRCA/Basal							mutation c1uster 9	TCGA-BH-A0BW	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71.0	Left Lower Outer Quadrant			TCGA-BH-A0BW-F59127	TCGA-BH-A0BW			Negative					Negative	Other					-25974.0			0.0	2371.0					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	NO	8.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0			No	M0	N0	T1c	Stage I		A0BW	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	Segmental mastectomy	6th		NO	YES	BH	Breast		LIVING	2006.0	ca5076dc-0fb2-444f-b34f-305c8479cba3	ca5076dc-0fb2-444f-b34f-305c8479cba3								TCGA-BH-A0BW-11A-12D-A112-05		TCGA-BH-A0BW-11			ca5076dc-0fb2-444f-b34f-305c8479cba3			TCGA-BH-A0BW-11	TCGA-BH-A0BW-11A-12R-A115-07	ca5076dc-0fb2-444f-b34f-305c8479cba3		
TCGA-BH-A0BZ-11		59.0			1492.0			FEMALE									1492.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0BZ-11		C3-BRCA/Luminal							mutation c1uster 10	TCGA-BH-A0BZ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59.0	Left			TCGA-BH-A0BZ-F58683	TCGA-BH-A0BZ	TCGA-BH-A0BZ-11A		Positive					Positive	Modified Radical Mastectomy					-21856.0	1084.0		0.0	2255.0					NO					2014-4-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	620.0	NO	Negative		NO	23.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1.0		True	No	M0	N1a	T3	Stage IIIA		A0BZ	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007.0	561e0da7-0e2c-430c-8a54-c9a3535a1679	561e0da7-0e2c-430c-8a54-c9a3535a1679				TCGA-BH-A0BZ-11A-61D-A12R-05	C3371B54-7D2D-4868-B8EF-E5C0466B0172					TCGA-BH-A0BZ-11			561e0da7-0e2c-430c-8a54-c9a3535a1679			TCGA-BH-A0BZ-11	TCGA-BH-A0BZ-11A-61R-A12P-07	561e0da7-0e2c-430c-8a54-c9a3535a1679		
TCGA-BH-A0C0-11		62.0			1270.0			FEMALE									1270.0	0.0	Normal						followup			LIVING	TCGA-BH-A0C0-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0C0	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62.0	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0C0-F4518	TCGA-BH-A0C0	TCGA-BH-A0C0-11A		Positive					Positive	Other		NO			-23006.0	1094.0		0.0	1270.0							90-99%	2.65		2010-11-16	FEMALE					2+	40.0	12.45	4.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	330.0	NO	Equivocal	Positive		35.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														1.0		True	No	M0	N1a	T1c	Stage IIA		A0C0	TUMOR FREE								60-69%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007.0	86c4b2fd-d034-469d-adfa-712055f30dc3	86c4b2fd-d034-469d-adfa-712055f30dc3				TCGA-BH-A0C0-11A-21D-A10Q-05								TCGA-BH-A0C0-11	86c4b2fd-d034-469d-adfa-712055f30dc3	TCGA-BH-A0C0-11			TCGA-BH-A0C0-11A-21R-A089-07	86c4b2fd-d034-469d-adfa-712055f30dc3		
TCGA-BH-A0C3-11		47.0			1464.0			FEMALE									1464.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0C3-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0C3	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47.0	Left			TCGA-BH-A0C3-F63533	TCGA-BH-A0C3	TCGA-BH-A0C3-11A		Positive					Negative	Other					-17221.0	1335.0		0.0	2709.0			2674		NO					2014-8-12	FEMALE										Mixed Histology (please specify)	with ductal and lobular phenotypes	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	200.0	NO	Negative		NO	4.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																									Bone	Distant Metastasis			YES	0.0		True	No	M0	N0	T1c	Stage I		A0C3	WITH TUMOR						YES	YES			YES	Solid Tissue Normal	11	Segmental mastectomy with sentinel node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2006.0	65923c68-2c86-4b4d-abe2-5320c08bb68f	65923c68-2c86-4b4d-abe2-5320c08bb68f				TCGA-BH-A0C3-11A-23D-A12R-05						TCGA-BH-A0C3-11			65923c68-2c86-4b4d-abe2-5320c08bb68f			TCGA-BH-A0C3-11	TCGA-BH-A0C3-11A-23R-A12P-07	65923c68-2c86-4b4d-abe2-5320c08bb68f		
TCGA-BH-A0DD-11		58.0			1393.0			MALE									1393.0	0.0	LumA						enrollment			LIVING	TCGA-BH-A0DD-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DD	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58.0	Right			TCGA-BH-A0DD-F60386	TCGA-BH-A0DD	TCGA-BH-A0DD-11A		Positive					Positive	Modified Radical Mastectomy					-21386.0	1248.0		0.0	2486.0					NO					2014-6-9	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	460.0	NO	Positive	Positive	NO	22.0	Negative																														NO	0.0		True	No	M0	N1a	T2	Stage IIB		A0DD	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2006.0	c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5	c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5													c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5				TCGA-BH-A0DD-11A-23R-A12P-07	c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5		
TCGA-BH-A0DG-11		30.0			713.0			FEMALE									713.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0DG-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DG	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					30.0	Right Upper Outer Quadrant			TCGA-BH-A0DG-F63658	TCGA-BH-A0DG	TCGA-BH-A0DG-11A		Positive					Negative	Other					-11204.0	972.0		0.0	2041.0					NO					2014-8-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	470.0	NO	Negative		NO	3.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0.0		True	No	M0	N0	T2	Stage IIA		A0DG	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	Total mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2007.0	61c8278b-4c06-4563-b1ac-97cceec76ca4	61c8278b-4c06-4563-b1ac-97cceec76ca4				TCGA-BH-A0DG-11A-43D-A12R-05						TCGA-BH-A0DG-11			61c8278b-4c06-4563-b1ac-97cceec76ca4			TCGA-BH-A0DG-11		61c8278b-4c06-4563-b1ac-97cceec76ca4		
TCGA-BH-A0DH-11		63.0			1156.0			FEMALE									1156.0	0.0	Normal						followup			LIVING	TCGA-BH-A0DH-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DH	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63.0	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0DH-F4529	TCGA-BH-A0DH	TCGA-BH-A0DH-11A	Negative	Positive		3+		Mastectomy NOS	Positive	Other		NO			-23366.0	968.0		0.0	1156.0							90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	280.0	NO	Negative			28.0	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														3.0		True	No	M0	N1a	T2	Stage IIB		A0DH	TUMOR FREE								40-49%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007.0	4a8c96d9-b08d-4812-93ec-c8c9db8139aa	4a8c96d9-b08d-4812-93ec-c8c9db8139aa				TCGA-BH-A0DH-11A-31D-A10Q-05									4a8c96d9-b08d-4812-93ec-c8c9db8139aa				TCGA-BH-A0DH-11A-31R-A089-07	4a8c96d9-b08d-4812-93ec-c8c9db8139aa		
TCGA-BH-A0DK-01	Stage IIA	49.0	2.0	Stage IIA	423.0		Positive	FEMALE	Negative	4.0	3.0	3.0	Negative	M0	Negative	N0	423.0	0.0	LumA	Luminal A	Positive	LumA/B	-4.0	-4.0	followup	T_Other	T2	LIVING	TCGA-BH-A0DK-01	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-BH-A0DK	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49.0	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0DK-F4532	TCGA-BH-A0DK	TCGA-BH-A0DK-01A		Positive					Positive	Simple Mastectomy		NO			-18237.0	254.0		0.0	423.0						H-SCORE 260				2010-11-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	240.0	NO	Negative			3.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3.0	2.0									0.0		True	No	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0DK.1E3F22FC-3D82-4911-9C97-8CB87A3D131C.pdf	A0DK	TUMOR FREE	H-SCORE 120			H-SCORE	H-SCORE					NO	Primary Tumor	1			YES	NO	YES	BH	Breast	A	LIVING	2009.0	fef221ff-634b-4188-92cf-5723b9a3c04d	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01A-11-A13B-20	TCGA-BH-A0DK-01A-21W-A071-09	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01A-21D-A10P-05	1ae8085b-99e9-4a9c-94a7-bcf4f903b95a	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01A-21W-A071-09		TCGA-BH-A0DK-01		TCGA-BH-A0DK-01A-21W-A071-09	TCGA-BH-A0DK-01	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01A-21D-A059-01		TCGA-BH-A0DK-01A-21R-A056-07	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01A-21D-A059-01	TCGA-BH-A0DK-01
TCGA-BH-A0DK-11		49.0			423.0			FEMALE									423.0	0.0	LumA						followup			LIVING	TCGA-BH-A0DK-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DK	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49.0	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0DK-F4532	TCGA-BH-A0DK	TCGA-BH-A0DK-11A		Positive					Positive	Simple Mastectomy		NO			-18237.0	254.0		0.0	423.0						H-SCORE 260				2010-11-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	550.0	NO	Negative			3.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														0.0		True	No	M0	N0 (i-)	T2	Stage IIA		A0DK	TUMOR FREE	H-SCORE 120			H-SCORE	H-SCORE					NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009.0	4c1d73ba-31f8-4652-a83d-cc367dde9f43	4c1d73ba-31f8-4652-a83d-cc367dde9f43				TCGA-BH-A0DK-11A-13D-A10Q-05	F17E1810-1E54-4920-A1EA-A5B693205A55							TCGA-BH-A0DK-11	4c1d73ba-31f8-4652-a83d-cc367dde9f43	TCGA-BH-A0DK-11			TCGA-BH-A0DK-11A-13R-A089-07	4c1d73ba-31f8-4652-a83d-cc367dde9f43		
TCGA-BH-A0DL-11		64.0			1467.0			FEMALE									1467.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0DL-11		C4-BRCA/Basal							mutation cluster 3	TCGA-BH-A0DL	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64.0	Left			TCGA-BH-A0DL-F60389	TCGA-BH-A0DL			Positive					Negative	Other					-23628.0			0.0	2381.0					NO					2014-6-9	FEMALE										Other, specify		No		C50.9	8575/3	C50.9		YES		Core needle biopsy			Negative		NO	3.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0			No	M0	N0	T2	Stage IIA		A0DL	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast		LIVING	2007.0	f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d	f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d								TCGA-BH-A0DL-11A-13D-A112-05		TCGA-BH-A0DL-11			f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d			TCGA-BH-A0DL-11	TCGA-BH-A0DL-11A-13R-A115-07	f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d		
TCGA-BH-A0DO-11		78.0			525.0			FEMALE									525.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0DO-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DO	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78.0	Left Upper Inner Quadrant			TCGA-BH-A0DO-F63671	TCGA-BH-A0DO			Positive					Positive	Simple Mastectomy					-28529.0			0.0	1644.0					NO					2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0			Yes	M0	N0	T1c	Stage I		A0DO	TUMOR FREE						NO	YES			NO	Solid Tissue Normal	11		6th		NO	YES	BH	Breast		LIVING	2009.0	eb9e415f-0545-4e97-ad35-b56b0f3db79b	eb9e415f-0545-4e97-ad35-b56b0f3db79b								TCGA-BH-A0DO-11A-22D-A12E-05		TCGA-BH-A0DO-11			eb9e415f-0545-4e97-ad35-b56b0f3db79b			TCGA-BH-A0DO-11	TCGA-BH-A0DO-11A-22R-A12D-07	eb9e415f-0545-4e97-ad35-b56b0f3db79b		
TCGA-BH-A0DP-11		60.0			476.0			FEMALE									476.0	0.0	Normal						followup			LIVING	TCGA-BH-A0DP-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DP	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60.0	Right	Sentinel node biopsy alone		TCGA-BH-A0DP-F4538	TCGA-BH-A0DP	TCGA-BH-A0DP-11A		Positive		3+			Positive	Simple Mastectomy		NO			-22199.0	293.0		0.0	476.0						H-SCORE 280	80-89%			2010-11-16	FEMALE			<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	290.0	NO	Negative			4.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0.0		True	No	M0	N0 (i-)	T3	Stage IIB		A0DP	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE			80-89%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009.0	6ff2976a-2570-409b-afde-b7d2e7f2e4ea	6ff2976a-2570-409b-afde-b7d2e7f2e4ea				TCGA-BH-A0DP-11A-12D-A10Q-05	6B935910-61A6-4AC5-87EB-D3557C0777E4							TCGA-BH-A0DP-11	6ff2976a-2570-409b-afde-b7d2e7f2e4ea	TCGA-BH-A0DP-11			TCGA-BH-A0DP-11A-12R-A089-07	6ff2976a-2570-409b-afde-b7d2e7f2e4ea		
TCGA-BH-A0DQ-11		42.0			98.0			FEMALE									98.0	0.0	LumA						followup			LIVING	TCGA-BH-A0DQ-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DQ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42.0	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DQ-F4560	TCGA-BH-A0DQ	TCGA-BH-A0DQ-11A		Positive		1+			Positive	Other		NO			-15533.0	190.0		0.0	98.0						H-SCORE 136	60-69%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	100.0	NO	Negative			25.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														1.0		True	No	M0	N1	T2	Stage IIB		A0DQ	TUMOR FREE	H-SCORE 140			H-SCORE	H-SCORE			70-79%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009.0	2b11e565-01a8-4054-a200-03e06765bd5e	2b11e565-01a8-4054-a200-03e06765bd5e				TCGA-BH-A0DQ-11A-12D-A10Q-05								TCGA-BH-A0DQ-11	2b11e565-01a8-4054-a200-03e06765bd5e	TCGA-BH-A0DQ-11			TCGA-BH-A0DQ-11A-12R-A089-07	2b11e565-01a8-4054-a200-03e06765bd5e		
TCGA-BH-A0DS-01	Stage IIIA	71.0	3.0	No_Conversion	77.0		Positive	FEMALE	Negative	4.0	5.0	3.0	Negative	M0	Positive	N2	77.0	0.0	LumA	Luminal A	Positive	LumA	-5.0	-7.0	followup	T_Other	T2	LIVING	TCGA-BH-A0DS-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-BH-A0DS	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71.0	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DS-F4573	TCGA-BH-A0DS	TCGA-BH-A0DS-01A		Positive		2+			Positive	Other		NO			-25944.0	79.0		0.0	78.0						H-SCORE 190	70-79%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	200.0	NO	Negative			14.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3.0	6.0									8.0		True	No	M0	N2a	T2	Stage IIIA	TCGA-BH-A0DS.E4CBDC29-63E2-4CF0-B02F-16CA9C69F26E.pdf	A0DS	TUMOR FREE	H-SCORE 162			H-SCORE	H-SCORE			70-79%		YES	Primary Tumor	1	Segmental mastectomy	7th	YES	NO	YES	BH	Breast	A	LIVING	2010.0	00ee8acd-0841-4c85-a99a-8966a6828dd7	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01A-21-A13B-20	TCGA-BH-A0DS-01A-11W-A071-09	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01A-11D-A10P-05	ad643947-edbf-4a15-a959-76ffd5589907	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01A-11W-A071-09		TCGA-BH-A0DS-01		TCGA-BH-A0DS-01A-11W-A071-09	TCGA-BH-A0DS-01	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01A-11D-A059-01		TCGA-BH-A0DS-01A-11R-A056-07	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01A-11D-A059-01	TCGA-BH-A0DS-01
TCGA-BH-A0DT-11		41.0			1170.0			FEMALE									1170.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0DT-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DT	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41.0	Right			TCGA-BH-A0DT-F59149	TCGA-BH-A0DT	TCGA-BH-A0DT-11A		Positive					Positive	Other					-15078.0	1044.0		0.0	2403.0					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250.0	NO	Negative		NO	18.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1.0		True	No	M0	N1a	T1c	Stage IIA		A0DT	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	Total mastectomy with sentinel lymoh node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007.0	75ba5803-449e-4770-8105-b675af8e6907	75ba5803-449e-4770-8105-b675af8e6907								TCGA-BH-A0DT-11A-12D-A12E-05		TCGA-BH-A0DT-11			75ba5803-449e-4770-8105-b675af8e6907			TCGA-BH-A0DT-11	TCGA-BH-A0DT-11A-12R-A12D-07	75ba5803-449e-4770-8105-b675af8e6907		
TCGA-BH-A0DV-11		54.0			1374.0			FEMALE									1374.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0DV-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DV	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54.0	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left			TCGA-BH-A0DV-F63672	TCGA-BH-A0DV	TCGA-BH-A0DV-11A		Positive					Positive	Modified Radical Mastectomy					-19781.0	975.0		0.0	2064.0					NO					2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200.0	NO	Negative		NO	9.0	Negative	Peri (6-12 months since last menstrual period)																													NO	9.0		True	No	M0	N2a	T2	Stage IIIA		A0DV	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007.0	09f570eb-a751-41db-9511-300be228f24e	09f570eb-a751-41db-9511-300be228f24e				TCGA-BH-A0DV-11A-22D-A12R-05						TCGA-BH-A0DV-11			09f570eb-a751-41db-9511-300be228f24e			TCGA-BH-A0DV-11	TCGA-BH-A0DV-11A-22R-A12P-07	09f570eb-a751-41db-9511-300be228f24e		
TCGA-BH-A0DZ-11		43.0			495.0			FEMALE									495.0	0.0							followup			LIVING	TCGA-BH-A0DZ-11		C3-BRCA/Luminal							mutation cluster 2	TCGA-BH-A0DZ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43.0	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DZ-F4588	TCGA-BH-A0DZ			Positive		2+			Positive	Simple Mastectomy		NO			-15980.0			0.0	495.0						H-SCORE 140	50-59%			2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy			Positive			5.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														1.0			No	M0	N1a	T2	Stage IIB		A0DZ	TUMOR FREE	H-SCORE 15			H-SCORE	H-SCORE			<10%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast		LIVING	2009.0	f59f9272-412f-4884-9874-a6ff59ab1740	f59f9272-412f-4884-9874-a6ff59ab1740				TCGA-BH-A0DZ-11A-22D-A10Q-05								TCGA-BH-A0DZ-11	f59f9272-412f-4884-9874-a6ff59ab1740	TCGA-BH-A0DZ-11			TCGA-BH-A0DZ-11A-22R-A089-07	f59f9272-412f-4884-9874-a6ff59ab1740		
TCGA-BH-A0E0-11		38.0			133.0			FEMALE									133.0	0.0	Normal						followup			LIVING	TCGA-BH-A0E0-11		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A0E0	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38.0	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0E0-F4603	TCGA-BH-A0E0	TCGA-BH-A0E0-11A		Negative		0			Negative	Modified Radical Mastectomy		NO			-14175.0	136.0		0.0	134.0						H-SCORE 0				2010-10-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	140.0	NO	Negative			21.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														10.0		True	No	M0	N3a	T3	Stage IIIC		A0E0	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE					YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009.0	5cc82d2c-f960-40c3-9b37-59e087563dc1	5cc82d2c-f960-40c3-9b37-59e087563dc1				TCGA-BH-A0E0-11A-13D-A10Q-05									5cc82d2c-f960-40c3-9b37-59e087563dc1				TCGA-BH-A0E0-11A-13R-A089-07	5cc82d2c-f960-40c3-9b37-59e087563dc1		
TCGA-BH-A0E1-11		52.0			477.0			FEMALE									477.0	0.0	Normal						followup			LIVING	TCGA-BH-A0E1-11		C3-BRCA/Luminal							mutation c1uster 10	TCGA-BH-A0E1	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52.0	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0E1-F4631	TCGA-BH-A0E1	TCGA-BH-A0E1-11A		Positive		3+			Positive	Simple Mastectomy		NO			-19192.0	301.0		0.0	477.0						H-SCORE 180	70-79%	1.67		2010-11-16	FEMALE					2+	40.0	2.81	1.69		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	500.0	NO	Equivocal	Negative		17.0	Negative	Peri (6-12 months since last menstrual period)																														2.0		True	No	M0	N1	T2	Stage IIB		A0E1	TUMOR FREE	H-SCORE 245			H-SCORE	H-SCORE			50-59%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009.0	b6302c6b-2bab-40b1-b835-7f285719fff5	b6302c6b-2bab-40b1-b835-7f285719fff5				TCGA-BH-A0E1-11A-13D-A10Q-05	B5FC6749-9A17-4739-9144-FE17660801C3							TCGA-BH-A0E1-11	b6302c6b-2bab-40b1-b835-7f285719fff5	TCGA-BH-A0E1-11			TCGA-BH-A0E1-11A-13R-A089-07	b6302c6b-2bab-40b1-b835-7f285719fff5		
TCGA-BH-A0E9-01	Stage IIB	53.0	3.0	Stage IIB	1405.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Positive	N1	1405.0	0.0	LumA	Luminal A	Positive	ReacI	-5.0	-7.0	enrollment	T_Other	T2	LIVING	TCGA-BH-A0E9-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-BH-A0E9	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53.0	Right			TCGA-BH-A0E9-F59107	TCGA-BH-A0E9	TCGA-BH-A0E9-01B		Positive					Positive	Modified Radical Mastectomy					-19415.0	1357.0		0.0	2489.0					NO					2014-5-1	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	480.0	NO	Negative		NO	12.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1.0	6.0								NO	3.0		True	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0E9.8FDACA3D-C172-4198-9BBB-8F9E5A5FF0D6.pdf	A0E9	TUMOR FREE						YES	YES			YES	Primary Tumor	1		6th		NO	YES	BH	Breast	B	LIVING	2006.0	bfc39e77-7a26-4699-a4a3-217d4ea9425b	bfc39e77-7a26-4699-a4a3-217d4ea9425b	TCGA-BH-A0E9-01B-21-A13A-20	TCGA-BH-A0E9-01B-11D-A10Y-09	TCGA-BH-A0E9-01		8eb64683-4ff3-4cc6-84ff-902fbb7a2bb1	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11D-A10Y-09	TCGA-BH-A0E9-01B-11D-A112-05	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11D-A10Y-09		bfc39e77-7a26-4699-a4a3-217d4ea9425b		TCGA-BH-A0E9-01B-11D-A111-01	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11R-A115-07	bfc39e77-7a26-4699-a4a3-217d4ea9425b	TCGA-BH-A0E9-01B-11D-A111-01	TCGA-BH-A0E9-01
TCGA-BH-A0H0-01	Stage IA	69.0	2.0	Stage I	461.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	461.0	0.0	LumB	Luminal B	Positive		-10.0	-3.0	followup	T1	T1	LIVING	TCGA-BH-A0H0-01	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-BH-A0H0	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69.0	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0H0-F4704	TCGA-BH-A0H0	TCGA-BH-A0H0-01A		Positive		2+			Positive	Other		NO			-25223.0	344.0		0.0	461.0						H-SCORE 190	50-59%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	70.0	NO	Negative			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	2.0									0.0		True	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0H0.94CF5704-1BE7-4CCC-870E-FB8527AC47E8.pdf	A0H0	TUMOR FREE	H-SCORE 7			H-SCORE	H-SCORE			<10%		YES	Primary Tumor	1	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009.0	38e26122-c473-41c1-afb0-cd3b9096e9f4	38e26122-c473-41c1-afb0-cd3b9096e9f4		TCGA-BH-A0H0-01A-11W-A071-09	TCGA-BH-A0H0-01	TCGA-BH-A0H0-01A-11D-A10P-05		TCGA-BH-A0H0-01	TCGA-BH-A0H0-01A-11W-A071-09		TCGA-BH-A0H0-01		TCGA-BH-A0H0-01A-11W-A071-09	TCGA-BH-A0H0-01	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01	TCGA-BH-A0H0-01A-11D-A059-01		TCGA-BH-A0H0-01A-11R-A056-07	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01A-11D-A059-01	TCGA-BH-A0H0-01
TCGA-BH-A0H5-11		45.0			1080.0			FEMALE									1080.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0H5-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0H5	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45.0	Right Upper Outer Quadrant			TCGA-BH-A0H5-F58727	TCGA-BH-A0H5			Positive					Positive	Other					-16719.0			0.0	1620.0					NO					2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	NO	1.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0			No	M0	N0 (i-)	T1c	Stage I		A0H5	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11	Right total mastectomy with lymph node left axillary lymph node excision	6th		NO	YES	BH	Breast		LIVING	2008.0	fe1a74fd-c9b4-405b-86a7-61bcb75f825d	fe1a74fd-c9b4-405b-86a7-61bcb75f825d								TCGA-BH-A0H5-11A-62D-A112-05		TCGA-BH-A0H5-11			fe1a74fd-c9b4-405b-86a7-61bcb75f825d			TCGA-BH-A0H5-11	TCGA-BH-A0H5-11A-62R-A115-07	fe1a74fd-c9b4-405b-86a7-61bcb75f825d		
TCGA-BH-A0H7-11		65.0			701.0			FEMALE									701.0	0.0	Normal						followup			LIVING	TCGA-BH-A0H7-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0H7	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65.0	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0H7-F4737	TCGA-BH-A0H7	TCGA-BH-A0H7-11A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-23972.0	542.0		0.0	702.0						H-SCORE 255	70-79%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	380.0	NO	Negative			16.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														6.0		True	No	M0	N2a	T1c	Stage IIIA		A0H7	TUMOR FREE	H-SCORE 150			H-SCORE	H-SCORE			30-39%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2008.0	6136a15e-6c8f-44bc-85c2-c7cbf675cab0	6136a15e-6c8f-44bc-85c2-c7cbf675cab0				TCGA-BH-A0H7-11A-13D-A10Q-05								TCGA-BH-A0H7-11	6136a15e-6c8f-44bc-85c2-c7cbf675cab0	TCGA-BH-A0H7-11			TCGA-BH-A0H7-11A-13R-A089-07	6136a15e-6c8f-44bc-85c2-c7cbf675cab0		
TCGA-BH-A0H9-11		69.0			1247.0			FEMALE									1247.0	0.0							followup			LIVING	TCGA-BH-A0H9-11		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A0H9	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69.0	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0H9-F4703	TCGA-BH-A0H9	TCGA-BH-A0H9-11A		Positive		1+			Positive	Other		NO			-25289.0	1088.0		0.0	1247.0							90-99%	2.98		2010-11-16	FEMALE					2+	40.0	3.43	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	220.0	NO	Equivocal	Negative		1.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0.0		True	No	M0	N0 (i-)	T2	Stage IIA		A0H9	TUMOR FREE								30-39%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007.0	27d4c881-e906-437f-921d-467eb107798a	27d4c881-e906-437f-921d-467eb107798a				TCGA-BH-A0H9-11A-22D-A093-05									27d4c881-e906-437f-921d-467eb107798a				TCGA-BH-A0H9-11A-22R-A089-07	27d4c881-e906-437f-921d-467eb107798a		
TCGA-BH-A0HA-01	Stage I	31.0	1.0	Stage I	856.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Negative	N0	856.0	0.0	LumA	Luminal A	Positive	ReacI	-5.0	-7.0	enrollment	T1	T1	LIVING	TCGA-BH-A0HA-01	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0HA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					31.0	Right			TCGA-BH-A0HA-F43320	TCGA-BH-A0HA			Positive					Positive	Other					-11379.0			0.0	1611.0					NO				Scheduled Follow-up Submission	2013-5-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	NO	4.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2.0	6.0								NO	0.0			No	M0	N0 (i-)	T1c	Stage I		A0HA	TUMOR FREE						NO	YES			NO	Primary Tumor	1	bilateral total mastectomies with right sentinel node biopsy	6th	NO	NO	YES	BH	Breast		LIVING	2008.0	cffc0fe5-533f-46f8-a54a-2e09c392767d	cffc0fe5-533f-46f8-a54a-2e09c392767d	TCGA-BH-A0HA-01A-21-A13C-20	TCGA-BH-A0HA-01A-11D-A12Q-09	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11D-A12R-05	f1a9fcd6-b351-4300-ab8c-e488c8d76cee	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11D-A12Q-09		TCGA-BH-A0HA-01	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11D-A12Q-09		cffc0fe5-533f-46f8-a54a-2e09c392767d		TCGA-BH-A0HA-01A-11D-A12N-01	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11R-A12P-07	cffc0fe5-533f-46f8-a54a-2e09c392767d	TCGA-BH-A0HA-01A-11D-A12N-01	TCGA-BH-A0HA-01
TCGA-BH-A0HA-11		31.0			856.0			FEMALE									856.0	0.0	Normal						enrollment			LIVING	TCGA-BH-A0HA-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0HA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					31.0	Right			TCGA-BH-A0HA-F43320	TCGA-BH-A0HA	TCGA-BH-A0HA-11A		Positive					Positive	Other					-11379.0	675.0		0.0	1611.0					NO				Scheduled Follow-up Submission	2013-5-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340.0	NO		Negative	NO	4.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0.0		True	No	M0	N0 (i-)	T1c	Stage I		A0HA	TUMOR FREE						NO	YES			NO	Solid Tissue Normal	11	bilateral total mastectomies with right sentinel node biopsy	6th	NO	NO	YES	BH	Breast	A	LIVING	2008.0	a521a6fa-da2b-48ef-94e8-3307030427b6	a521a6fa-da2b-48ef-94e8-3307030427b6				TCGA-BH-A0HA-11A-31D-A12R-05	4DD09312-C6DE-4532-811D-242BAAE47F9D					TCGA-BH-A0HA-11			a521a6fa-da2b-48ef-94e8-3307030427b6			TCGA-BH-A0HA-11	TCGA-BH-A0HA-11A-31R-A12P-07	a521a6fa-da2b-48ef-94e8-3307030427b6		
TCGA-BH-A0HF-01	Stage IA	77.0		Stage I	727.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	727.0	0.0	LumA	Luminal A	Positive		-5.0	-7.0	followup	T1	T1	LIVING	TCGA-BH-A0HF-01			cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-BH-A0HF	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77.0	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HF-F4734	TCGA-BH-A0HF	TCGA-BH-A0HF-01A		Positive		1+			Positive	Other		NO			-28233.0	549.0		0.0	727.0						H-Score 295	90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	40.0	NO	Negative			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	4.0									0.0		True	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HF.71291A56-C2DB-4EB9-8223-DD7563CBBDC9.pdf	A0HF	TUMOR FREE	H-Score 15			H-Score	H-Score			<10%		YES	Primary Tumor	1	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008.0	5b92fd62-9fec-4b18-b7c3-50c88fa0d464	5b92fd62-9fec-4b18-b7c3-50c88fa0d464			TCGA-BH-A0HF-01	TCGA-BH-A0HF-01A-11D-A10P-05			TCGA-BH-A0HF-01A-11W-A071-09					TCGA-BH-A0HF-01	5b92fd62-9fec-4b18-b7c3-50c88fa0d464	TCGA-BH-A0HF-01			TCGA-BH-A0HF-01A-11R-A056-07	5b92fd62-9fec-4b18-b7c3-50c88fa0d464		TCGA-BH-A0HF-01
TCGA-BH-A0HI-01	Stage IA	78.0	2.0	Stage I	619.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	619.0	0.0	LumA	Luminal A	Positive		-12.0	-3.0	followup	T1	T1	LIVING	TCGA-BH-A0HI-01	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0HI	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78.0	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HI-F4756	TCGA-BH-A0HI	TCGA-BH-A0HI-01A		Positive		1+			Positive	Other		YES			-28644.0	554.0		0.0	620.0						H-Score 240	50-59%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	20.0	NO	Negative			1.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	7.0									0.0	0.0	True	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HI.EE9E0908-05D2-4F26-B3C2-2B40A48FEA6D.pdf	A0HI	TUMOR FREE	H-Score 160			H-Score	H-Score			40-49%		YES	Primary Tumor	1	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008.0	682942cb-589f-4348-abc2-3c7cc76fb34d	682942cb-589f-4348-abc2-3c7cc76fb34d		TCGA-BH-A0HI-01A-11D-A099-09	TCGA-BH-A0HI-01	TCGA-BH-A0HI-01A-11D-A10P-05		TCGA-BH-A0HI-01	TCGA-BH-A0HI-01A-11D-A099-09		TCGA-BH-A0HI-01		TCGA-BH-A0HI-01A-11D-A099-09	TCGA-BH-A0HI-01	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01	TCGA-BH-A0HI-01A-11D-A087-01		TCGA-BH-A0HI-01A-11R-A084-07	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01A-11D-A087-01	TCGA-BH-A0HI-01
TCGA-BH-A0HK-11		81.0			178.0			FEMALE									178.0	0.0	Normal						followup			LIVING	TCGA-BH-A0HK-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0HK	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81.0	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0HK-F4758	TCGA-BH-A0HK	TCGA-BH-A0HK-11A		Positive		0			Negative	Modified Radical Mastectomy		NO			-29751.0	35.0		0.0	178.0						H-SCORE 260	70-79%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	240.0	NO	Negative			17.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														2.0		True	No	M0	N1	T2	Stage IIB		A0HK	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE			<10%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2010.0	01163f75-8956-40a6-97a5-3c0478d904f8	01163f75-8956-40a6-97a5-3c0478d904f8				TCGA-BH-A0HK-11A-11D-A10Q-05	9959CAD8-B950-41C0-A0C7-3EF86F4DA9EC							TCGA-BH-A0HK-11	01163f75-8956-40a6-97a5-3c0478d904f8	TCGA-BH-A0HK-11			TCGA-BH-A0HK-11A-11R-A089-07	01163f75-8956-40a6-97a5-3c0478d904f8		
TCGA-BH-A0HP-01	Stage IIIA	65.0	2.0	No_Conversion	414.0		Positive	FEMALE	Negative	3.0	4.0	3.0	Negative	M0	Positive	N2	414.0	0.0	LumA	Luminal A	Negative	ReacI	-5.0	-7.0	followup	T_Other	T3	LIVING	TCGA-BH-A0HP-01	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-BH-A0HP	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65.0	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0HP-F4784	TCGA-BH-A0HP	TCGA-BH-A0HP-01A		Positive		0			Negative	Modified Radical Mastectomy		NO			-23883.0	346.0		0.0	414.0						H-Score 280	80-89%			2010-11-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	720.0	NO	Negative			17.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Negative			1.0	6.0									8.0		True	No	M0	N2a	T3	Stage IIIA	TCGA-BH-A0HP.F13CE7B3-F275-4EEE-90A3-11B8B92FA431.pdf	A0HP	TUMOR FREE	H-Score 0			H-Score	H-Score					YES	Primary Tumor	1			YES	NO	YES	BH	Breast	A	LIVING	2009.0	f0c59856-0421-46e3-a2f9-e17f0f267930	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01A-21-A13C-20	TCGA-BH-A0HP-01A-12D-A099-09	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01A-12D-A10P-05	189540a2-042e-4bac-99f0-b7b0feda0a23	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01A-12D-A099-09		TCGA-BH-A0HP-01		TCGA-BH-A0HP-01A-12D-A099-09	TCGA-BH-A0HP-01	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01A-12D-A087-01		TCGA-BH-A0HP-01A-12R-A084-07	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01A-12D-A087-01	TCGA-BH-A0HP-01
TCGA-BH-A18J-11		56.0			611.0	611.0		FEMALE									611.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18J-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18J	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56.0	Right				TCGA-BH-A18J	TCGA-BH-A18J-11A		Positive					Positive	Modified Radical Mastectomy					-20678.0	3948.0	612.0	0.0						YES		40-49%			2011-6-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			230.0	NO	Negative				Negative			Negative			Positive								Negative				Positive	Bone														True	No	M1	N2	T4b	Stage IV		A18J	WITH TUMOR								30-39%			Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	2000.0	9fa440b0-6e8d-4c48-a425-50abc2682f6e	9fa440b0-6e8d-4c48-a425-50abc2682f6e								TCGA-BH-A18J-11A-31D-A12E-05		TCGA-BH-A18J-11			9fa440b0-6e8d-4c48-a425-50abc2682f6e			TCGA-BH-A18J-11	TCGA-BH-A18J-11A-31R-A12D-07	9fa440b0-6e8d-4c48-a425-50abc2682f6e		
TCGA-BH-A18K-11		46.0			2547.0	2762.0		FEMALE									2762.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18K-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18K	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46.0	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A18K			Positive					Positive	Other					-16824.0		2763.0	0.0						NO					2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			11.0	Negative																															0.0			No	M0	N0	T1	Stage I		A18K	WITH TUMOR							YES				Solid Tissue Normal	11	segmental mastectomy with axillary dissection	5th		NO	YES	BH	Breast		DECEASED	1999.0	dc55c016-0e33-46b0-ac5e-f854c667a378	dc55c016-0e33-46b0-ac5e-f854c667a378								TCGA-BH-A18K-11A-13D-A12E-05		TCGA-BH-A18K-11			dc55c016-0e33-46b0-ac5e-f854c667a378			TCGA-BH-A18K-11	TCGA-BH-A18K-11A-13R-A12D-07	dc55c016-0e33-46b0-ac5e-f854c667a378		
TCGA-BH-A18L-11		50.0			372.0	811.0		FEMALE									811.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18L-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18L	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50.0	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-BH-A18L	TCGA-BH-A18L-11A		Positive					Positive	Other					-18519.0	2669.0	811.0	0.0						NO					2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	530.0	NO	Negative			3.0	Negative																															1.0	1.0	True	No	M0	N1mi	T3	Stage IIIA		A18L								YES				Solid Tissue Normal	11	total mastectomy and sentinel node biopsy	6th		NO	YES	BH	Breast	A	DECEASED	2003.0	0b937a20-66d4-4d05-bf50-4828cead9c92	0b937a20-66d4-4d05-bf50-4828cead9c92					AE6873BA-EA4A-4FE3-9D4F-B32FFC5BBF98			TCGA-BH-A18L-11A-42D-A12E-05		TCGA-BH-A18L-11			0b937a20-66d4-4d05-bf50-4828cead9c92			TCGA-BH-A18L-11	TCGA-BH-A18L-11A-42R-A12D-07	0b937a20-66d4-4d05-bf50-4828cead9c92		
TCGA-BH-A18M-11		39.0			2207.0	2207.0		FEMALE									2207.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18M-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18M	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39.0	Left Upper Inner Quadrant				TCGA-BH-A18M	TCGA-BH-A18M-11A		Positive					Positive	Modified Radical Mastectomy					-14532.0	3629.0	2207.0	0.0						NO					2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3		YES		Core needle biopsy	310.0	NO	Positive	Positive		6.0	Negative																															4.0	4.0	True	No	M0	N1	T3	Stage IIIA		A18M								YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	2001.0	2147e537-16f0-4bc3-a87f-572f8dcb9191	2147e537-16f0-4bc3-a87f-572f8dcb9191								TCGA-BH-A18M-11A-33D-A12E-05		TCGA-BH-A18M-11			2147e537-16f0-4bc3-a87f-572f8dcb9191			TCGA-BH-A18M-11	TCGA-BH-A18M-11A-33R-A12D-07	2147e537-16f0-4bc3-a87f-572f8dcb9191		
TCGA-BH-A18N-11		88.0			1148.0	1148.0		FEMALE									1148.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18N-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18N	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88.0	Left	Axillary lymph node dissection alone		TCGA-BH-A18N-F59153	TCGA-BH-A18N	TCGA-BH-A18N-11A		Positive					Positive	Modified Radical Mastectomy					-32404.0	3374.0	1148.0	0.0						NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	590.0	NO	Negative		NO	26.0	Negative																															2.0	2.0	True	No	M0	N1b	T2	Stage IIA		A18N							NO	YES			NO	Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001.0	d40f0f2c-4acf-4ea6-b344-1eca23f50fa6	d40f0f2c-4acf-4ea6-b344-1eca23f50fa6					3A6CFBA6-849B-416F-A652-F3540DEBEB02			TCGA-BH-A18N-11A-43D-A12E-05		TCGA-BH-A18N-11			d40f0f2c-4acf-4ea6-b344-1eca23f50fa6			TCGA-BH-A18N-11	TCGA-BH-A18N-11A-43R-A12D-07	d40f0f2c-4acf-4ea6-b344-1eca23f50fa6		
TCGA-BH-A18P-11		60.0			921.0	921.0		FEMALE									921.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18P-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18P	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60.0	Left Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-BH-A18P	TCGA-BH-A18P-11A		Positive					Negative	Simple Mastectomy					-22222.0	2639.0	921.0	0.0								<10%			2011-6-22	FEMALE			10-19%		2+					Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3	1+	YES		Fine needle aspiration biopsy	520.0	NO	Positive	Positive		2.0	Negative																															0.0		True	No	M0	N0	T1	Stage I		A18P	WITH TUMOR							YES				Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	DECEASED	2003.0	08236177-a046-4cfe-a11c-a24292a1f777	08236177-a046-4cfe-a11c-a24292a1f777					5C2F7AFD-3F6E-46BB-A17B-F10BE5E243FC			TCGA-BH-A18P-11A-43D-A12E-05		TCGA-BH-A18P-11			08236177-a046-4cfe-a11c-a24292a1f777			TCGA-BH-A18P-11	TCGA-BH-A18P-11A-43R-A12D-07	08236177-a046-4cfe-a11c-a24292a1f777		
TCGA-BH-A18Q-11		56.0			1692.0	1692.0		FEMALE									1692.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18Q-11		C4-BRCA/Basal							mutation cluster 13	TCGA-BH-A18Q	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56.0	Left	Axillary lymph node dissection alone			TCGA-BH-A18Q	TCGA-BH-A18Q-11A		Negative					Negative	Modified Radical Mastectomy					-20675.0	3417.0	1692.0	0.0											2011-6-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.8	8500/3	C50.8		YES		Core needle biopsy	510.0	NO	Positive	Negative		25.0	Negative																															2.0	2.0	True	No	M0	N1b	T2	Stage IIB		A18Q								YES				Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001.0	120bc298-f016-4c80-aa5f-a9006444942c	120bc298-f016-4c80-aa5f-a9006444942c					E36930F3-2442-4C58-B426-DC2C0CDCB79D			TCGA-BH-A18Q-11A-34D-A12E-05		TCGA-BH-A18Q-11			120bc298-f016-4c80-aa5f-a9006444942c			TCGA-BH-A18Q-11	TCGA-BH-A18Q-11A-34R-A12D-07	120bc298-f016-4c80-aa5f-a9006444942c		
TCGA-BH-A18R-11		50.0			1099.0	1141.0		FEMALE									1141.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18R-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18R	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50.0	Right Upper Outer Quadrant				TCGA-BH-A18R	TCGA-BH-A18R-11A		Indeterminate					Negative	Modified Radical Mastectomy					-18524.0	3571.0	1142.0	0.0						NO		20-29%			2011-7-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	350.0	NO	Positive	Positive		15.0	Negative																															10.0		True	No	M0	N1	T2b	Stage IIA		A18R	TUMOR FREE							YES				Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001.0	5462aaff-d060-4ba7-9ab5-0e6977accb91	5462aaff-d060-4ba7-9ab5-0e6977accb91					0F909B7E-B7B3-4B79-B3E6-31BAAFFFA9C6			TCGA-BH-A18R-11A-42D-A12E-05		TCGA-BH-A18R-11			5462aaff-d060-4ba7-9ab5-0e6977accb91			TCGA-BH-A18R-11	TCGA-BH-A18R-11A-42R-A12D-07	5462aaff-d060-4ba7-9ab5-0e6977accb91		
TCGA-BH-A18S-01	Stage I	79.0	5.0	Stage I	2009.0	2009.0	Positive	FEMALE		3.0	3.0	3.0	Negative	M0	Negative	N0	2009.0	1.0	LumA	Luminal A	Positive	LumA/B	-12.0	-3.0	enrollment	T1	T1	DECEASED	TCGA-BH-A18S-01	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 12	TCGA-BH-A18S	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79.0	Right Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-BH-A18S			Positive					Positive	Other					-28974.0		2009.0	0.0											2011-7-2	FEMALE										Mucinous Carcinoma		No		C50.3	8523/3	C50.3		YES		Core needle biopsy			Negative			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	7.0									0.0			No	M0	N0	T1c	Stage I		A18S	TUMOR FREE							YES				Primary Tumor	1	total mastectomy	6th		NO	YES	BH	Breast		DECEASED	2003.0	cf00b389-d06b-4dd5-9b18-737b06ab9bed	cf00b389-d06b-4dd5-9b18-737b06ab9bed	TCGA-BH-A18S-01A-21-A13E-20	TCGA-BH-A18S-01A-11D-A12B-09	TCGA-BH-A18S-01		cd625353-3b48-44c0-9695-074db13850d9	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11D-A12B-09	TCGA-BH-A18S-01A-11D-A12E-05	TCGA-BH-A18S-01	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11D-A12B-09		cf00b389-d06b-4dd5-9b18-737b06ab9bed		TCGA-BH-A18S-01A-11D-A12A-01	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11R-A12D-07	cf00b389-d06b-4dd5-9b18-737b06ab9bed	TCGA-BH-A18S-01A-11D-A12A-01	TCGA-BH-A18S-01
TCGA-BH-A18S-11		79.0			2009.0	2009.0		FEMALE									2009.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18S-11		C3-BRCA/Luminal							mutation cluster 12	TCGA-BH-A18S	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79.0	Right Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-BH-A18S			Positive					Positive	Other					-28974.0		2009.0	0.0											2011-7-2	FEMALE										Mucinous Carcinoma		No		C50.3	8523/3	C50.3		YES		Core needle biopsy			Negative			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0.0			No	M0	N0	T1c	Stage I		A18S	TUMOR FREE							YES				Solid Tissue Normal	11	total mastectomy	6th		NO	YES	BH	Breast		DECEASED	2003.0	fa7bcdff-10e1-44f1-86ed-90fab26bc61f	fa7bcdff-10e1-44f1-86ed-90fab26bc61f								TCGA-BH-A18S-11A-43D-A12E-05		TCGA-BH-A18S-11			fa7bcdff-10e1-44f1-86ed-90fab26bc61f			TCGA-BH-A18S-11	TCGA-BH-A18S-11A-43R-A12D-07	fa7bcdff-10e1-44f1-86ed-90fab26bc61f		
TCGA-BH-A18U-11		72.0			1317.0	1563.0		FEMALE									1563.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18U-11		C3-BRCA/Luminal							mutation cluster 13	TCGA-BH-A18U	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72.0	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A18U	TCGA-BH-A18U-11A		Positive					Positive	Other					-26426.0	2697.0	1563.0	0.0											2011-7-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	230.0	NO	Positive			16.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														9.0		True	No	M0	N2a	T2	Stage IIIA		A18U	TUMOR FREE							YES				Solid Tissue Normal	11	total mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003.0	02222fea-f3da-4328-8188-8ef24d1f55e4	02222fea-f3da-4328-8188-8ef24d1f55e4								TCGA-BH-A18U-11A-23D-A12E-05		TCGA-BH-A18U-11			02222fea-f3da-4328-8188-8ef24d1f55e4			TCGA-BH-A18U-11	TCGA-BH-A18U-11A-23R-A12D-07	02222fea-f3da-4328-8188-8ef24d1f55e4		
TCGA-BH-A18V-01	Stage IIB	48.0	1.0	No_Conversion	1555.0	1555.0	Negative	FEMALE	Negative	2.0	2.0	2.0	Negative	M0	Positive	N1	1555.0	1.0	Basal	Basal-like	Negative	Basal	-13.0	-12.0	enrollment	T_Other	T2	DECEASED	TCGA-BH-A18V-01	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-BH-A18V	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48.0	Right	Axillary lymph node dissection alone			TCGA-BH-A18V	TCGA-BH-A18V-01A		Negative					Negative	Other					-17682.0	3621.0	1556.0	0.0						YES					2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	300.0	NO	Negative			25.0	Negative			Negative			Negative												Negative	Other, specify	axilaary node negative but intrammary node positive	5.0	5.0									0.0		True	No	M0	N1b	T2	Stage IIB	TCGA-BH-A18V.3C1C2CED-A1CF-48FC-BCB2-658D74E1982B.pdf	A18V								YES				Primary Tumor	1	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001.0	429b50eb-316f-459c-bc3a-0aca6e6dba46	429b50eb-316f-459c-bc3a-0aca6e6dba46		TCGA-BH-A18V-01A-11D-A12B-09	TCGA-BH-A18V-01		7bf9da92-5872-4f29-ba4d-f247ec7984f0	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11D-A12B-09	TCGA-BH-A18V-01A-11D-A12E-05	TCGA-BH-A18V-01	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11D-A12B-09		429b50eb-316f-459c-bc3a-0aca6e6dba46		TCGA-BH-A18V-01A-11D-A12A-01	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11R-A12D-07	429b50eb-316f-459c-bc3a-0aca6e6dba46	TCGA-BH-A18V-01A-11D-A12A-01	TCGA-BH-A18V-01
TCGA-BH-A18V-11		48.0			1555.0	1555.0		FEMALE									1555.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A18V-11		C4-BRCA/Basal							mutation cluster 2	TCGA-BH-A18V	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48.0	Right	Axillary lymph node dissection alone			TCGA-BH-A18V	TCGA-BH-A18V-11A		Negative					Negative	Other					-17682.0	3621.0	1556.0	0.0						YES					2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	450.0	NO	Negative			25.0	Negative			Negative			Negative												Negative	Other, specify	axilaary node negative but intrammary node positive											0.0		True	No	M0	N1b	T2	Stage IIB		A18V								YES				Solid Tissue Normal	11	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001.0	288c81eb-4c43-406b-a5e5-fee452a95afb	288c81eb-4c43-406b-a5e5-fee452a95afb					1D76CB85-A291-45F8-88B0-29D72E04FA07			TCGA-BH-A18V-11A-52D-A12E-05					288c81eb-4c43-406b-a5e5-fee452a95afb				TCGA-BH-A18V-11A-52R-A12D-07	288c81eb-4c43-406b-a5e5-fee452a95afb		
TCGA-BH-A1EN-11		78.0				2052.0		FEMALE									2052.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1EN-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EN	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78.0	Right				TCGA-BH-A1EN			Negative					Negative	Other					-28724.0		2127.0	0.0						NO					2011-9-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy			Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																																	No	M0	NX	T2	Stage IIA		A1EN	TUMOR FREE											Solid Tissue Normal	11	right segmental mastectomy	5th		NO	YES	BH	Breast		DECEASED	1999.0	c03683bd-2fe1-4ab2-9a16-796553be5467	c03683bd-2fe1-4ab2-9a16-796553be5467				TCGA-BH-A1EN-11A-23D-A13T-05						TCGA-BH-A1EN-11			c03683bd-2fe1-4ab2-9a16-796553be5467			TCGA-BH-A1EN-11		c03683bd-2fe1-4ab2-9a16-796553be5467		
TCGA-BH-A1EO-11		68.0				2798.0		FEMALE									2798.0	1.0	LumA						enrollment			DECEASED	TCGA-BH-A1EO-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EO	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68.0	Right				TCGA-BH-A1EO	TCGA-BH-A1EO-11A		Positive					Positive	Other					-25136.0	4330.0	2798.0	0.0						NO					2011-9-6	FEMALE										Mixed Histology (please specify)	ductal and lobular features	No		C50.9	8522/3	C50.9		YES		Excisional Biopsy	250.0	NO	Negative			15.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														1.0		True	No	M0	N1	T1c	Stage IIA		A1EO	TUMOR FREE							YES				Solid Tissue Normal	11	right segmental mastectomy witrh axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999.0	71cc9cf0-2992-4ac6-8642-6fdb66958fca	71cc9cf0-2992-4ac6-8642-6fdb66958fca				TCGA-BH-A1EO-11A-31D-A138-05									71cc9cf0-2992-4ac6-8642-6fdb66958fca				TCGA-BH-A1EO-11A-31R-A137-07	71cc9cf0-2992-4ac6-8642-6fdb66958fca		
TCGA-BH-A1ET-11		55.0				2520.0		FEMALE									2520.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1ET-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1ET	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55.0	Left				TCGA-BH-A1ET	TCGA-BH-A1ET-11B		Positive					Positive	Other					-20425.0	4137.0	2520.0	0.0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	380.0	NO	Negative			19.0																																1.0		False	No	M0	N0	T1	Stage I		A1ET	TUMOR FREE							YES				Solid Tissue Normal	11	Left segmental mastectomy with left axillary lymph node dissection	5th		NO	YES	BH	Breast	B	DECEASED	1999.0	ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be	ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be				TCGA-BH-A1ET-11B-23D-A138-05	48D344A0-2C10-412C-A51E-BB830474D9D5					TCGA-BH-A1ET-11			ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be			TCGA-BH-A1ET-11	TCGA-BH-A1ET-11B-23R-A137-07	ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be		
TCGA-BH-A1EU-11		83.0				1286.0		FEMALE									1286.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1EU-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1EU	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					83.0	Right				TCGA-BH-A1EU	TCGA-BH-A1EU-11A		Positive					Positive						-30339.0	4106.0	1286.0	0.0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240.0	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																																True	No	M0	N0	T1	Stage I		A1EU	TUMOR FREE							NO				Solid Tissue Normal	11	Right segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1999.0	9e12314d-d1f0-44be-93f7-e50a56f86b46	9e12314d-d1f0-44be-93f7-e50a56f86b46				TCGA-BH-A1EU-11A-23D-A138-05						TCGA-BH-A1EU-11			9e12314d-d1f0-44be-93f7-e50a56f86b46			TCGA-BH-A1EU-11	TCGA-BH-A1EU-11A-23R-A137-07	9e12314d-d1f0-44be-93f7-e50a56f86b46		
TCGA-BH-A1EV-11		45.0				365.0		FEMALE									365.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1EV-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1EV	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45.0	Left			TCGA-BH-A1EV-F59154	TCGA-BH-A1EV	TCGA-BH-A1EV-11A		Positive					Positive	Modified Radical Mastectomy					-16504.0	4103.0	365.0	0.0											2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	580.0	NO	Positive		NO	10.0																															NO	3.0		True	No	M0	N1b	T3	Stage IIIA		A1EV	WITH TUMOR						NO	YES			YES	Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1999.0	7b234c36-729b-422d-8e2a-ebd42af74bce	7b234c36-729b-422d-8e2a-ebd42af74bce				TCGA-BH-A1EV-11A-24D-A138-05						TCGA-BH-A1EV-11			7b234c36-729b-422d-8e2a-ebd42af74bce			TCGA-BH-A1EV-11		7b234c36-729b-422d-8e2a-ebd42af74bce		
TCGA-BH-A1EW-11		38.0				1694.0		FEMALE									1694.0	1.0	LumA						enrollment			DECEASED	TCGA-BH-A1EW-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EW	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38.0	Left Upper Outer Quadrant				TCGA-BH-A1EW	TCGA-BH-A1EW-11B		Negative					Negative	Other					-14090.0	4230.0	1694.0	0.0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1030.0	NO	Negative			16.0		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														1.0		False	No	M0	N1b	T2	Stage IIA		A1EW	WITH TUMOR							YES				Solid Tissue Normal	11	Left segmental mastectomy with level 1 and level 2 axillary dissection	5th		NO	YES	BH	Breast	B	DECEASED	1999.0	cf1027dc-9ba9-4e3c-80d9-4bb13021cc31	cf1027dc-9ba9-4e3c-80d9-4bb13021cc31				TCGA-BH-A1EW-11B-33D-A138-05	6AC30F47-7622-4DBF-94E9-4E6D93D8442F					TCGA-BH-A1EW-11			cf1027dc-9ba9-4e3c-80d9-4bb13021cc31			TCGA-BH-A1EW-11	TCGA-BH-A1EW-11B-33R-A137-07	cf1027dc-9ba9-4e3c-80d9-4bb13021cc31		
TCGA-BH-A1EY-01	Stage IIA	79.0	2.0	Stage IIA		538.0	Positive	FEMALE	Negative				Negative	M0	Negative	N0	538.0	1.0	LumA		Positive				enrollment	T_Other	T2	DECEASED	TCGA-BH-A1EY-01	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-BH-A1EY	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79.0	Left Upper Outer Quadrant			TCGA-BH-A1EY-F59173	TCGA-BH-A1EY	TCGA-BH-A1EY-01A		Positive					Positive	Modified Radical Mastectomy					-28940.0	3840.0	538.0	0.0				396							2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290.0	NO	Negative		NO	12.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	1.0				Lung	Distant Metastasis	Liver		YES	0.0		True	No	M0	N0	T2	Stage IIA	TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28.pdf	A1EY	WITH TUMOR						NO	YES			NO	Primary Tumor	1		5th		NO	YES	BH	Breast	A	DECEASED	2000.0	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	TCGA-BH-A1EY-01A-21-A17I-20	TCGA-BH-A1EY-01A-11D-A13L-09	TCGA-BH-A1EY-01	TCGA-BH-A1EY-01A-11D-A13K-05	7de680e0-63d0-41b4-ace3-82a8e80aaae3	TCGA-BH-A1EY-01	TCGA-BH-A1EY-01A-11D-A13L-09			TCGA-BH-A1EY-01	TCGA-BH-A1EY-01A-11D-A13L-09		4a6f7935-86f8-4c08-9d0e-9fe77878f2ce		TCGA-BH-A1EY-01A-11D-A13J-01	TCGA-BH-A1EY-01		4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	TCGA-BH-A1EY-01A-11D-A13J-01	
TCGA-BH-A1F0-11		80.0				785.0		FEMALE									785.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1F0-11		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1F0	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80.0	Left				TCGA-BH-A1F0	TCGA-BH-A1F0-11B		Negative					Indeterminate	Modified Radical Mastectomy					-29335.0	3879.0	785.0	0.0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	180.0	NO	Negative			9.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														1.0		False	No	M0	N1c	T1a	Stage IIA		A1F0	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	2000.0	889f6f61-9b3a-406c-9af8-ddee74a8a19e	889f6f61-9b3a-406c-9af8-ddee74a8a19e				TCGA-BH-A1F0-11B-23D-A138-05						TCGA-BH-A1F0-11			889f6f61-9b3a-406c-9af8-ddee74a8a19e			TCGA-BH-A1F0-11	TCGA-BH-A1F0-11B-23R-A137-07	889f6f61-9b3a-406c-9af8-ddee74a8a19e		
TCGA-BH-A1F2-11		53.0				959.0		FEMALE									959.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1F2-11		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A1F2	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53.0	Left				TCGA-BH-A1F2	TCGA-BH-A1F2-11A		Positive					Positive	Modified Radical Mastectomy					-19701.0	4147.0	959.0	0.0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES		Core needle biopsy	270.0	NO	Positive			19.0																																6.0		True	No	M0	N1b	T4b	Stage IIIB		A1F2	TUMOR FREE							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1999.0	85e9922a-0ede-4fea-8338-ead05addef79	85e9922a-0ede-4fea-8338-ead05addef79				TCGA-BH-A1F2-11A-32D-A13T-05						TCGA-BH-A1F2-11			85e9922a-0ede-4fea-8338-ead05addef79			TCGA-BH-A1F2-11		85e9922a-0ede-4fea-8338-ead05addef79		
TCGA-BH-A1F6-11		51.0				2965.0		FEMALE									2965.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1F6-11		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1F6	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51.0	Left				TCGA-BH-A1F6			Negative					Negative	Modified Radical Mastectomy					-18691.0		2965.0	0.0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			6.0																																6.0			No	MX	N2a	T4d			A1F6								YES				Solid Tissue Normal	11				NO	YES	BH	Breast		DECEASED	1996.0	a248476b-7c40-42c6-905b-b9c3ba6b2aed	a248476b-7c40-42c6-905b-b9c3ba6b2aed				TCGA-BH-A1F6-11B-94D-A13T-05						TCGA-BH-A1F6-11			a248476b-7c40-42c6-905b-b9c3ba6b2aed			TCGA-BH-A1F6-11		a248476b-7c40-42c6-905b-b9c3ba6b2aed		
TCGA-BH-A1F8-11		90.0				749.0		FEMALE									749.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1F8-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1F8	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90.0	Left				TCGA-BH-A1F8	TCGA-BH-A1F8-11B		Positive					Positive	Modified Radical Mastectomy					-32871.0	4301.0	763.0	0.0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750.0	NO	Positive			13.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														12.0		False	No	M0	N2	T4b	Stage IIIB		A1F8	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1999.0	c6cc7496-98d2-4181-8517-fbd875fd5623	c6cc7496-98d2-4181-8517-fbd875fd5623				TCGA-BH-A1F8-11B-21D-A13T-05	80FD1099-D66E-4A9A-AA9E-CB7D0178D612					TCGA-BH-A1F8-11			c6cc7496-98d2-4181-8517-fbd875fd5623			TCGA-BH-A1F8-11		c6cc7496-98d2-4181-8517-fbd875fd5623		
TCGA-BH-A1FB-11		60.0				3669.0		FEMALE									3669.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FB-11		C3-BRCA/Luminal								TCGA-BH-A1FB	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60.0	Right				TCGA-BH-A1FB	TCGA-BH-A1FB-11A		Positive					Positive						-21933.0	3871.0	3669.0	0.0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320.0	NO	Negative			15.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0.0		True	No	M0	N1b	T2	Stage IIB		A1FB	WITH TUMOR							YES				Solid Tissue Normal	11	segmental mastectomy with sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	2000.0	71899388-d223-4774-a1ce-3be260240b2c	71899388-d223-4774-a1ce-3be260240b2c				TCGA-BH-A1FB-11A-33D-A13T-05						TCGA-BH-A1FB-11			71899388-d223-4774-a1ce-3be260240b2c			TCGA-BH-A1FB-11		71899388-d223-4774-a1ce-3be260240b2c		
TCGA-BH-A1FC-11		78.0				3471.0		FEMALE									3471.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FC-11		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1FC	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78.0	Right Upper Outer Quadrant				TCGA-BH-A1FC	TCGA-BH-A1FC-11A		Negative					Negative	Other					-28706.0	4456.0	3472.0	0.0											2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	260.0	NO	Negative			23.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														1.0		True	No	M0	N1b	T1c	Stage IIA		A1FC	TUMOR FREE							YES				Solid Tissue Normal	11	localized segmental mastectomy with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998.0	58e94be5-2da2-4a96-944a-060f20216572	58e94be5-2da2-4a96-944a-060f20216572				TCGA-BH-A1FC-11A-32D-A13T-05						TCGA-BH-A1FC-11			58e94be5-2da2-4a96-944a-060f20216572			TCGA-BH-A1FC-11		58e94be5-2da2-4a96-944a-060f20216572		
TCGA-BH-A1FD-11		68.0				1008.0		FEMALE									1008.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FD-11		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A1FD	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68.0	Left				TCGA-BH-A1FD	TCGA-BH-A1FD-11B		Positive					Positive						-24940.0	4420.0	1009.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	440.0	NO	Negative			19.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0.0		False	No	M0	N0	T1c	Stage I		A1FD	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998.0	e0ed3e93-0ead-4fc0-a82d-79807c7d5162	e0ed3e93-0ead-4fc0-a82d-79807c7d5162				TCGA-BH-A1FD-11B-21D-A13T-05	81425ECA-DA4A-428C-BAAE-E3B55821C356					TCGA-BH-A1FD-11			e0ed3e93-0ead-4fc0-a82d-79807c7d5162			TCGA-BH-A1FD-11		e0ed3e93-0ead-4fc0-a82d-79807c7d5162		
TCGA-BH-A1FE-11		31.0				2273.0		FEMALE									2273.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FE-11		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A1FE	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					31.0	Left				TCGA-BH-A1FE	TCGA-BH-A1FE-11B		Positive					Positive	Modified Radical Mastectomy					-11650.0	4456.0	2273.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	520.0	NO				12.0																																1.0		True	No	M0	N1	T2	Stage IIB		A1FE	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998.0	64f3f52d-a484-49c6-9048-6eadedd2c2c5	64f3f52d-a484-49c6-9048-6eadedd2c2c5				TCGA-BH-A1FE-11B-14D-A13T-05	160198A9-3024-40DF-9887-E20F9371AC0A					TCGA-BH-A1FE-11			64f3f52d-a484-49c6-9048-6eadedd2c2c5			TCGA-BH-A1FE-11		64f3f52d-a484-49c6-9048-6eadedd2c2c5		
TCGA-BH-A1FG-11		88.0				3738.0		FEMALE									3738.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FG-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FG	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88.0	Left				TCGA-BH-A1FG			Positive					Positive	Other					-32295.0		3736.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy			Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																																	No	M0	NX	T1c	Stage I		A1FG												Solid Tissue Normal	11	segmental mastectomy	5th		NO	YES	BH	Breast		DECEASED	1998.0	ea037776-3759-425c-a7f4-35e8a5571025	ea037776-3759-425c-a7f4-35e8a5571025				TCGA-BH-A1FG-11B-12D-A13T-05						TCGA-BH-A1FG-11			ea037776-3759-425c-a7f4-35e8a5571025			TCGA-BH-A1FG-11		ea037776-3759-425c-a7f4-35e8a5571025		
TCGA-BH-A1FH-11		47.0				1123.0		FEMALE									1123.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FH-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FH	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47.0	Left Upper Outer Quadrant				TCGA-BH-A1FH	TCGA-BH-A1FH-11B		Positive					Negative	Modified Radical Mastectomy					-17172.0	4670.0	1034.0	0.0						YES					2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280.0	NO				13.0																				Bone												8.0		False	No	M1	N1b	T2	Stage IV		A1FH	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998.0	1b831e2d-c265-4eac-aee0-248493a14218	1b831e2d-c265-4eac-aee0-248493a14218				TCGA-BH-A1FH-11B-42D-A13T-05						TCGA-BH-A1FH-11			1b831e2d-c265-4eac-aee0-248493a14218			TCGA-BH-A1FH-11		1b831e2d-c265-4eac-aee0-248493a14218		
TCGA-BH-A1FJ-11		66.0				1927.0		FEMALE									1927.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FJ-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FJ	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66.0	Right Upper Outer Quadrant				TCGA-BH-A1FJ	TCGA-BH-A1FJ-11B		Negative					Positive	Modified Radical Mastectomy					-24262.0	4574.0	1927.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380.0	NO				35.0																																6.0		False	No	M0	N1b	T3	Stage IIIA		A1FJ								YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998.0	3078c384-b624-4f5a-ae36-fc896212e616	3078c384-b624-4f5a-ae36-fc896212e616				TCGA-BH-A1FJ-11B-42D-A13T-05						TCGA-BH-A1FJ-11			3078c384-b624-4f5a-ae36-fc896212e616			TCGA-BH-A1FJ-11		3078c384-b624-4f5a-ae36-fc896212e616		
TCGA-BH-A1FM-11		44.0				1388.0		FEMALE									1388.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FM-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FM	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44.0	Right Upper Outer Quadrant				TCGA-BH-A1FM	TCGA-BH-A1FM-11B		Positive					Negative	Modified Radical Mastectomy					-16289.0	4753.0	1388.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210.0	NO				10.0																																8.0		False	No	M0	N2	T2	Stage IIIA		A1FM								YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998.0	39ec3623-c15f-4af6-b2df-5413eec21bec	39ec3623-c15f-4af6-b2df-5413eec21bec				TCGA-BH-A1FM-11B-23D-A13T-05						TCGA-BH-A1FM-11			39ec3623-c15f-4af6-b2df-5413eec21bec			TCGA-BH-A1FM-11		39ec3623-c15f-4af6-b2df-5413eec21bec		
TCGA-BH-A1FN-11		34.0				2192.0		FEMALE									2192.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FN-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1FN	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34.0	Right Upper Outer Quadrant				TCGA-BH-A1FN	TCGA-BH-A1FN-11A		Positive					Positive	Other					-12525.0	4838.0	2192.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy		NO				29.0																																0.0		True	No	M0	N0	T2	Stage IIA		A1FN	WITH TUMOR							YES				Solid Tissue Normal	11	segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1997.0	48353101-484c-4d47-ae60-239d710ec00a	48353101-484c-4d47-ae60-239d710ec00a				TCGA-BH-A1FN-11A-34D-A13T-05	BAC42747-AC16-4A8B-A673-236A4F3F0568					TCGA-BH-A1FN-11			48353101-484c-4d47-ae60-239d710ec00a			TCGA-BH-A1FN-11		48353101-484c-4d47-ae60-239d710ec00a		
TCGA-BH-A1FR-11		73.0				4398.0		FEMALE									4398.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FR-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FR	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73.0	Right Upper Inner Quadrant				TCGA-BH-A1FR			Positive					Positive	Other					-26684.0		1642.0	0.0											2011-9-8	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES		Core needle biopsy						10.0																																4.0			No	M0	N1a	T4b	Stage IIIB		A1FR	WITH TUMOR							YES				Solid Tissue Normal	11	segmental mastectomy with excision of mass on chest wall and axillary node dissection	5th		NO	YES	BH	Breast		DECEASED	1997.0	c2db17b1-c288-4f73-8e22-22929d846678	c2db17b1-c288-4f73-8e22-22929d846678				TCGA-BH-A1FR-11B-42D-A13T-05						TCGA-BH-A1FR-11			c2db17b1-c288-4f73-8e22-22929d846678			TCGA-BH-A1FR-11		c2db17b1-c288-4f73-8e22-22929d846678		
TCGA-BH-A1FU-11		44.0				2192.0		FEMALE									2192.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A1FU-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1FU	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44.0	Right Upper Outer Quadrant				TCGA-BH-A1FU			Negative					Negative	Modified Radical Mastectomy					-16174.0		1688.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy						5.0																																0.0			No	M0	N0	T1c	Stage IA		A1FU	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast		DECEASED	1997.0	df661ba2-098b-49e0-884c-27cf2ecd87f2	df661ba2-098b-49e0-884c-27cf2ecd87f2										TCGA-BH-A1FU-11			df661ba2-098b-49e0-884c-27cf2ecd87f2			TCGA-BH-A1FU-11		df661ba2-098b-49e0-884c-27cf2ecd87f2		
TCGA-BH-A203-11		78.0				1174.0		FEMALE									1174.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A203-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A203	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78.0	Right				TCGA-BH-A203	TCGA-BH-A203-11A								Lumpectomy					-28609.0	5418.0	1174.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			480.0	NO				39.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														35.0		False	No	M0	N1b	T2	Stage IIB		A203	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1996.0	6e5015d8-55e8-448a-9663-7b8625f170ae	6e5015d8-55e8-448a-9663-7b8625f170ae				TCGA-BH-A203-11A-42D-A16A-05	87EB8632-D2C0-4E37-A707-66410942D9A1					TCGA-BH-A203-11			6e5015d8-55e8-448a-9663-7b8625f170ae			TCGA-BH-A203-11		6e5015d8-55e8-448a-9663-7b8625f170ae		
TCGA-BH-A204-11		80.0				2534.0		FEMALE									2534.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A204-11		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A204	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80.0	Left				TCGA-BH-A204	TCGA-BH-A204-11A								Modified Radical Mastectomy					-29529.0	5538.0	2534.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	450.0	NO				16.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														2.0		False	No	M0	N1b	T2	Stage IIB		A204								YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1996.0	6b52803e-274b-4a1b-910f-2d307932bbb2	6b52803e-274b-4a1b-910f-2d307932bbb2				TCGA-BH-A204-11A-53D-A161-05						TCGA-BH-A204-11			6b52803e-274b-4a1b-910f-2d307932bbb2			TCGA-BH-A204-11		6b52803e-274b-4a1b-910f-2d307932bbb2		
TCGA-BH-A208-11		48.0				1759.0		FEMALE									1759.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A208-11		C3-BRCA/Luminal							mutation cluster 8	TCGA-BH-A208	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48.0	Left				TCGA-BH-A208	TCGA-BH-A208-11A								Lumpectomy					-17715.0	5893.0	1759.0	0.0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	920.0	NO				15.0																																3.0		False	No	M0	N1b	T2	Stage IIB		A208	TUMOR FREE							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1995.0	a0ac3d9f-7700-4319-929a-fb51d85c9d49	a0ac3d9f-7700-4319-929a-fb51d85c9d49				TCGA-BH-A208-11A-51D-A161-05	CE2C9C0F-7CD7-4C05-AF2F-85D4552F8183					TCGA-BH-A208-11			a0ac3d9f-7700-4319-929a-fb51d85c9d49			TCGA-BH-A208-11		a0ac3d9f-7700-4319-929a-fb51d85c9d49		
TCGA-BH-A209-11		77.0				3959.0		FEMALE									3959.0	1.0	Normal						enrollment			DECEASED	TCGA-BH-A209-11		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A209	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77.0	Left Upper Outer Quadrant				TCGA-BH-A209	TCGA-BH-A209-11A		Positive					Positive	Lumpectomy					-28403.0	5392.0	3959.0	0.0											2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	400.0	NO				12.0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0.0		False	No	M0	N0	T1c	Stage I		A209	TUMOR FREE							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1996.0	7a4e994d-ed10-45e7-9107-51dc02068963	7a4e994d-ed10-45e7-9107-51dc02068963				TCGA-BH-A209-11A-42D-A161-05						TCGA-BH-A209-11			7a4e994d-ed10-45e7-9107-51dc02068963			TCGA-BH-A209-11		7a4e994d-ed10-45e7-9107-51dc02068963		
TCGA-BH-A28O-01																													TCGA-BH-A28O-01	Quiet			Low purity c2			miRNA cluster 4			TCGA-BH-A28O	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50.0	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A28O-F64237	TCGA-BH-A28O	TCGA-BH-A28O-01A		Positive					Positive	Other		NO			-18501.0	163.0		0.0	1120.0					NO					2014-8-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80.0	NO	Negative		NO	14.0	Negative																														NO	14.0		True	No	M0	N3	T3a	Stage IIIC	TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf	A28O	TUMOR FREE						YES	YES			YES	Primary Tumor	1	Segmental mastectomy	7th		YES	NO	BH	Breast	A	LIVING	2010.0	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b			TCGA-BH-A28O-01	TCGA-BH-A28O-01A-11D-A22B-05		TCGA-BH-A28O-01	TCGA-BH-A28O-01A-11D-A228-09			TCGA-BH-A28O-01			7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b		TCGA-BH-A28O-01A-11D-A227-01	TCGA-BH-A28O-01		7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	TCGA-BH-A28O-01A-11D-A227-01	
TCGA-BH-A6R9-01																													TCGA-BH-A6R9-01										TCGA-BH-A6R9	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61.0	Left			TCGA-BH-A6R9-F63678	TCGA-BH-A6R9	TCGA-BH-A6R9-01A		Negative					Positive	Modified Radical Mastectomy					-22325.0	237.0		0.0	160.0										2014-8-15	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	220.0	NO	Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			True	No	M0	N0	T2	Stage IIA	TCGA-BH-A6R9.1DB8FAFB-FC4A-4401-8316-30FB5352335D.pdf	A6R9	TUMOR FREE						NO				NO	Primary Tumor	1		7th		YES	NO	BH	Breast	A	LIVING	2012.0	7c73dae6-4478-4cbc-aee1-0b18e730f7a2	7c73dae6-4478-4cbc-aee1-0b18e730f7a2			TCGA-BH-A6R9-01	TCGA-BH-A6R9-01A-21D-A32T-05	8C499FE0-D3D8-41FD-9E45-679C3403942C	TCGA-BH-A6R9-01				TCGA-BH-A6R9-01			7c73dae6-4478-4cbc-aee1-0b18e730f7a2		TCGA-BH-A6R9-01A-21D-A32H-01	TCGA-BH-A6R9-01		7c73dae6-4478-4cbc-aee1-0b18e730f7a2	TCGA-BH-A6R9-01A-21D-A32H-01	
TCGA-C8-A12Q-01	Stage IIIA	78.0	5.0	No_Conversion	0.0		Negative	FEMALE	Positive	1.0	1.0	1.0	Negative	M0	Positive	N2	0.0	0.0	Her2	HER2-enriched	Negative	Her2	-11.0	-5.0	enrollment	T1	T1	LIVING	TCGA-C8-A12Q-01	High	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12Q	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		78.0	Left	Axillary lymph node dissection alone		TCGA-C8-A12Q-F20253	TCGA-C8-A12Q	TCGA-C8-A12Q-01A		Negative					Negative	Other					-28733.0	57.0	385.0	0.0	2.0									Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	810.0	NO	Positive			7.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	4.0				Liver	Distant Metastasis			YES			True	No	M0	N2	T1	Stage IIIA	TCGA-C8-A12Q.90AF32F0-5684-4D5B-B619-2B12DA3823C6.pdf	A12Q	WITH TUMOR										NO	Primary Tumor	1	Pateys Surgery		NO	YES	NO	C8	Breast	A	DECEASED	2010.0	e042ea6d-3204-41a7-9811-25f4ac0c3558	e042ea6d-3204-41a7-9811-25f4ac0c3558	TCGA-C8-A12Q-01A-21-A13D-20	TCGA-C8-A12Q-01A-11D-A10Y-09	TCGA-C8-A12Q-01		588f723a-3e25-4cdc-91f6-36d00bb179e5	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11D-A10Y-09	TCGA-C8-A12Q-01A-11D-A112-05	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11D-A10Y-09		e042ea6d-3204-41a7-9811-25f4ac0c3558		TCGA-C8-A12Q-01A-11D-A111-01	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11R-A115-07	e042ea6d-3204-41a7-9811-25f4ac0c3558	TCGA-C8-A12Q-01A-11D-A111-01	TCGA-C8-A12Q-01
TCGA-C8-A1HM-01	Stage II	74.0	3.0	Stage IIA	6.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	6.0	0.0	LumB	Luminal B	Positive		-2.0	-5.0	enrollment	T_Other	T2	LIVING	TCGA-C8-A1HM-01	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-C8-A1HM	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74.0	Left	Axillary lymph node dissection alone		TCGA-C8-A1HM-F70806	TCGA-C8-A1HM			Positive					Positive	Modified Radical Mastectomy					-27063.0			0.0	375.0					NO				Scheduled Follow-up Submission	2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0								NO				No	M0	N0	T2	Stage IIA		A1HM	TUMOR FREE				Allred Score 5	Allred Score 8	YES	NO			NO	Primary Tumor	1		6th	YES	YES	NO	C8	Breast		LIVING	2010.0	eb908a6f-d6f2-40ef-90da-97438cd2281e	eb908a6f-d6f2-40ef-90da-97438cd2281e	TCGA-C8-A1HM-01A-21-A17J-20	TCGA-C8-A1HM-01A-12D-A135-09	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12D-A138-05	e15bb106-69e3-4af4-bd2f-9c9098aa34e3	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12D-A135-09		TCGA-C8-A1HM-01	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12D-A135-09		eb908a6f-d6f2-40ef-90da-97438cd2281e		TCGA-C8-A1HM-01A-12D-A134-01	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12R-A137-07	eb908a6f-d6f2-40ef-90da-97438cd2281e	TCGA-C8-A1HM-01A-12D-A134-01	TCGA-C8-A1HM-01
TCGA-C8-A274-01	Stage IIA	63.0	2.0	Stage IIA	1.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1.0	0.0	LumB		Positive				enrollment	T_Other	T2	LIVING	TCGA-C8-A274-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 1	TCGA-C8-A274	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63.0	Right			TCGA-C8-A274-F70831	TCGA-C8-A274	TCGA-C8-A274-01A		Positive					Positive	Other					-23337.0	163.0		0.0	508.0									Scheduled Follow-up Submission	2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	470.0	NO	Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3.0									NO			True	No	M0	N0	T2	Stage IIA	TCGA-C8-A274.A7FAA4F2-1846-48CF-9FB5-15E98430F6CE.pdf	A274	TUMOR FREE				Allred Score 7	Allred Score 8	YES	NO			NO	Primary Tumor	1	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010.0	f9521be2-aaaf-414c-a906-3ba53a060614	f9521be2-aaaf-414c-a906-3ba53a060614	TCGA-C8-A274-01A-21-A17K-20	TCGA-C8-A274-01A-11D-A16D-09	TCGA-C8-A274-01	TCGA-C8-A274-01A-11D-A16G-05	99762a09-75aa-4d91-8911-2f259e4f4f40	TCGA-C8-A274-01	TCGA-C8-A274-01A-11D-A16D-09			TCGA-C8-A274-01	TCGA-C8-A274-01A-11D-A16D-09		f9521be2-aaaf-414c-a906-3ba53a060614		TCGA-C8-A274-01A-11D-A16C-01	TCGA-C8-A274-01		f9521be2-aaaf-414c-a906-3ba53a060614	TCGA-C8-A274-01A-11D-A16C-01	
TCGA-D8-A1J8-01	Stage IIB	77.0	2.0	Stage IIB	256.0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	256.0	0.0	LumB		Positive				enrollment	T_Other	T2	LIVING	TCGA-D8-A1J8-01	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-D8-A1J8	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1J8-F14040	TCGA-D8-A1J8			Positive					Positive	Modified Radical Mastectomy					-28444.0			0.0	431.0							70-79%		Scheduled Follow-up Submission	2011-7-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			16.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3.0	4.0								NO	3.0			No	M0	N1a	T2	Stage IIB		A1J8	TUMOR FREE								70-79%		NO	Primary Tumor	1		7th	YES	YES	NO	D8	Breast		LIVING	2010.0	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	TCGA-D8-A1J8-01A-21-A17J-20		TCGA-D8-A1J8-01	TCGA-D8-A1J8-01A-11D-A13K-05	f1a4f40a-6d0d-49a8-ab70-d275856a8996	TCGA-D8-A1J8-01	TCGA-D8-A1J8-01A-11D-A13L-09			TCGA-D8-A1J8-01			ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef		TCGA-D8-A1J8-01A-11D-A13J-01	TCGA-D8-A1J8-01		ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	TCGA-D8-A1J8-01A-11D-A13J-01	
TCGA-D8-A1JM-01	Stage IIB	59.0	1.0	Stage IIB	238.0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	238.0	0.0	Basal		Negative				enrollment	T_Other	T2	LIVING	TCGA-D8-A1JM-01	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-D8-A1JM	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JM-F20742	TCGA-D8-A1JM	TCGA-D8-A1JM-01A		Positive					Negative	Modified Radical Mastectomy					-21602.0	243.0		0.0	590.0						manual counting	<10%		Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	350.0	NO	Negative			11.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0									NO	3.0		False	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1JM.947954F1-4CBA-42D3-99B2-6BE6E44E5239.pdf	A1JM	TUMOR FREE	manual counting			0%			YES			YES	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010.0	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	TCGA-D8-A1JM-01A-21-A17J-20	TCGA-D8-A1JM-01A-11D-A13L-09	TCGA-D8-A1JM-01	TCGA-D8-A1JM-01A-11D-A13K-05	8d31dc1e-928f-4d15-9ebc-cdab6a5e3527	TCGA-D8-A1JM-01	TCGA-D8-A1JM-01A-11D-A13L-09				TCGA-D8-A1JM-01A-11D-A13L-09		ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525		TCGA-D8-A1JM-01A-11D-A13J-01			ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	TCGA-D8-A1JM-01A-11D-A13J-01	
TCGA-D8-A1X8-01	Stage IIA	62.0	2.0	Stage IIIA	272.0		Positive	FEMALE	Negative				Negative	M0	Positive	N2	272.0	0.0	LumA		Indeterminate				enrollment	T1	T1	LIVING	TCGA-D8-A1X8-01	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-D8-A1X8	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62.0	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X8-F29428	TCGA-D8-A1X8	TCGA-D8-A1X8-01A		Positive		2+	4 Point Scale		Indeterminate	Modified Radical Mastectomy		NO			-22995.0	225.0		0.0	783.0					NO	% IHC			Scheduled Follow-up Submission	2012-10-19	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	360.0	NO	Negative			11.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	1.0								NO	9.0	0.0	False	No	M0	N2a	T1c	Stage IIIA	TCGA-D8-A1X8.5F1C3B85-5E5C-428B-8779-3A5878DCE1F2.pdf	A1X8	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010.0	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	TCGA-D8-A1X8-01A-21-A17K-20	TCGA-D8-A1X8-01A-11D-A14K-09	TCGA-D8-A1X8-01	TCGA-D8-A1X8-01A-11D-A14N-05	9bd7faf1-8b85-4e46-b968-35a1a5cc2cb5	TCGA-D8-A1X8-01	TCGA-D8-A1X8-01A-11D-A14K-09			TCGA-D8-A1X8-01	TCGA-D8-A1X8-01A-11D-A14K-09		cbc8608e-ffe1-41d5-93c5-66dd665c9bf0		TCGA-D8-A1X8-01A-11D-A14J-01	TCGA-D8-A1X8-01		cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	TCGA-D8-A1X8-01A-11D-A14J-01	
TCGA-D8-A1XG-01	Stage IIIB	86.0	3.0	Stage IIIB	196.0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	196.0	0.0	LumA		Negative				enrollment	T_Other	T4	LIVING	TCGA-D8-A1XG-01	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-D8-A1XG	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					86.0	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XG-F29444	TCGA-D8-A1XG	TCGA-D8-A1XG-01A		Positive					Negative	Modified Radical Mastectomy		YES			-31748.0	169.0		0.0	448.0					NO	% IHC			Scheduled Follow-up Submission	2012-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	590.0	NO	Negative			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	1.0								NO	2.0	0.0	False	No	M0	N1a	T4b	Stage IIIB	TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf	A1XG	TUMOR FREE					10-75%		YES			NO	Primary Tumor	1		7th	NO	YES	NO	D8	Breast	A	LIVING	2010.0	56bc2076-bafe-47aa-8255-9f03d438cb00	56bc2076-bafe-47aa-8255-9f03d438cb00	TCGA-D8-A1XG-01A-21-A17K-20	TCGA-D8-A1XG-01A-11D-A14G-09	TCGA-D8-A1XG-01	TCGA-D8-A1XG-01A-11D-A14H-05	c51c59e6-0a2c-4597-88df-59166bf2c096	TCGA-D8-A1XG-01	TCGA-D8-A1XG-01A-11D-A14G-09			TCGA-D8-A1XG-01	TCGA-D8-A1XG-01A-11D-A14G-09		56bc2076-bafe-47aa-8255-9f03d438cb00		TCGA-D8-A1XG-01A-11D-A14F-01	TCGA-D8-A1XG-01		56bc2076-bafe-47aa-8255-9f03d438cb00	TCGA-D8-A1XG-01A-11D-A14F-01	
TCGA-D8-A1XM-01	Stage IA	57.0	3.0	Stage I	218.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	218.0	0.0	LumA		Positive				enrollment	T1	T1	LIVING	TCGA-D8-A1XM-01	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XM	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57.0	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XM-F29445	TCGA-D8-A1XM	TCGA-D8-A1XM-01A		Positive					Positive	Lumpectomy		NO			-21056.0	189.0		0.0	538.0					NO	% IHC			Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200.0	NO	Negative			1.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1.0	4.0								NO	0.0	0.0	False	No	M0	N0	T1c	Stage IA	TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf	A1XM	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	1		7th	NO	YES	NO	D8	Breast	A	LIVING	2010.0	3049e9ab-8e65-4264-865a-b7a14e27aae1	3049e9ab-8e65-4264-865a-b7a14e27aae1	TCGA-D8-A1XM-01A-11-A17K-20	TCGA-D8-A1XM-01A-21D-A14K-09	TCGA-D8-A1XM-01	TCGA-D8-A1XM-01A-21D-A14N-05	6885966b-8453-46b3-8f90-6dfc1117e87b	TCGA-D8-A1XM-01	TCGA-D8-A1XM-01A-21D-A14K-09			TCGA-D8-A1XM-01	TCGA-D8-A1XM-01A-21D-A14K-09		3049e9ab-8e65-4264-865a-b7a14e27aae1		TCGA-D8-A1XM-01A-21D-A14J-01	TCGA-D8-A1XM-01		3049e9ab-8e65-4264-865a-b7a14e27aae1	TCGA-D8-A1XM-01A-21D-A14J-01	
TCGA-D8-A1XW-01	Stage IIA	53.0	3.0	Stage IIA	117.0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	117.0	0.0	Normal		Positive				enrollment	T_Other	T2	LIVING	TCGA-D8-A1XW-01	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-D8-A1XW	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53.0	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A1XW-F72205	TCGA-D8-A1XW	TCGA-D8-A1XW-01A		Negative					Positive	Modified Radical Mastectomy		NO			-19478.0	76.0		0.0	1309.0					NO	% IHC			Scheduled Follow-up Submission	2015-4-29	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	310.0	NO	Negative		NO	1.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5.0	3.0								NO	0.0	0.0	False	No	M0	N0	T2	Stage IIA	TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf	A1XW	TUMOR FREE					0%	YES	YES	<10%		NO	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2011.0	8e24b2f8-459c-4861-9d31-d171e8d1a08b	8e24b2f8-459c-4861-9d31-d171e8d1a08b	TCGA-D8-A1XW-01A-21-A17K-20	TCGA-D8-A1XW-01A-11D-A14K-09	TCGA-D8-A1XW-01	TCGA-D8-A1XW-01A-11D-A14N-05	645dc9bf-f601-46eb-84e0-cb5df8d9981b	TCGA-D8-A1XW-01	TCGA-D8-A1XW-01A-11D-A14K-09			TCGA-D8-A1XW-01	TCGA-D8-A1XW-01A-11D-A14K-09		8e24b2f8-459c-4861-9d31-d171e8d1a08b		TCGA-D8-A1XW-01A-11D-A14J-01	TCGA-D8-A1XW-01		8e24b2f8-459c-4861-9d31-d171e8d1a08b	TCGA-D8-A1XW-01A-11D-A14J-01	
TCGA-E2-A106-01	Stage IB	34.0	4.0	No_Conversion	1807.0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1807.0	0.0	LumA	Luminal A	Positive		0.0	-3.0	followup	T1	T1	LIVING	TCGA-E2-A106-01	Kirc+		cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-E2-A106	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34.0	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A106-F70397	TCGA-E2-A106		Negative	Positive				Other	Positive	Simple Mastectomy	inner-upper margin re-excision	NO			-12528.0			0.0	2541.0							90-99%		Scheduled Follow-up Submission	2015-3-17	FEMALE			10-19%		2+			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	16.0	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4.0	4.0								NO	1.0			No	M0	N1mi	T1c	Stage IB		A106	TUMOR FREE						YES		80-89%		NO	Primary Tumor	1			YES	NO	YES	E2	Breast		LIVING	2006.0	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2			TCGA-E2-A106-01	TCGA-E2-A106-01A-11D-A10N-05								TCGA-E2-A106-01	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2	TCGA-E2-A106-01			TCGA-E2-A106-01A-11R-A10J-07	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2		TCGA-E2-A106-01
TCGA-E2-A107-01	Stage IIIA	54.0	2.0	No_Conversion	1046.0		Positive	FEMALE	Negative	1.0	3.0	4.0	Negative	M0	Positive	N2	1046.0	0.0		Luminal B	Negative	LumA/B	0.0	-3.0	followup	T_Other	T3	LIVING	TCGA-E2-A107-01	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A107	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54.0	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A107-F17173	TCGA-E2-A107	TCGA-E2-A107-01A		Positive					Negative	Simple Mastectomy		NO			-20065.0	715.0		0.0	1047.0						Allred score 5+3=8			Scheduled Follow-up Submission	2011-9-28	FEMALE					2+			1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170.0	NO	Equivocal	Negative		27.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0								NO	4.0		False	No	M0	N2a	T3	Stage IIIA	TCGA-E2-A107.BA87D188-A3B3-4A6F-B3AF-1FEB25B9E357.pdf	A107	TUMOR FREE	Allred score 0+0=0			Allred score 0	Allred score 8					YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2008.0	254c611f-7808-4745-9155-f2d578b29df2	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01A-21-A13D-20	TCGA-E2-A107-01A-11D-A10M-09	TCGA-E2-A107-01	TCGA-E2-A107-01A-11D-A10N-05	ea9612ed-23f6-44e6-92f4-7cc7d3cef266	TCGA-E2-A107-01	TCGA-E2-A107-01A-11D-A10M-09		TCGA-E2-A107-01		TCGA-E2-A107-01A-11D-A10M-09	TCGA-E2-A107-01	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01	TCGA-E2-A107-01A-11D-A10L-01		TCGA-E2-A107-01A-11R-A10J-07	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01A-11D-A10L-01	TCGA-E2-A107-01
TCGA-E2-A14V-01	Stage IIB	53.0	5.0	Stage IIB	748.0		Positive	FEMALE	Positive	1.0	1.0	1.0	Negative	M0	Positive	N1	748.0	0.0	Her2	HER2-enriched	Positive	Her2	-1.0	-5.0	enrollment	T_Other	T2	LIVING	TCGA-E2-A14V-01	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A14V	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53.0	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14V-F18870	TCGA-E2-A14V	TCGA-E2-A14V-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-19643.0	722.0		0.0	1042.0					NO				Scheduled Follow-up Submission	2011-11-4	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160.0	NO	Positive			24.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	4.0								NO	3.0		False	No	M0	N1	T2	Stage IIB	TCGA-E2-A14V.DC8FD7C7-A908-4B90-860F-04984244167C.pdf	A14V	TUMOR FREE							YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2008.0	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	TCGA-E2-A14V-01A-21-A13E-20	TCGA-E2-A14V-01A-11D-A12B-09	TCGA-E2-A14V-01		40a19899-83c4-44c1-8e91-c4b4339d7ea8	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11D-A12B-09	TCGA-E2-A14V-01A-11D-A12E-05	TCGA-E2-A14V-01	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11D-A12B-09		d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf		TCGA-E2-A14V-01A-11D-A12A-01	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11R-A12D-07	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	TCGA-E2-A14V-01A-11D-A12A-01	TCGA-E2-A14V-01
TCGA-E2-A153-11		51.0			586.0			FEMALE									586.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A153-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A153	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51.0	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A153-F18945	TCGA-E2-A153			Positive					Positive	Modified Radical Mastectomy		NO			-18875.0			0.0	707.0					NO				Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			15.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	3.0			No	M0	N1a	T2	Stage IIB		A153	TUMOR FREE							YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast		LIVING	2009.0	b5ab3b76-36f6-45a7-acad-77288da0d13c	b5ab3b76-36f6-45a7-acad-77288da0d13c								TCGA-E2-A153-11A-31D-A12E-05		TCGA-E2-A153-11			b5ab3b76-36f6-45a7-acad-77288da0d13c			TCGA-E2-A153-11	TCGA-E2-A153-11A-31R-A12D-07	b5ab3b76-36f6-45a7-acad-77288da0d13c		
TCGA-E2-A158-11		43.0			450.0			FEMALE									450.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A158-11		C4-BRCA/Basal							mutation cluster 5	TCGA-E2-A158	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43.0	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A158-F18956	TCGA-E2-A158	TCGA-E2-A158-11A		Negative					Negative	Simple Mastectomy		NO			-15903.0	436.0		0.0	450.0					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170.0	NO	Negative			2.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1.0		False	Yes	M0	N1mi	T1c	Stage IIA		A158	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009.0	5ba99650-56d2-4951-aa24-3d2fea3d1921	5ba99650-56d2-4951-aa24-3d2fea3d1921								TCGA-E2-A158-11A-22D-A12E-05					5ba99650-56d2-4951-aa24-3d2fea3d1921				TCGA-E2-A158-11A-22R-A12D-07	5ba99650-56d2-4951-aa24-3d2fea3d1921		
TCGA-E2-A15I-11		44.0			411.0			FEMALE									411.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A15I-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A15I	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44.0	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15I-F70023	TCGA-E2-A15I			Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16163.0			0.0	1692.0					NO		90-99%		Scheduled Follow-up Submission	2015-2-9	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Equivocal	Negative	NO	4.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0.0			No	M0	N0	T2	Stage IIA		A15I	TUMOR FREE						YES	YES	90-99%		NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast		LIVING	2009.0	f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9	f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9				TCGA-E2-A15I-11A-32D-A138-05						TCGA-E2-A15I-11			f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9			TCGA-E2-A15I-11	TCGA-E2-A15I-11A-32R-A137-07	f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9		
TCGA-E2-A15K-11		58.0			34.0			FEMALE									34.0	0.0							enrollment			LIVING	TCGA-E2-A15K-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A15K	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A15K-F18869	TCGA-E2-A15K	TCGA-E2-A15K-11A		Positive					Positive	Lumpectomy		NO			-21514.0	309.0		0.0	275.0					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120.0	NO	Equivocal	Negative		17.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2.0		False	No	M0	N1a	T2	Stage IIB		A15K	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES			YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010.0	49a33b4d-4b1e-4b30-b0ba-a7c7d594db41	49a33b4d-4b1e-4b30-b0ba-a7c7d594db41				TCGA-E2-A15K-11A-13D-A12R-05						TCGA-E2-A15K-11			49a33b4d-4b1e-4b30-b0ba-a7c7d594db41			TCGA-E2-A15K-11		49a33b4d-4b1e-4b30-b0ba-a7c7d594db41		
TCGA-E2-A15M-11		66.0			234.0			FEMALE									234.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A15M-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-E2-A15M	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66.0	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15M-F18852	TCGA-E2-A15M			Positive					Positive	Lumpectomy		NO			-24266.0		336.0	0.0	235.0					NO				Scheduled Follow-up Submission	2011-11-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection			Negative			5.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0			No	M0	N0	T2	Stage IIA		A15M	TUMOR FREE				Allred score = 8	Allred score = 8		YES			YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast		DECEASED	2010.0	f75e5efb-056f-40bf-afed-33d971478ca4	f75e5efb-056f-40bf-afed-33d971478ca4								TCGA-E2-A15M-11A-22D-A12E-05		TCGA-E2-A15M-11			f75e5efb-056f-40bf-afed-33d971478ca4			TCGA-E2-A15M-11	TCGA-E2-A15M-11A-22R-A12D-07	f75e5efb-056f-40bf-afed-33d971478ca4		
TCGA-E2-A1BC-11		63.0			297.0			FEMALE									297.0	0.0							enrollment			LIVING	TCGA-E2-A1BC-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A1BC	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63.0	Right	Sentinel node biopsy alone		TCGA-E2-A1BC-F19427	TCGA-E2-A1BC			Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-23168.0			0.0	501.0					NO				Scheduled Follow-up Submission	2011-12-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8524/3	C50.9		YES		Tumor resection			Negative			4.0	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0			Yes	M0	N0	T1c	Stage IA		A1BC	TUMOR FREE							YES			NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast		LIVING	2010.0	afe373b9-f1c1-412d-9506-091749d47534	afe373b9-f1c1-412d-9506-091749d47534				TCGA-E2-A1BC-11A-32D-A12R-05						TCGA-E2-A1BC-11			afe373b9-f1c1-412d-9506-091749d47534			TCGA-E2-A1BC-11	TCGA-E2-A1BC-11A-32R-A12P-07	afe373b9-f1c1-412d-9506-091749d47534		
TCGA-E2-A1IG-11		45.0			755.0			FEMALE									755.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A1IG-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E2-A1IG	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45.0	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IG-F70394	TCGA-E2-A1IG	TCGA-E2-A1IG-11A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16757.0	679.0		0.0	2140.0					NO				Scheduled Follow-up Submission	2015-3-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210.0	NO	Negative		NO	3.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1.0		False	No	M0	N1mi	T2	Stage IIB		A1IG	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009.0	1e55cf08-da43-471d-813c-9d37c7abc730	1e55cf08-da43-471d-813c-9d37c7abc730										TCGA-E2-A1IG-11			1e55cf08-da43-471d-813c-9d37c7abc730			TCGA-E2-A1IG-11		1e55cf08-da43-471d-813c-9d37c7abc730		
TCGA-E2-A1IH-01	Stage I	80.0	2.0	Stage I	658.0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	658.0	0.0	LumA		Positive				enrollment	T1	T1	LIVING	TCGA-E2-A1IH-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 10	TCGA-E2-A1IH	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80.0	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IH-F19960	TCGA-E2-A1IH	TCGA-E2-A1IH-01A		Positive					Positive	Lumpectomy		NO			-29444.0	883.0		0.0	1026.0					NO	allred score 5+3=8			Scheduled Follow-up Submission	2011-12-21	FEMALE			20-29%		2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	80.0	NO	Equivocal			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2.0	6.0								NO	0.0		False	No	M0	N0	T1c	Stage I	TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf	A1IH	TUMOR FREE	allred score 5+3+8			allred score = 8	allred score = 8		YES			NO	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2008.0	2d06908f-3332-4b77-b88c-145dc5c4828f	2d06908f-3332-4b77-b88c-145dc5c4828f		TCGA-E2-A1IH-01A-11D-A188-09	TCGA-E2-A1IH-01	TCGA-E2-A1IH-01A-11D-A13K-05		TCGA-E2-A1IH-01	TCGA-E2-A1IH-01A-11D-A188-09			TCGA-E2-A1IH-01	TCGA-E2-A1IH-01A-11D-A188-09		2d06908f-3332-4b77-b88c-145dc5c4828f		TCGA-E2-A1IH-01A-11D-A13J-01	TCGA-E2-A1IH-01		2d06908f-3332-4b77-b88c-145dc5c4828f	TCGA-E2-A1IH-01A-11D-A13J-01	
TCGA-E2-A1II-01	Stage I	51.0	2.0	Stage I	850.0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	850.0	0.0	Basal		Positive				enrollment	T1	T1	LIVING	TCGA-E2-A1II-01	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A1II	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51.0	Left	Sentinel node biopsy alone		TCGA-E2-A1II-F19954	TCGA-E2-A1II			Negative					Positive	Lumpectomy		NO			-18788.0			0.0	1025.0					NO	allred score 0 + 0 = 0			Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			5.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5.0	5.0								NO	0.0			No	M0	N0	T1c	Stage I		A1II	TUMOR FREE	allred score 2+2 = 4			allred score = 4	allred score = 0		YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast		LIVING	2008.0	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a		TCGA-E2-A1II-01A-11D-A142-09	TCGA-E2-A1II-01	TCGA-E2-A1II-01A-11D-A145-05		TCGA-E2-A1II-01	TCGA-E2-A1II-01A-11D-A142-09			TCGA-E2-A1II-01	TCGA-E2-A1II-01A-11D-A142-09		f7a5cfcb-623c-4858-ba32-e6ca63c75d2a		TCGA-E2-A1II-01A-11D-A141-01	TCGA-E2-A1II-01		f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	TCGA-E2-A1II-01A-11D-A141-01	
TCGA-E2-A1L7-11		40.0			633.0			FEMALE									633.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A1L7-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-E2-A1L7	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			40.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1L7-F70298	TCGA-E2-A1L7	TCGA-E2-A1L7-11A		Negative					Negative	Modified Radical Mastectomy		NO			-14854.0	548.0		0.0	1836.0		1662.0	1619		NO	Allred score 1+1 = 2			Scheduled Follow-up Submission	2015-3-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280.0	NO	Negative		NO	20.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)					Negative												Negative								Other, specify	New Primary Tumor	left breast	YES	YES	7.0		False	No	M0	N2	T2	Stage IIIA		A1L7	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 2	YES	YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009.0	53e9749e-5554-443b-b41e-5efade6fce7a	53e9749e-5554-443b-b41e-5efade6fce7a				TCGA-E2-A1L7-11A-33D-A145-05						TCGA-E2-A1L7-11			53e9749e-5554-443b-b41e-5efade6fce7a			TCGA-E2-A1L7-11		53e9749e-5554-443b-b41e-5efade6fce7a		
TCGA-E2-A1LB-11		41.0			972.0			FEMALE									972.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A1LB-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E2-A1LB	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LB-F70015	TCGA-E2-A1LB			Negative					Negative	Lumpectomy		NO			-15283.0			0.0	2306.0					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-2-9	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Positive		NO	25.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	2.0			No	M0	N1	T2	Stage IIB		A1LB	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast		LIVING	2008.0	b34ad5ac-c581-4747-88db-e2d52fa7e463	b34ad5ac-c581-4747-88db-e2d52fa7e463				TCGA-E2-A1LB-11A-22D-A145-05						TCGA-E2-A1LB-11			b34ad5ac-c581-4747-88db-e2d52fa7e463			TCGA-E2-A1LB-11		b34ad5ac-c581-4747-88db-e2d52fa7e463		
TCGA-E2-A1LE-01																													TCGA-E2-A1LE-01	Squamous			BRCA CIMP c7	BRCA basal-like c6		miRNA cluster 7			TCGA-E2-A1LE	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		71.0	Right Upper Inner Quadrant|Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1LE-F20657	TCGA-E2-A1LE	TCGA-E2-A1LE-01A		Negative					Negative	Simple Mastectomy		NO			-26239.0	986.0	879.0	0.0				361		NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2012-1-18	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	600.0	NO	Positive			28.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Lung	Distant Metastasis			YES	27.0		False	No	M0	N3a	T2	Stage IIIC	TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf	A1LE	WITH TUMOR	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	DECEASED	2008.0	776c18b3-4e53-41d6-8838-70a6029c07dd	776c18b3-4e53-41d6-8838-70a6029c07dd	TCGA-E2-A1LE-01A-21-A24A-20		TCGA-E2-A1LE-01	TCGA-E2-A1LE-01A-12D-A19Z-05	fc80abcf-e8e0-4354-8646-d9ea84d87f7d	TCGA-E2-A1LE-01	TCGA-E2-A1LE-01A-12D-A19Y-09			TCGA-E2-A1LE-01			776c18b3-4e53-41d6-8838-70a6029c07dd		TCGA-E2-A1LE-01A-12D-A19X-01	TCGA-E2-A1LE-01		776c18b3-4e53-41d6-8838-70a6029c07dd	TCGA-E2-A1LE-01A-12D-A19X-01	
TCGA-E2-A1LH-11		59.0			2875.0			FEMALE									2875.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A1LH-11		C4-BRCA/Basal							mutation cluster 2	TCGA-E2-A1LH	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59.0	Right	Sentinel node biopsy alone		TCGA-E2-A1LH-F20649	TCGA-E2-A1LH			Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21628.0			0.0	3247.0					NO				Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0			No	M0	N0	T1c	Stage I		A1LH	TUMOR FREE		ACIS					YES			YES	Solid Tissue Normal	11		5th	YES	NO	YES	E2	Breast		LIVING	2002.0	c0c2059a-2931-4834-84a7-bfacf137c182	c0c2059a-2931-4834-84a7-bfacf137c182										TCGA-E2-A1LH-11			c0c2059a-2931-4834-84a7-bfacf137c182			TCGA-E2-A1LH-11		c0c2059a-2931-4834-84a7-bfacf137c182		
TCGA-E2-A1LS-11		46.0			239.0			FEMALE									239.0	0.0	Normal						enrollment			LIVING	TCGA-E2-A1LS-11		C4-BRCA/Basal							mutation cluster 5	TCGA-E2-A1LS	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46.0	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LS-F70016	TCGA-E2-A1LS	TCGA-E2-A1LS-11A		Negative					Negative	Simple Mastectomy		NO			-16887.0	176.0		0.0	1604.0					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-2-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280.0	NO	Negative		NO	5.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0.0		False	No	M0	N0	T1c	Stage IA		A1LS	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010.0	a2c2973d-0af5-4065-a5b0-1dd73abdc581	a2c2973d-0af5-4065-a5b0-1dd73abdc581				TCGA-E2-A1LS-11A-32D-A161-05									a2c2973d-0af5-4065-a5b0-1dd73abdc581					a2c2973d-0af5-4065-a5b0-1dd73abdc581		
TCGA-E9-A1N4-11		41.0			0.0			FEMALE									0.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1N4-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1N4	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41.0	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N4-F39767	TCGA-E9-A1N4	TCGA-E9-A1N4-11A		Positive					Positive			NO			-15055.0	65.0		0.0	1000.0					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Tumor resection	340.0	NO	Positive		NO	7.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	4.0	0.0	True	No	M0	N2	T2	Stage IIIA		A1N4	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010.0	922b7051-1447-4e8d-9343-c5521ee45346	922b7051-1447-4e8d-9343-c5521ee45346				TCGA-E9-A1N4-11A-33D-A14N-05						TCGA-E9-A1N4-11			922b7051-1447-4e8d-9343-c5521ee45346			TCGA-E9-A1N4-11		922b7051-1447-4e8d-9343-c5521ee45346		
TCGA-E9-A1N5-01	Stage IIB	45.0	5.0	Stage IIB	0.0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0.0	0.0	LumA		Positive				enrollment	T_Other	T2	LIVING	TCGA-E9-A1N5-01	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-E9-A1N5	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N5-F39765	TCGA-E9-A1N5	TCGA-E9-A1N5-01A		Positive					Positive			NO			-16736.0	63.0		0.0	1120.0					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	190.0	NO	Positive		NO	11.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4.0	2.0								NO	2.0	0.0	True	No	M0	N1	T2	Stage IIB	TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf	A1N5	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th	YES	YES	NO	E9	Breast	A	LIVING	2010.0	1adf0e70-b1fb-4862-8a01-6454b09636f4	1adf0e70-b1fb-4862-8a01-6454b09636f4	TCGA-E9-A1N5-01A-21-A17J-20	TCGA-E9-A1N5-01A-11D-A14G-09	TCGA-E9-A1N5-01	TCGA-E9-A1N5-01A-11D-A14H-05	1efeb02c-7e68-449e-9f4f-8b8f985ab01e	TCGA-E9-A1N5-01	TCGA-E9-A1N5-01A-11D-A14G-09			TCGA-E9-A1N5-01	TCGA-E9-A1N5-01A-11D-A14G-09		1adf0e70-b1fb-4862-8a01-6454b09636f4		TCGA-E9-A1N5-01A-11D-A14F-01	TCGA-E9-A1N5-01		1adf0e70-b1fb-4862-8a01-6454b09636f4	TCGA-E9-A1N5-01A-11D-A14F-01	
TCGA-E9-A1N5-11		45.0			0.0			FEMALE									0.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1N5-11		C3-BRCA/Luminal							mutation cluster 3	TCGA-E9-A1N5	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N5-F39765	TCGA-E9-A1N5	TCGA-E9-A1N5-11A		Positive					Positive			NO			-16736.0	63.0		0.0	1120.0					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection		NO	Positive		NO	11.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2.0	0.0	True	No	M0	N1	T2	Stage IIB		A1N5	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010.0	8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7	8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7				TCGA-E9-A1N5-11A-41D-A14H-05	0D7A5303-6F45-4910-8BC5-F08E8FC11463					TCGA-E9-A1N5-11			8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7			TCGA-E9-A1N5-11		8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7		
TCGA-E9-A1N6-11		52.0			0.0			FEMALE									0.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1N6-11		C3-BRCA/Luminal								TCGA-E9-A1N6	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			52.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N6-F63536	TCGA-E9-A1N6	TCGA-E9-A1N6-11A		Positive					Positive			NO			-19327.0	63.0	678.0	0.0	410.0			443		NO				Scheduled Follow-up Submission	2014-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	670.0	NO	Positive		NO	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Bone	Distant Metastasis		NO	YES	2.0	0.0	True	No	M0	N1	T2	Stage IIB		A1N6	WITH TUMOR						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2010.0	0f263a65-a664-4e23-bd9c-91e955f3bf21	0f263a65-a664-4e23-bd9c-91e955f3bf21				TCGA-E9-A1N6-11A-32D-A145-05	F251633F-A6B6-4238-93A8-6C32EFCA1607					TCGA-E9-A1N6-11			0f263a65-a664-4e23-bd9c-91e955f3bf21			TCGA-E9-A1N6-11		0f263a65-a664-4e23-bd9c-91e955f3bf21		
TCGA-E9-A1N9-11		58.0			0.0			FEMALE									0.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1N9-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-E9-A1N9	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58.0	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N9-F58373	TCGA-E9-A1N9	TCGA-E9-A1N9-11A		Negative					Positive			YES			-21228.0	44.0		0.0	1101.0					NO				Scheduled Follow-up Submission	2014-4-8	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	1190.0	NO	Positive		NO	8.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	True	No	M0	N0	T2	Stage IIA		A1N9	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	f6e8424b-338c-4f9a-bdc7-f7d8de0c5634	f6e8424b-338c-4f9a-bdc7-f7d8de0c5634					39636744-785B-4D93-8EE5-40D075AEAB71					TCGA-E9-A1N9-11			f6e8424b-338c-4f9a-bdc7-f7d8de0c5634			TCGA-E9-A1N9-11		f6e8424b-338c-4f9a-bdc7-f7d8de0c5634		
TCGA-E9-A1NA-11		58.0			0.0			FEMALE									0.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1NA-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1NA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58.0	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1-F39782	TCGA-E9-A1	TCGA-E9-A1-11A		Positive					Positive			YES			-21397.0	42.0		0.0	1112.0					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	330.0	NO	Positive		NO	11.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	True	No	M0	N0	T2	Stage IIA		A1	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	7b9569bc-f513-4b64-9a7c-7bb53b9be79b	7b9569bc-f513-4b64-9a7c-7bb53b9be79b				TCGA-E9-A1NA-11A-33D-A145-05						TCGA-E9-A1NA-11			7b9569bc-f513-4b64-9a7c-7bb53b9be79b			TCGA-E9-A1NA-11		7b9569bc-f513-4b64-9a7c-7bb53b9be79b		
TCGA-E9-A1ND-11		75.0			0.0			FEMALE									0.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1ND-11		C4-BRCA/Basal							mutation cluster 2	TCGA-E9-A1ND	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1ND-F62586	TCGA-E9-A1ND	TCGA-E9-A1ND-11A		Negative					Negative			YES			-27400.0	37.0		0.0	1266.0					NO				Scheduled Follow-up Submission	2014-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	1070.0	NO	Positive		NO	11.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1.0	0.0	True	No	M0	N1	T2	Stage IIB		A1ND	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	ef84a69f-37bc-46fa-98ac-b3976212e11d	ef84a69f-37bc-46fa-98ac-b3976212e11d				TCGA-E9-A1ND-11A-43D-A145-05	1DFA3ABA-51BC-48FA-B854-39ED4F94E701					TCGA-E9-A1ND-11			ef84a69f-37bc-46fa-98ac-b3976212e11d			TCGA-E9-A1ND-11		ef84a69f-37bc-46fa-98ac-b3976212e11d		
TCGA-E9-A1NF-11		60.0			0.0			FEMALE									0.0	0.0	LumA						enrollment			LIVING	TCGA-E9-A1NF-11		C3-BRCA/Luminal							mutation cluster 13	TCGA-E9-A1NF	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES		NO		60.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NF-F39778	TCGA-E9-A1NF	TCGA-E9-A1NF-11A		Positive					Positive			YES			-21981.0	31.0	1072.0	0.0	610.0			90		NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	1520.0	NO	Negative		NO	9.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Lung	Distant Metastasis			NO	0.0	0.0	True	No	M0	N0	T2	Stage IIA		A1NF	WITH TUMOR						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011.0	39f6a4d4-650f-4caf-a778-4a24af4f11ba	39f6a4d4-650f-4caf-a778-4a24af4f11ba				TCGA-E9-A1NF-11A-73D-A14H-05	DF5927EA-DE81-492A-B1AD-03A0E533A338								39f6a4d4-650f-4caf-a778-4a24af4f11ba					39f6a4d4-650f-4caf-a778-4a24af4f11ba		
TCGA-E9-A1NG-11		62.0			0.0			FEMALE									0.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1NG-11		C3-BRCA/Luminal							mutation cluster 1	TCGA-E9-A1NG	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NG-F39774	TCGA-E9-A1NG	TCGA-E9-A1NG-11A		Positive					Positive			YES			-22896.0	30.0	786.0	0.0	656.0					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	740.0	NO	Negative		NO	5.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	True	No	M0	N0	T2	Stage IIA		A1NG	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011.0	a4172e12-2a82-436e-8cb9-a532dc0e9ec4	a4172e12-2a82-436e-8cb9-a532dc0e9ec4				TCGA-E9-A1NG-11A-52D-A14N-05	89FE3D24-088B-4F16-82A2-534DB14FF98D					TCGA-E9-A1NG-11			a4172e12-2a82-436e-8cb9-a532dc0e9ec4			TCGA-E9-A1NG-11		a4172e12-2a82-436e-8cb9-a532dc0e9ec4		
TCGA-E9-A1R7-11		64.0			34.0			FEMALE									34.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1R7-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1R7	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R7-F71424	TCGA-E9-A1R7	TCGA-E9-A1R7-11A								Lumpectomy		NO			-23397.0	51.0		0.0	1467.0					NO				Scheduled Follow-up Submission	2015-3-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	440.0	NO			NO	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0		False	No	M0	N0	T2	Stage IIA		A1R7	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	1457ae2c-4b9b-448a-b455-432a7121beb4	1457ae2c-4b9b-448a-b455-432a7121beb4				TCGA-E9-A1R7-11A-42D-A14N-05						TCGA-E9-A1R7-11			1457ae2c-4b9b-448a-b455-432a7121beb4			TCGA-E9-A1R7-11		1457ae2c-4b9b-448a-b455-432a7121beb4		
TCGA-E9-A1RB-11		40.0			21.0			FEMALE									21.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1RB-11		C3-BRCA/Luminal							mutation cluster 5	TCGA-E9-A1RB	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40.0	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RB-F39530	TCGA-E9-A1RB	TCGA-E9-A1RB-11A								Modified Radical Mastectomy		NO			-14755.0	39.0	976.0	0.0	633.0					NO				Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	640.0	NO			NO	10.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0.0	0.0	False	No	M0	N0	T2	Stage IIA		A1RB	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011.0	b8499b28-1746-4ffd-a183-a765e6d290e3	b8499b28-1746-4ffd-a183-a765e6d290e3				TCGA-E9-A1RB-11A-33D-A161-05	0EFB66E0-3439-4FAE-9B6A-C5D085876AAF					TCGA-E9-A1RB-11			b8499b28-1746-4ffd-a183-a765e6d290e3			TCGA-E9-A1RB-11		b8499b28-1746-4ffd-a183-a765e6d290e3		
TCGA-E9-A1RC-11		56.0			1228.0			FEMALE									1228.0	0.0	LumA						enrollment			LIVING	TCGA-E9-A1RC-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RC	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RC-F48701	TCGA-E9-A1RC	TCGA-E9-A1RC-11A								Modified Radical Mastectomy		NO			-20795.0	1246.0		0.0	1224.0					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	1040.0	NO			YES	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	10.0	0.0	False	No	M0	N3	T4b	Stage IIIC		A1RC	TUMOR FREE							YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2007.0	81769714-1765-4b76-8a3a-18f79e314852	81769714-1765-4b76-8a3a-18f79e314852				TCGA-E9-A1RC-11A-33D-A161-05	68A3D687-0B01-4BDD-B650-D8D204E65559								81769714-1765-4b76-8a3a-18f79e314852					81769714-1765-4b76-8a3a-18f79e314852		
TCGA-E9-A1RD-01	Stage IIA	67.0	2.0	Stage IIA	20.0			FEMALE	Negative				Negative	M0	Negative	N0	20.0	0.0	LumA						enrollment	T_Other	T2	LIVING	TCGA-E9-A1RD-01	Iq	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-E9-A1RD	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67.0	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RD-F48702	TCGA-E9-A1RD									Modified Radical Mastectomy		NO			-24719.0			0.0	34.0					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)					YES	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3.0									NO	0.0			No	M0	N0	T2	Stage IIA		A1RD	TUMOR FREE							YES			NO	Primary Tumor	1		7th	YES	YES	NO	E9	Breast		LIVING	2011.0	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	TCGA-E9-A1RD-01A-21-A17J-20	TCGA-E9-A1RD-01A-11D-A159-09	TCGA-E9-A1RD-01	TCGA-E9-A1RD-01A-11D-A161-05	ef7d073e-90b6-4d14-bcad-a6d9759122dc	TCGA-E9-A1RD-01	TCGA-E9-A1RD-01A-11D-A159-09			TCGA-E9-A1RD-01	TCGA-E9-A1RD-01A-11D-A159-09		eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16		TCGA-E9-A1RD-01A-11D-A160-01	TCGA-E9-A1RD-01		eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	TCGA-E9-A1RD-01A-11D-A160-01	
TCGA-E9-A1RD-11		67.0			20.0			FEMALE									20.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1RD-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RD	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67.0	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RD-F48702	TCGA-E9-A1RD	TCGA-E9-A1RD-11A								Modified Radical Mastectomy		NO			-24719.0	38.0		0.0	34.0					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	640.0	NO			YES	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0		False	No	M0	N0	T2	Stage IIA		A1RD	TUMOR FREE							YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	000d877f-8d03-44bc-8607-27b5ba84b5fe	000d877f-8d03-44bc-8607-27b5ba84b5fe				TCGA-E9-A1RD-11A-33D-A161-05	738328DA-0CBE-4801-A523-667D56E6A73E					TCGA-E9-A1RD-11			000d877f-8d03-44bc-8607-27b5ba84b5fe			TCGA-E9-A1RD-11		000d877f-8d03-44bc-8607-27b5ba84b5fe		
TCGA-E9-A1RF-01	Stage IIIA	68.0	5.0	Stage IIIA	38.0			FEMALE	Negative				Negative	M0	Positive	N2	38.0	0.0	LumA						enrollment	T_Other	T2	LIVING	TCGA-E9-A1RF-01	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-E9-A1RF	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RF-F48703	TCGA-E9-A1RF	TCGA-E9-A1RF-01A								Modified Radical Mastectomy		NO			-25119.0	56.0		0.0	200.0					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	330.0	NO			YES	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3.0									NO	5.0		True	No	M0	N2	T2	Stage IIIA	TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf	A1RF	TUMOR FREE							YES			YES	Primary Tumor	1		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	502939cc-3381-4bc2-9ae6-332846cf836b	502939cc-3381-4bc2-9ae6-332846cf836b	TCGA-E9-A1RF-01A-21-A17J-20	TCGA-E9-A1RF-01A-11D-A159-09	TCGA-E9-A1RF-01	TCGA-E9-A1RF-01A-11D-A161-05	97534d53-162f-4e78-bf68-a227f1c2ae36	TCGA-E9-A1RF-01	TCGA-E9-A1RF-01A-11D-A159-09			TCGA-E9-A1RF-01	TCGA-E9-A1RF-01A-11D-A159-09		502939cc-3381-4bc2-9ae6-332846cf836b		TCGA-E9-A1RF-01A-11D-A160-01	TCGA-E9-A1RF-01		502939cc-3381-4bc2-9ae6-332846cf836b	TCGA-E9-A1RF-01A-11D-A160-01	
TCGA-E9-A1RF-11		68.0			38.0			FEMALE									38.0	0.0	LumA						enrollment			LIVING	TCGA-E9-A1RF-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1RF	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RF-F48703	TCGA-E9-A1RF	TCGA-E9-A1RF-11A								Modified Radical Mastectomy		NO			-25119.0	56.0		0.0	200.0					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	1050.0	NO			YES	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5.0		False	No	M0	N2	T2	Stage IIIA		A1RF	TUMOR FREE							YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	da13db3f-cde6-4e25-9596-009147aa3fa9	da13db3f-cde6-4e25-9596-009147aa3fa9				TCGA-E9-A1RF-11A-32D-A161-05	97627951-60EF-4283-940A-9550114962F1								da13db3f-cde6-4e25-9596-009147aa3fa9					da13db3f-cde6-4e25-9596-009147aa3fa9		
TCGA-E9-A1RH-11		63.0			14.0			FEMALE									14.0	0.0	Normal						enrollment			LIVING	TCGA-E9-A1RH-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RH	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63.0	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RH-F70141	TCGA-E9-A1RH	TCGA-E9-A1RH-11A								Lumpectomy		NO			-23224.0	32.0		0.0	1417.0					NO				Scheduled Follow-up Submission	2015-1-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	720.0	NO			NO	10.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0		False	No	M0	N0	T2	Stage IIA		A1RH	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	6574e15e-7e1f-4dca-899e-56e911f27848	6574e15e-7e1f-4dca-899e-56e911f27848				TCGA-E9-A1RH-11A-34D-A16A-05	ABDD9B9C-278F-4077-BB4F-5B890D7E58C7					TCGA-E9-A1RH-11			6574e15e-7e1f-4dca-899e-56e911f27848			TCGA-E9-A1RH-11		6574e15e-7e1f-4dca-899e-56e911f27848		
TCGA-E9-A1RI-11		43.0			48.0			FEMALE									48.0	0.0	LumA						enrollment			LIVING	TCGA-E9-A1RI-11		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RI	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43.0	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RI-F70144	TCGA-E9-A1RI	TCGA-E9-A1RI-11A								Modified Radical Mastectomy		NO			-15942.0	64.0		0.0	1449.0					NO				Scheduled Follow-up Submission	2015-1-28	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	800.0	NO			NO	10.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	5.0		False	No	M0	N2	T1c	Stage IIIA		A1RI	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011.0	7391b882-0be5-45b0-aa01-43c3381a476d	7391b882-0be5-45b0-aa01-43c3381a476d				TCGA-E9-A1RI-11A-41D-A16A-05	21E8CC9D-962D-4FA5-9814-8134FFA59C51								7391b882-0be5-45b0-aa01-43c3381a476d					7391b882-0be5-45b0-aa01-43c3381a476d		
TCGA-E9-A54X-01																													TCGA-E9-A54X-01										TCGA-E9-A54X	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					85.0	Left|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A54X-F66449	TCGA-E9-A54X	TCGA-E9-A54X-01A		Positive		3+			Positive	Lumpectomy		NO			-31173.0	78.0		0.0	727.0							90-99%			2014-10-15	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9	3+	YES		Core needle biopsy	220.0	NO	Negative		NO	2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0		True	No	M0	N0 (i-)	T1b	Stage IA	TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf	A54X	TUMOR FREE						NO	YES	90-99%		NO	Primary Tumor	1		7th		YES	NO	E9	Breast	A	LIVING	2012.0	fc36b662-fabd-4caa-81f7-00fe0a3164a6	fc36b662-fabd-4caa-81f7-00fe0a3164a6			TCGA-E9-A54X-01	TCGA-E9-A54X-01A-11D-A268-05	4168faaa-8df8-48b5-a9cb-86932b2a0ffe	TCGA-E9-A54X-01	TCGA-E9-A54X-01A-11D-A25Q-09			TCGA-E9-A54X-01			fc36b662-fabd-4caa-81f7-00fe0a3164a6		TCGA-E9-A54X-01A-11D-A25N-01	TCGA-E9-A54X-01		fc36b662-fabd-4caa-81f7-00fe0a3164a6	TCGA-E9-A54X-01A-11D-A25N-01	
TCGA-E9-A5UO-01																													TCGA-E9-A5UO-01										TCGA-E9-A5UO	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5UO-F70210	TCGA-E9-A5UO	TCGA-E9-A5UO-01A								Other		NO			-15050.0	98.0		0.0	785.0										2015-1-30	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	400.0	NO			NO	10.0	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0.0		True	No	M0	N0	T2	Stage IIA	TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf	A5UO	TUMOR FREE						NO	YES			NO	Primary Tumor	1	Partial mastectomy	7th		YES	NO	E9	Breast	A	LIVING	2012.0	4d601c2f-824f-461e-9270-42db0ab9138e	4d601c2f-824f-461e-9270-42db0ab9138e			TCGA-E9-A5UO-01	TCGA-E9-A5UO-01A-11D-A28C-05	9efb2dc7-5c0d-459f-9819-f1ca46df5bb0	TCGA-E9-A5UO-01	TCGA-E9-A5UO-01A-11D-A28B-09			TCGA-E9-A5UO-01			4d601c2f-824f-461e-9270-42db0ab9138e		TCGA-E9-A5UO-01A-11D-A28A-01	TCGA-E9-A5UO-01		4d601c2f-824f-461e-9270-42db0ab9138e	TCGA-E9-A5UO-01A-11D-A28A-01	
TCGA-EW-A1P1-01	Stage IIIC	68.0	1.0	Stage IIIC	919.0		Negative	FEMALE	Negative				Negative	M0	Positive	N3	919.0	0.0			Negative				enrollment	T_Other	T2	LIVING	TCGA-EW-A1P1-01	Kirc+	C5-KIRC	cluster 1	Low purity c2	KIRC-like c1		miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-EW-A1P1	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	YES		68.0	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P1-F29115	TCGA-EW-A1P1	TCGA-EW-A1P1-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO		1200.0	-24923.0	850.0		0.0	1210.0			1014		YES		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		2+			1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200.0	NO	Equivocal	Negative		32.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal	1+		Negative	<10%		<10%							<10%		Negative	Lung		1.0	6.0				Lung	Distant Metastasis			YES	11.0		True	No	MX	N3b	T2	Stage IIIC	TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf	A1P1	TUMOR FREE							YES	<10%		YES	Primary Tumor	1		6th	YES	NO	YES	EW	Breast	A	LIVING	2008.0	8a430d45-6511-4900-954e-fd01106d0f22	8a430d45-6511-4900-954e-fd01106d0f22	TCGA-EW-A1P1-01A-21-A17J-20	TCGA-EW-A1P1-01A-31D-A14G-09	TCGA-EW-A1P1-01	TCGA-EW-A1P1-01A-31D-A14H-05	3d649ce7-95df-442d-a4bb-88e71c4f5b10	TCGA-EW-A1P1-01	TCGA-EW-A1P1-01A-31D-A14G-09			TCGA-EW-A1P1-01	TCGA-EW-A1P1-01A-31D-A14G-09		8a430d45-6511-4900-954e-fd01106d0f22		TCGA-EW-A1P1-01A-31D-A14F-01	TCGA-EW-A1P1-01		8a430d45-6511-4900-954e-fd01106d0f22	TCGA-EW-A1P1-01A-31D-A14F-01	
TCGA-EW-A6SA-01																													TCGA-EW-A6SA-01										TCGA-EW-A6SA	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59.0	Left|Left Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-EW-A6SA	TCGA-EW-A6SA-01A		Positive					Negative	Simple Mastectomy		YES			-21623.0	152.0		0.0	510.0							50-59%			2015-2-27	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80.0	NO	Negative			4.0	Negative																														NO		1.0	True	No	MX	N0 (i+)	T2	Stage II	TCGA-EW-A6SA.9C971870-BA92-4E0C-9861-31C56B7E7D64.pdf	A6SA	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		YES	NO	EW	Breast	A	LIVING	2013.0	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168			TCGA-EW-A6SA-01	TCGA-EW-A6SA-01A-21D-A32T-05	3C4C4A1F-544E-4CB5-A1E8-50534496B737	TCGA-EW-A6SA-01				TCGA-EW-A6SA-01			2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168		TCGA-EW-A6SA-01A-21D-A32H-01	TCGA-EW-A6SA-01		2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	TCGA-EW-A6SA-01A-21D-A32H-01	
TCGA-GI-A2C8-11																			LumA										TCGA-GI-A2C8-11		C3-BRCA/Luminal							mutation c1uster 9	TCGA-GI-A2C8	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63.0	Right	Sentinel node biopsy alone		TCGA-GI-A2C8-F21661	TCGA-GI-A2C8	TCGA-GI-A2C8-11A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-23103.0	2429.0		0.0	225.0					NO		90-99%		Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9	3+	YES			100.0	NO	Negative	Negative		10.0	Negative																														NO	0.0		False	No	MX	N0	T4b	Stage IIIB		A2C8								YES	<10%		YES	Solid Tissue Normal	11		6th	YES	NO	YES	GI	Breast	A	LIVING	2004.0	6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7	6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7													6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7					6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7		
TCGA-GI-A2C9-11																			Normal										TCGA-GI-A2C9-11		C4-BRCA/Basal								TCGA-GI-A2C9	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58.0	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-GI-A2C9-F21663	TCGA-GI-A2C9	TCGA-GI-A2C9-11A		Negative					Negative	Lumpectomy		YES			-21534.0	2979.0		0.0	3342.0					NO				Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120.0	NO	Negative			4.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	False	No	MX	N0	T3	Stage IIB		A2C9	TUMOR FREE							YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	GI	Breast	A	LIVING	2003.0	69a8b5fd-7ca6-49d7-b16a-2beba16e40b1	69a8b5fd-7ca6-49d7-b16a-2beba16e40b1										TCGA-GI-A2C9-11			69a8b5fd-7ca6-49d7-b16a-2beba16e40b1			TCGA-GI-A2C9-11		69a8b5fd-7ca6-49d7-b16a-2beba16e40b1		
TCGA-GM-A2DD-01		53.0			1309.0		Negative	FEMALE									1309.0	0.0	Normal		Negative				enrollment			LIVING	TCGA-GM-A2DD-01	High	C3-BRCA/Luminal		BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DD	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53.0	Right	Sentinel node biopsy alone		TCGA-GM-A2DD-F47070	TCGA-GM-A2DD			Negative					Negative	Simple Mastectomy		YES			-19415.0			0.0	2282.0					NO		<10%	1.45		2013-8-22	FEMALE			<10%		2+	60.0	1.62	1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0		Yes	M0	N0 (i-)	T1c	Stage I		A2DD	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	1		6th		NO	YES	GM	Breast		LIVING	2007.0	ddc6e148-34b7-4466-b692-3bb227004e2b	ddc6e148-34b7-4466-b692-3bb227004e2b	TCGA-GM-A2DD-01A-21-A24A-20		TCGA-GM-A2DD-01	TCGA-GM-A2DD-01A-11D-A17Z-05	cf5d72b5-6d47-450b-90e3-8ffe9e291e75	TCGA-GM-A2DD-01	TCGA-GM-A2DD-01A-11D-A17W-09			TCGA-GM-A2DD-01			ddc6e148-34b7-4466-b692-3bb227004e2b		TCGA-GM-A2DD-01A-11D-A17U-01	TCGA-GM-A2DD-01		ddc6e148-34b7-4466-b692-3bb227004e2b	TCGA-GM-A2DD-01A-11D-A17U-01	
TCGA-JL-A3YX-01																													TCGA-JL-A3YX-01					KIRC-like c1		miRNA cluster 4			TCGA-JL-A3YX	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46.0	Left	Axillary lymph node dissection alone			TCGA-JL-A3YX	TCGA-JL-A3YX-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy						306.0		0.0	352.0							30-39%			2012-11-8	FEMALE			30-39%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Tumor resection	900.0	NO	Positive			16.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	False	No	M0	N0	T2	Stage IIA	TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237.pdf	A3YX							NO	YES	30-39%		NO	Primary Tumor	1		7th		YES	NO	JL	Breast	A	LIVING	2011.0	b2b92b23-3f2a-4305-8c6c-27c91c67c072	b2b92b23-3f2a-4305-8c6c-27c91c67c072	TCGA-JL-A3YX-01A-21-A24B-20		TCGA-JL-A3YX-01	TCGA-JL-A3YX-01A-11D-A230-05	28195fde-9084-494d-9b76-a65c7fe11ba9	TCGA-JL-A3YX-01	TCGA-JL-A3YX-01A-11D-A22X-09			TCGA-JL-A3YX-01			b2b92b23-3f2a-4305-8c6c-27c91c67c072		TCGA-JL-A3YX-01A-11D-A22W-01	TCGA-JL-A3YX-01		b2b92b23-3f2a-4305-8c6c-27c91c67c072	TCGA-JL-A3YX-01A-11D-A22W-01	
TCGA-LL-A50Y-01																													TCGA-LL-A50Y-01										TCGA-LL-A50Y	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84.0	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A50Y-F50406	TCGA-LL-A50Y	TCGA-LL-A50Y-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-30934.0	91.0		0.0	762.0							90-99%	2.5		2013-10-23	FEMALE					2+	167.0	2.6	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130.0	NO	Equivocal	Negative	NO	8.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	0.0	False	Yes	MX	N0	T2	Stage IIA	TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf	A50Y	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	1		7th		YES	NO	LL	Breast	A	LIVING	2012.0	02a65cb0-158c-478b-b72e-d6bae04429c7	02a65cb0-158c-478b-b72e-d6bae04429c7			TCGA-LL-A50Y-01	TCGA-LL-A50Y-01A-11D-A268-05	acabe392-7b49-4967-90b5-81ac53cfec8e	TCGA-LL-A50Y-01	TCGA-LL-A50Y-01A-11D-A25Q-09			TCGA-LL-A50Y-01			02a65cb0-158c-478b-b72e-d6bae04429c7		TCGA-LL-A50Y-01A-11D-A25N-01	TCGA-LL-A50Y-01		02a65cb0-158c-478b-b72e-d6bae04429c7	TCGA-LL-A50Y-01A-11D-A25N-01	
TCGA-LL-A7T0-01																													TCGA-LL-A7T0-01										TCGA-LL-A7T0	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70.0	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-LL-A7T0-F64970	TCGA-LL-A7T0	TCGA-LL-A7T0-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		NO			-25867.0	70.0		0.0	376.0							90-99%			2014-9-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	380.0	NO	Positive		NO	4.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1.0		False	No	M0	N1a	T2	Stage IIB	TCGA-LL-A7T0.5540DD9C-FA3F-48B6-8243-414616816A76.pdf	A7T0	TUMOR FREE						NO	YES	<10%		NO	Primary Tumor	1		7th		YES	NO	LL	Breast	A	LIVING	2013.0	67e967d6-be17-4fe1-a1fb-197655fad18d	67e967d6-be17-4fe1-a1fb-197655fad18d			TCGA-LL-A7T0-01	TCGA-LL-A7T0-01A-31D-A357-05		TCGA-LL-A7T0-01				TCGA-LL-A7T0-01			67e967d6-be17-4fe1-a1fb-197655fad18d		TCGA-LL-A7T0-01A-31D-A350-01	TCGA-LL-A7T0-01		67e967d6-be17-4fe1-a1fb-197655fad18d	TCGA-LL-A7T0-01A-31D-A350-01	
TCGA-OL-A5D6-01																													TCGA-OL-A5D6-01										TCGA-OL-A5D6	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71.0	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5D6-F55437	TCGA-OL-A5D6	TCGA-OL-A5D6-01A		Negative					Negative	Simple Mastectomy					-26052.0	1378.0	1104.0	0.0	385.0										2014-1-10	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200.0	NO		Negative	NO	2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO		0.0	True	No	MX	N0	T2	Stage IIA	TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf	A5D6	TUMOR FREE						YES	YES			NO	Primary Tumor	1		6th		NO	YES	OL	Breast	A	DECEASED	2009.0	5657c6b6-ba04-4dd8-8623-2a3834820f7d	5657c6b6-ba04-4dd8-8623-2a3834820f7d			TCGA-OL-A5D6-01	TCGA-OL-A5D6-01A-21D-A27Y-05		TCGA-OL-A5D6-01	TCGA-OL-A5D6-01A-21D-A27P-09			TCGA-OL-A5D6-01			5657c6b6-ba04-4dd8-8623-2a3834820f7d		TCGA-OL-A5D6-01A-21D-A27O-01	TCGA-OL-A5D6-01		5657c6b6-ba04-4dd8-8623-2a3834820f7d	TCGA-OL-A5D6-01A-21D-A27O-01	
TCGA-S3-AA17-01																													TCGA-S3-AA17-01										TCGA-S3-AA17	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64.0	Right|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-S3-AA17-F67708	TCGA-S3-AA17	TCGA-S3-AA17-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		YES			-23642.0	92.0		0.0	424.0						CAP SCORING GUIDELINE 2010	90-99%	35		2014-11-11	FEMALE		CAP SCORING GUIDELINE 2010		CAP SCORING GUIDELINE 2010	2+	20.0	61	1.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	520.0	NO	Equivocal	Negative	NO	2.0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0.0	1.0	True	Yes	cM0 (i+)	N1mi	T2	Stage IIB	TCGA-S3-AA17.D7E24E6B-797F-4FC9-B0FB-794C4D379091.pdf	AA17	TUMOR FREE	CAP SCORING GUIDELINE 2010			MODERATE	STRONG	YES	YES	70-79%		YES	Primary Tumor	1		7th		YES	NO	S3	Breast	A	LIVING	2013.0	5e032694-2d7f-4e11-8800-0451ff71e5fe	5e032694-2d7f-4e11-8800-0451ff71e5fe			TCGA-S3-AA17-01	TCGA-S3-AA17-01A-11D-A41Q-05	6D0969F0-27F9-4FF0-B943-F4F4510F917D	TCGA-S3-AA17-01				TCGA-S3-AA17-01			5e032694-2d7f-4e11-8800-0451ff71e5fe		TCGA-S3-AA17-01A-11D-A41E-01	TCGA-S3-AA17-01		5e032694-2d7f-4e11-8800-0451ff71e5fe	TCGA-S3-AA17-01A-11D-A41E-01	
TCGA-Z7-A8R5-01																													TCGA-Z7-A8R5-01										TCGA-Z7-A8R5	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61.0	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-Z7-A8R5-F58763	TCGA-Z7-A8R5	TCGA-Z7-A8R5-01A		Positive	4 Point Scale	1+	4 Point Scale		Positive	Other		YES			-22280.0	2928.0		0.0	3287.0			3287							2014-7-9	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	450.0	NO	Negative		NO	5.0	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Bone	Locoregional Recurrence			YES	3.0	3.0	True	Yes	MX	N1a	T3	Stage IIIA	TCGA-Z7-A8R5.7726F7AA-88A8-4DD6-B322-6FC68893E0D2.pdf	A8R5	WITH TUMOR						YES	YES			NO	Primary Tumor	1	Segmental Mastectomy	6th		NO	YES	Z7	Breast	A	LIVING	2005.0	43c6d23b-2fcd-499e-82ef-10f15d8ede90	43c6d23b-2fcd-499e-82ef-10f15d8ede90			TCGA-Z7-A8R5-01	TCGA-Z7-A8R5-01A-42D-A41Q-05	049AE25E-31B6-4E0D-B67F-08B7034BF093	TCGA-Z7-A8R5-01				TCGA-Z7-A8R5-01			43c6d23b-2fcd-499e-82ef-10f15d8ede90		TCGA-Z7-A8R5-01A-42D-A41E-01	TCGA-Z7-A8R5-01		43c6d23b-2fcd-499e-82ef-10f15d8ede90	TCGA-Z7-A8R5-01A-42D-A41E-01	
